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ABSTRACT	  
	  
	   RNA	  sequencing	  (RNA-­‐seq)	  is	  one	  of	  the	  most	  common	  technologies	  in	  use	  today	  for	  the	  analysis	  of	  gene	  expression	  and	  transcriptome	  variation	   in	  biological	  samples	  (Zhong	  Wang	   et	   al.	   2009).	   As	   of	   2011,	   the	   NCBI	   Sequence	   Read	   Archive	   (SRA)	   surpassed	   100	  terabases	  of	   sequence	  data,	   comprising	  nearly	  40,000	  RNA	  and	  260,000	  DNA	  sequencing	  projects.	  In	  2013	  the	  SRA	  comprises	  over	  500	  terabases,	  with	  a	  projected	  doubling	  time	  of	  22.3	   months.	   The	   explosive	   growth	   of	   next-­‐generation	   sequence	   data	   now	   exceeds	   the	  growth	  rate	  of	  storage	  capacity	  (Kodama	  et	  al.	  2012).	  Researchers’	  ability	   to	  process	  and	  analyze	   this	   data	   depends	   upon	   bioinformatics	   tools	   that	   are	   accurate,	   easy	   to	   use,	   and	  fast—especially	   when	   multiple	   data	   sets	   are	   available	   for	   processing	   and	   additional	  analysis	  beyond	  standard	  mapping	  is	  required.	  To	  address	  these	  issues	  I	  have	  developed	  SNAP-­‐RNA,	  a	  new	  RNA-­‐seq	  alignment	  and	  analysis	   pipeline	   designed	   for	   datasets	   involving	   hundreds	   or	   thousands	   of	   RNA-­‐seq	  libraries,	   while	   maintaining	   high	   alignment	   accuracy.	   SNAP-­‐RNA	   is	   capable	   of	   natively	  reading	  from	  FASTQ,	  gzipped	  FASTQ,	  SAM,	  and	  BAM	  formats,	  and	  directly	  writing	  to	  BAM	  and	   sorted	   BAM	   formats	   for	   immediate	   visualization,	   without	   any	   need	   for	   external	  software	  packages	  such	  as	  SAMtools	  (Heng	  Li	  et	  al.	  2009).	  Quality	  filtering	  of	  input	  reads	  is	  incorporated	  directly	  into	  the	  alignment	  process.	  SNAP-­‐RNA	  can	  automatically	  identify	  and	  report	  contaminants	  or	  viral/bacterial	  infections	  in	  samples,	  and	  gene	  read	  counts	  suitable	  for	   downstream	   analysis	   with	   popular	   statistical	   programs	   such	   as	   DESeq	   (Anders	   and	  Huber	   2010),	   edgeR	   (Robinson	   et	   al.	   2010),	   or	   baySeq	   (Hardcastle	   and	   Kelly	   2010)	   are	  automatically	   generated	   with	   no	   running	   time	   penalty.	   Finally,	   SNAP-­‐RNA	   automatically	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identifies	   intra-­‐	   and	   inter-­‐chromosomal	   gene	   fusions	   with	   high	   accuracy,	   reporting	   the	  results	   automatically,	   while	   maintaining	   speeds	   competitive	   with	   the	   fastest	   available	  aligners.	   I	  demonstrate	  the	  capabilities	  of	  SNAP-­‐RNA	  through	  the	  analysis	  of	  nearly	  1300	  high-­‐quality	  RNA-­‐seq	  samples	  from	  several	  different	  cancer	  types	  derived	  from	  The	  Cancer	  Genome	  Atlas,	  using	  recently	  published	  studies	  as	  my	  benchmarks.	  Recent	  developments	   in	  next-­‐generation	  sequencing	  have	  revealed	  unprecedented	  levels	   of	   RNA	   editing	   of	   expressed	   transcripts,	   the	  majority	   of	  which	   occur	   in	   the	   brain.	  Alterations	   in	   transcript	  editing	   levels	  are	   increasing	  being	   linked	  to	  pathology	   in	  human	  cancer.	   Using	   a	   novel	   RNA	   editing	   analysis	   pipeline	   enabled	   by	   SNAP-­‐RNA	   I	   have	  characterized	   changes	   in	   A-­‐to-­‐I	   editing	   percentages	   in	   nearly	   400	   glioblastoma	   and	  astrocytoma	  primary	  tumor,	  normal	  brain,	  and	  cell	  line	  samples.	  This	  study	  represents	  the	  first	   global	   view	   of	   differential	   editing	   across	  multiple	   brain	   regions	   and	   low-­‐	   and	   high-­‐grade	   astrocytoma.	   I	   identify	   relationships	   between	   expression	   of	   the	   editing	   enzymes	  
ADAR,	  ADARB1,	  and	  ADARB2	  and	  editing	  profiles	  in	  both	  healthy	  and	  diseased	  states	  of	  the	  brain.	   Furthermore,	   I	   identify	   many	   differentially	   edited	   bases	   across	   normal	   brain	   and	  gliomas	   that	   have	   not	   previously	   been	   characterized.	   My	   results	   highlight	   biologically	  relevant	  editing	  events	  that	  may	  contribute	  to	  astrocytoma	  pathology.	  As	  next-­‐generation	  RNA	  sequencing	  technology	  has	  become	  ubiquitous,	  researchers	  have	  sought	  to	  use	  this	  expression	  data	  to	  identify	  distinct	  gene	  relationships	  that	  classify	  disease	  states,	  allowing	  for	  accurate	  diagnosis	  of	  diseases	  given	  the	  expression	  patterns	  of	  a	  few	  genes.	  Such	  methods	  include	  support	  vector	  machines	  (Brown	  et	  al.	  2000),	  decision	  trees	   (Zhang	   et	   al.	   2003),	   and	   neural	   networks	   (Khan	   et	   al.	   2001).	   The	   top-­‐scoring	   pair	  (TSP)	  and	  the	  top-­‐scoring	  triplet	  (TST)	  algorithms	  have	  demonstrated	  similar	  accuracies	  to	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these	  methods	  while	   remaining	   relatively	   simple,	   resistant	   to	   overfitting,	   and	   consistent	  across	  data	  normalization	  methods	  (Geman	  et	  al.	  2004;	  Tan	  et	  al.	  2005;	  Price	  et	  al.	  2007;	  Lin	   et	   al.	   2009).	  Despite	   these	   advantages,	   the	  TSP	   and	   especially	   the	  TST	   algorithm	  are	  computationally	   intensive	   and	   therefore	   slow.	   The	   graphics	   processing	   unit	   (GPU)	   is	  increasingly	   applied	   to	   computationally-­‐challenging	   scientific	   problems	   including	  molecular	  dynamics	  simulations	  (John	  E	  Stone	  et	  al.	  2010)	  and	  medical	  imaging	  (S	  S	  Stone	  et	   al.	   2008).	   The	   GPU	   is	   designed	   for	   massive	   parallelism	   involving	   thousands	   of	  simultaneous	   executing	   threads,	   but	   requires	   different	   coding	   than	   that	   which	   runs	   on	  CPUs.	   I	  have	  implemented	  both	  the	  TSP	  and	  the	  TST	  algorithm	  on	  the	  GPU,	  resulting	   in	  a	  dramatic	   speedup	   of	   two	   orders	   of	   magnitude,	   greatly	   increasing	   the	   searchable	  combinations	  and	  accelerating	  the	  pace	  of	  discovery.	  	  	  In	   addition	   to	   acceleration	   of	   existing	   relative	   expression	   classifiers,	   I	   have	  developed	  a	  new	  classifier	  called	  the	  top-­‐scoring	  ‘N’	  algorithm	  (TSN).	  TSN	  is	  a	  generalized	  form	   of	   relative	   expression	   algorithm	   that	   uses	   generic	   permutations	   and	   a	   dynamic	  classifier	   size	   to	   control	   both	   the	   permutation	   and	   combination	   space	   available	   for	  classification.	  TSN	  performs	  competitively	  against	  a	  wide	  variety	  of	  different	  classification	  methods	   while	   exhibiting	   low	   levels	   of	   overfitting	   on	   training	   data	   compared	   to	   other	  methods,	   giving	   confidence	   that	   results	   obtained	   during	   cross-­‐validation	   will	   be	   more	  generally	   applicable	   to	   external	   validation	   sets.	   TSN	   preserves	   the	   strengths	   of	   other	  relative	  expression	  algorithms	  while	  allowing	  a	  much	  larger	  permutation	  and	  combination	  space	  to	  be	  explored,	  potentially	  improving	  classification	  accuracies	  when	  fewer	  numbers	  of	  measured	  features	  are	  available.	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CHAPTER	  1:	  INTRODUCTION	  
Next-­‐generation	  RNA	  sequencing	  	  Early	   studies	   of	   quantitative	   transcriptomics	   relied	   on	  microarray	   technology,	  which	  consists	  of	  short	  oligonucleotide	  probes	  that	  hybridize	  to	  complementary	  sequences	  from	  a	  fluorescently-­‐labeled	  RNA	  or	  cDNA	  library	  (Allison	  et	  al.	  2006).	  Upon	  laser	  stimulation,	  the	  amount	   of	   fluorescence	   per	   probe	   quantitatively	   reflects	   the	   presence	   of	   a	   particular	  transcript	   fragment	   in	   a	   sample.	   One	   major	   limitation	   of	   this	   technology	   consists	   of	   its	  reliance	   upon	   prior	   knowledge	   of	   genes	   for	   accurate	   probe	   design.	   Additionally,	  microarrays	   suffer	   from	   limited	   dynamic	   range	   and	   cross-­‐hybridization	   issues	   that	   may	  distort	   the	  quantitative	  measurements	  of	  gene	  expression	   (Okoniewski	  and	  Miller	  2006).	  	  The	   alternative	   to	   probe-­‐based	   interrogations	   of	   gene	   expression	   is	   direct	   sequencing	   of	  cDNA	   libraries	   or	   expressed	   sequence	   tags	   (ESTs)	   (Gerhard	   et	   al.	   2004).	   Initial	   studies	  made	  use	  of	  Sanger	  sequencing	  technology,	  which	  suffers	  from	  low	  coverage	  and	  remains	  too	   expensive	   to	   be	   broadly	   applied	   (Metzker	   2005).	   Next-­‐generation	   RNA	   sequencing	  (RNA-­‐seq),	  in	  contrast,	  provides	  high-­‐throughput	  and	  high	  coverage	  of	  a	  cDNA	  library	  at	  an	  ever-­‐decreasing	  cost	  (Metzker	  2009).	  There	  are	  several	  technologies	  available	  for	  RNA-­‐seq,	  of	   which	   the	   most	   commonly	   used	   today	   is	   IlluminaTM.	   The	   largest	   public	   repository	   of	  next-­‐generation	   sequencing	   data	   is	   the	   NCBI	   Sequence	   Read	   Archive	   (SRA).	   As	   of	   2011,	  84%	   of	   the	   data	   in	   the	   SRA	   was	   derived	   from	   the	   IlluminaTM	   platform.	   ABI	   SOLiDTM	  technology,	   the	   next	  most	   common	   platform,	   consists	   of	   12%	  of	   the	   SRA	   (Kodama	   et	   al.	  2012).	   The	   output	   of	   short	   read	   sequencers	   using	   IlluminaTM	   or	   SOLiDTM	   technology	  consists	  of	  billions	  of	  short	  sequences,	  a	  few	  dozen	  to	  a	  few	  hundred	  nucleotides	  in	  length.	  These	  short	  reads	  can	  either	  be	  aligned	  directly	  to	  a	  sequenced	  genome,	  or	  assembled	  into	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short	  contigs	  prior	  to	  alignment.	  The	  emergence	  of	  short	  read	  sequencing	  brought	  the	  read	  mapping	  problem	  to	  the	  forefront	  of	  computational	  biology	  research.	  	  	  	   Computer	  algorithms	  for	  pairwise	  sequence	  comparisons	  have	  existed	  for	  decades,	  most	  famously	  Needleman-­‐Wunsch,	  (Needleman	  and	  Wunsch	  1970),	  Smith-­‐Waterman	  (T	  F	  Smith	  and	  Waterman	  1981),	  and	  the	  basic	  local	  alignment	  search	  tool	  (BLAST)	  (Altschul	  et	  al.	   1990).	   These	   algorithms	   have	   generally	   been	   used	   for	   identifying	   homologous	  relationships	   between	   relatively	   long	   nucleotide	   and	   protein	   sequences.	   Although	   the	  heuristic-­‐based	  BLAST	  represented	  a	  significant	  speed	  increase	  over	  the	  optimal	  dynamic	  programming	   approaches	   of	   Needleman-­‐Wunsch	   and	   Smith-­‐Waterman,	   none	   of	   these	  algorithms	  were	  designed	  to	  efficiently	  align	  billions	  of	  short	  sequences	  to	  a	  much	  longer	  reference	  such	  as	  an	  assembled	  genome.	  Dozens	  of	  algorithms	  have	  since	  been	  developed	  to	  address	  this	  short	  read	  mapping	  problem,	  including	  but	  not	  limited	  to	  SOAP	  (Ruiqiang	  Li	  et	  al.	  2008),	  MAQ	  (Heng	  Li	  et	  al.	  2008),	  RMAP	  (Andrew	  D	  Smith	  et	  al.	  2008),	  BWA	  (Heng	  Li	  and	  Durbin	  2009),	  SOAP2	  (Ruiqiang	  Li	  et	  al.	  2009),	  Bowtie	  (Langmead	  et	  al.	  2009),	  BFAST	  (Homer	   et	   al.	   2009),	   Bowtie2	   (Langmead	   and	   Salzberg	   2012),	   and	   Subread	   (Liao	   et	   al.	  2013).	   Generally,	   these	   algorithms	   fall	   into	   one	   of	   two	   primary	   categories:	   k-­‐mer	   hash	  tables	  and	  prefix/suffix	  tries.	  	  The	  hash	  table	  is	  an	  associative	  array	  that	  maps	  keys	  to	  values,	  where	  the	  value	  of	  a	  query	  is	  retrieved	  using	  a	  numeric	  or	  alphabetic	  key	  converted	  into	  a	  numeric	  array	  index	  using	  a	  hashing	  algorithm	  (McKenzie	  et	  al.	  1990).	  Genome	  hash	  tables	  consist	  of	  short	  k-­‐mers	   or	   ‘seeds’	   of	   the	   genome	   as	   the	   keys,	   with	   the	   value	   of	   the	   key/value	   pair	   as	   the	  genomic	   coordinate	   or	   coordinates	   of	   each	   particular	   seed.	   Well-­‐structured	   hash	   tables	  exhibit	  an	  average	  time	  complexity	  of	  O(1),	  enabling	  insertions,	  deletions,	  and	  query	  times	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independent	  of	  the	  size	  of	  the	  genome	  used	  to	  build	  the	  hash	  table.	  To	  ensure	  the	  efficiency	  of	   the	   data	   structure,	   it	   is	   desirable	   that	   the	   hash	   function	   produce	   as	   few	   collisions	   as	  possible,	  in	  which	  different	  keys	  map	  to	  the	  same	  index	  value.	  In	  other	  words,	  while	  a	  hash	  function	  must	  produce	  the	  same	  index	  given	  two	  identical	  keys,	  a	  good	  hash	  function	  will	  generate	  highly	  divergent	  indices	  from	  highly	  similar,	  though	  not	  identical,	  input	  keys.	  This	  property	   is	   both	   a	   strength	   and	   a	   weakness	   for	   short	   read	   aligners:	   while	   it	   ensures	  efficient	   hash	   queries	   it	   disallows	  mismatches	   of	   any	   kind	   in	   the	   query	   seeds.	   Standard	  hash	  tables	  therefore	  cannot	  directly	  account	  for	  any	  mismatches	  between	  short	  reads	  and	  the	   reference	   genome,	   as	   might	   arise	   from	   single	   nucleotide	   variants	   (SNVs),	  insertions/deletions	   (indels),	   RNA	   editing,	   or	   sequencing	   error.	   As	   a	   result,	   some	   hash	  table-­‐based	   short	   read	   aligners	   rely	   on	   each	   input	   read	   contributing	   at	   least	   one	   perfect	  seed	  match	  to	  the	  reference	  genome,	  narrowing	  down	  the	  possible	  search	  space,	  followed	  by	   a	  more	   traditional	   local	   alignment	   to	   identify	   the	   correct	   position.	   Alternatively,	   seed	  
templates	   may	   be	   used,	   which	   allow	   only	   certain	   positions	   in	   a	   seed	   to	   contribute	   to	   a	  match	  (Ma	  et	  al.	  2002).	  The	  choice	  of	  seed	  length	  can	  be	  of	  critical	  importance	  and	  depends	  largely	  on	   read	   length	  and	   sequencing	   fidelity:	  while	   longer	   seeds	  produce	   fewer	  unique	  hits,	   speeding	  up	   the	  search	  per	  seed,	   shorter	  seeds	  are	   less	   likely	   to	  contain	  sequencing	  errors	  or	  SNPs,	  potentially	  reducing	  the	  number	  of	  seed	  queries	  required	  to	  find	  the	  correct	  match	  for	  that	  read.	  SOAP,	  MAQ,	  RMAP,	  BFAST,	  and	  Subread	  fall	  into	  the	  k-­‐mer	  hash	  table	  category.	  	  The	  other	  major	   category	  of	   short	   read	  aligner	  are	   those	  designed	  using	  prefix	  or	  suffix	   tries.	   A	   trie,	   short	   for	   retrieval,	   is	   a	   data	   structure	   that	   stores	   all	   the	   symbols	   of	   a	  particular	   string	   in	   a	   tree-­‐like	   structure	   that	   can	   be	   efficiently	   searched	   for	   any	   possible	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substring.	  Beginning	  at	  the	  root	  node	  of	  a	  genome	  suffix	  trie	  the	  algorithm	  iterates	  through	  the	   query	   string	   one	   character	   at	   a	   time.	   Each	  match	   between	   the	   query	   string	   and	   the	  reference	   genome	   exists	   as	   an	   edge	   to	   a	   node.	   If	   the	   substring	   exists	   in	   the	   genome,	   a	  continuous	   path	   exists	   through	   the	   trie	   for	   the	   entire	   query	   string.	   Building	   such	   a	   data	  structure	  is	  very	  memory	  intensive,	  in	  the	  worst	  case	  requiring	  O(L2)	  space	  where	  L	  is	  the	  length	  of	  the	  reference	  genome.	  Several	  proposals	  for	  more	  efficient	  space	  usage	  have	  been	  implemented,	   the	  most	  common	  of	  which	   is	   the	  Burrows-­‐Wheeler	   transformation	  (BWT)	  (Burrows	  and	  Wheeler	  1994).	  The	  BWT	  is	  a	  reversible	  permutation	  of	  the	  characters	  in	  a	  text,	  originally	  designed	  to	  improve	  compression	  efficiency	  with	  the	  side	  effect	  that	  it	  also	  reduces	  the	  size	  of	  a	  trie	  required	  to	  represent	  all	  suffixes	  or	  prefixes	  of	  that	  text	  (Ferragina	  and	  Manzini	  2000).	  BWT	  genomes	  can	  be	  stored	  in	  a	  prefix/suffix	  tree	  or	  FM-­‐index	  using	  less	  than	  2	  GB	  of	  memory	  (Langmead	  et	  al.	  2009).	  Querying	  these	  data	  structures	  requires	  O(m)	  time,	  where	  m	  is	  the	  length	  of	  the	  query	  sequence.	  SOAP2,	  BWA,	  Bowtie,	  and	  Bowtie2	  use	  prefix/suffix	  tries	  as	  their	  primary	  data	  structure.	  	   The	   complexity	   of	   the	   transcriptome,	   as	   opposed	   to	   the	   genome,	   presents	   further	  difficulties	   for	   short	   read	   aligners.	   The	   transcriptome	   is	   commonly	   defined	   as	   the	   set	   of	  expressed	  transcripts	  in	  a	  sample,	  or	  less	  commonly,	  the	  set	  of	  annotated	  transcripts	  for	  a	  particular	  genome,	  such	  as	  provided	  by	  RefSeq	  (Pruitt	  et	  al.	  2009)	  or	  Ensembl	  (Flicek	  et	  al.	  2013).	  Bacterial	  RNA-­‐seq	  can	  be	  processed	  using	   traditional	   short	   read	  aligners,	  because	  reads	   align	   contiguously	   to	   the	   genome.	   Eukaryotic	   RNA-­‐seq	   represents	   a	  more	   difficult	  problem	   due	   to	   the	   presence	   of	   RNA	   splicing.	   The	   Smith-­‐Waterman	   and	   Needleman-­‐Wunsch	   dynamic	   programing	   algorithms	   can	   account	   for	   gapped	   local	   and	   global	  alignments,	  respectively,	  using	  a	  set	  of	  gap	  open	  and	  extension	  scoring	  penalties.	  However,	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most	   modern	   short	   read	   aligners	   do	   not	   allow	   for	   noncontiguous	   alignments	   to	   the	  reference	  genome.	  Instead,	  a	  second	  set	  of	  tools	  have	  been	  developed	  that	  make	  use	  of	  the	  speed	  of	  short	  read	  aligners	  to	  find	  initial	  mappings	  while	  adding	  additional	  functionality	  to	   map	   across	   annotated	   splice	   junctions	   and/or	   discover	   novel	   splice	   junctions.	   These	  tools	   include	   QPALMA	   (De	   Bona	   et	   al.	   2008),	   ERANGE	   (Mortazavi	   et	   al.	   2008),	   TopHat	  (Trapnell	   et	   al.	   2009),	   SpliceMap	   (Au	   et	   al.	   2010),	   MapSplice	   (Kai	   Wang	   et	   al.	   2010),	  HMMSplicer	  (Dimon	  et	  al.	  2010),	  SOAPsplice	  (Huang	  et	  al.	  2011),	  RNASEQR	  (Leslie	  Y	  Chen	  et	  al.	  2012),	  TopHat2	  (Kim	  et	  al.	  2013),	  TrueSight	  (Yang	  Li	  et	  al.	  2013),	  Subjunc	  (Liao	  et	  al.	  2013),	  and	  STAR	  (Dobin	  et	  al.	  2013).	  	  As	  expected,	  splice	  junction	  mapping	  tools	  are	  much	  more	  varied	  than	  the	  standard	  genomic	   short	   read	   aligners.	   QPALMA	   extended	   the	   Smith-­‐Waterman	   algorithm	   to	   score	  noncontiguous	   alignments	   based	   on	   canonical	   splice	   sites	   using	   a	   machine	   learning	  approach.	   ERANGE	   aligns	   RNA-­‐seq	   reads	   directly	   to	   the	   genome	   and	   across	   annotated	  splice	  junctions,	  without	  attempting	  to	  find	  novel	  splice	  junctions.	  TopHat	  and	  TopHat2	  use	  Bowtie/Bowtie2	   to	   align	   those	   reads	   completely	   contained	   within	   exons,	   and	   use	   the	  resulting	  ‘islands’	  to	  predict	  novel	  splice	  junctions.	  Initially	  unmapped	  (IUM)	  reads	  are	  split	  into	  segments	  of	  a	  fixed	  size,	  which	  are	  independently	  aligned	  across	  the	  set	  of	  predicted	  splice	   junctions.	   SpliceMap	   independently	  aligns	  each	  half	  of	  an	   IUM	  read,	   restricting	   the	  junction	  search	  to	  the	  canonical	  GT	  donor	  and	  AG	  acceptor	  splice	  features.	  MapSplice	  aligns	  segmented	   IUM	  reads	  without	   requiring	  canonical	   splice	   features	   in	  order	   to	  detect	  non-­‐canonical	  splice	  junctions.	  HMMSplicer	  attempts	  to	  identify	  exon	  boundaries	  using	  hidden	  Markov	   models.	   SOAPSplice	   uses	   a	   similar	   approach	   as	   TopHat	   and	   MapSplice,	   while	  adding	  a	  two-­‐part	  filtering	  strategy	  to	  eliminate	  false	  positives.	  RNASEQR	  aligns	  reads	  first	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to	   the	   annotated	   transcriptome,	   the	   remaining	   unmapped	   reads	   to	   the	   genome,	   and	   the	  final	   set	   of	   unmapped	   reads	   are	   aligned	   with	   gaps	   using	   BLAT	   (Kent	   2002).	   TrueSight	  makes	   use	   of	   the	   segmenting	   strategy	   but	   incorporates	   a	   logistic	   regression	   model	   to	  identify	   the	   most	   probable	   alignment	   out	   of	   a	   set	   of	   alternative	   gapped	   alignments.	  TrueSight	  also	  incorporates	  mapping	  qualities,	  exon	  coding	  potentials,	  and	  canonical	  splice	  features.	   Subjunc	   maps	   k-­‐mer	   seeds	   from	   each	   read	   directly	   to	   the	   genome,	   identifying	  correct	  alignment	  positions	  using	  a	  seed-­‐and-­‐vote	  strategy.	  STAR	  makes	  use	  of	  the	  maximal	  mappable	   seeds	   from	   each	   read,	   rather	   than	   a	   fixed-­‐size	   k-­‐mer,	   to	   align	   noncontiguous	  segments	   directly	   to	   the	   genome.	  While	  many	   alignment	   tools	   sacrifice	   speed	   to	   reduce	  memory	   usage	   (e.g.	   using	   Burrows-­‐Wheeler	   transformations),	   STAR	   leverages	   the	   high	  memory	   capabilities	   of	   modern	   workstations,	   building	   uncompressed	   suffix	   arrays	   to	  vastly	  improve	  mapping	  speed.	  	  	  Once	   RNA-­‐seq	   reads	   have	   been	   successfully	   mapped	   to	   the	   reference	  genome/transcriptome,	   several	   analysis	   options	   are	  possible.	   The	  most	   common	  method	  for	   storing	   read	   alignment	   information	   is	   the	   Sequence	   Alignment/Map	   (SAM)	   and	  accompanying	  Binary	  Alignment/Map	  (BAM)	  formats	  (Heng	  Li	  et	  al.	  2009).	  Most	  short	  read	  aligners	  and	  splice	   junction	  mappers	  output	  directly	   to	  SAM	  format,	   relying	  on	  the	   third-­‐party	   software	   package	   SAMtools	   to	   create	   the	   compressed,	   sorted,	   and	   indexed	   BAM	  format	  suitable	  for	  read	  visualization	  and	  downstream	  analysis.	  BAM	  format	  is	  now	  the	  de	  
facto	   standard	   for	   alignment	   storage	   and	   post-­‐processing,	   although	   the	   largest	   public	  repository	  of	  next-­‐generation	  sequence	  data,	  the	  NCBI	  Sequence	  Read	  Archive	  (Kodama	  et	  al.	   2012)	   as	   well	   as	   the	   controlled-­‐access	   NCBI	   Database	   of	   Genotypes	   and	   Phenotypes	  (dbGaP)	  (Mailman	  et	  al.	  2007),	  has	  adopted	  its	  own	  standard	  SRA	  format.	  The	  other	  major	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repositories	  of	  next-­‐generation	   sequence	  data,	   such	  as	  The	  Cancer	  Genome	  Atlas	   (TCGA)	  from	   NCI	   (http://cancergenome.nih.gov),	   the	   1000	   Genomes	   Project	   (1000	   Genomes	  Project	  Consortium	  et	  al.	  2012),	   the	  European	  Nucleotide	  Archive	  (Cochrane	  et	  al.	  2013),	  and	  ENCODE	  project	  (Rosenbloom	  et	  al.	  2012)	  have	  adopted	  BAM	  for	  storage,	  distribution,	  and	   analysis	   of	   alignment	   data.	   Common	   forms	   of	   downstream	   analysis	   include	   gene	  expression	   quantitation,	   transcript	   isoform	   quantitation,	   gene	   fusion	   identification,	   SNV	  and	  indel	  calling,	  and	  RNA	  editing	  discovery.	  
	  
RNA	  editing	  RNA	  editing	  is	  the	  enzymatic	  modification	  of	  expressed	  transcripts.	  The	  emergence	  of	   RNA-­‐seq	   for	   quantitative	   transcriptomics	   has	   revealed	   unprecedented	   levels	   of	   RNA	  editing	  in	  cells,	  occurring	  in	  expressed	  mRNA	  transcripts	  (Mingyao	  Li	  et	  al.	  2011;	  Carmi	  et	  al.	  2011;	  Bahn	  et	  al.	  2012;	  Peng	  et	  al.	  2012;	  Jin	  Billy	  Li	  et	  al.	  2009).	  The	  Database	  of	  RNA	  Editing	   (DARNED)	   contains	   over	   333,000	   editing	   positions	   in	   the	   hg19	   assembly	   of	   the	  human	   genome	   (Kiran	   et	   al.	   2013).	   Two	   primary	   enzyme	   families	   are	   known	   to	   edit	  transcripts:	  ADARs	  and	  APOBECs.	  The	  ADAR	  family	  of	  enzymes,	  encoded	  by	  genes	  ADAR,	  
ADARB1,	  and	  ADARB2,	  bind	  to	  double-­‐stranded	  RNA	  (dsRNA)	  and	  catalyze	  the	  deamination	  of	   adenosine	   (A)	   to	   inosine	   (I),	   also	   known	   as	   A-­‐to-­‐I	   editing.	   Because	   adenosine	  preferentially	  base	  pairs	  with	  uridine	  and	   inosine	  preferentially	  base	  pairs	  with	   cytosine	  (Vendeix	  et	  al.	  2009;	  Janke	  et	  al.	  2011),	  this	  modification	  introduces	  mismatched	  base	  pairs	  and	   destabilizes	   the	   RNA	   duplex.	   	   As	   more	   adenosines	   in	   the	   duplex	   are	   modified,	  eventually	   the	   duplex	   substrate	   destabilizes	   into	   single-­‐stranded	   RNA	   and	   the	   ADAR	  enzyme	  falls	  off.	  ADARs	  can	  exhibit	  promiscuous	  behavior,	  deaminating	  many	  adenosines	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in	  a	  wide	  range,	  or	  can	  exhibit	  high	  specificity,	  targeting	  a	  specific	  adenosine	  in	  a	  particular	  location.	  The	  level	  of	  specificity	  is	  dependent	  on	  the	  structure	  of	  the	  target	  substrate.	  Very	  stable,	   low	   energy	   dsRNA	   structures	   tend	   to	   be	   highly	   deaminated	   by	  ADARs,	  while	   less	  stable	   duplexes	   containing	   bulges	   or	   other	  mismatches	   are	  more	   selectively	   deaminated	  (Bass	  2002).	  An	  example	  of	  a	  highly	  specific	  deamination	  event	  occurs	  in	  the	  mammalian	  AMPA-­‐selective	   glutamate	   receptor	   family,	   in	   which	   a	   specific	   editing	   event	   by	   ADARB1	  leads	   to	   an	   amino	   acid	   substitution	   of	   glutamine	   to	   arginine	   within	   the	   receptor	   ion	  channel,	  altering	  the	  permeability	  of	  the	  channel	  to	  calcium	  ion	  (Ca2+).	  This	  particular	  non-­‐synonymous	   edit	   is	   essential:	  ADARB1-­‐/-­‐	  mice	  with	   reduced	   or	   absent	   levels	   of	   editing	   at	  this	   location	  experience	  excess	   influx	  of	  Ca2+	   in	  neuronal	  cells	  and	  die	  of	  epilepsy	  shortly	  after	  birth	   (Seeburg	  et	  al.	  2001).	  A-­‐to-­‐I	  editing	   is	  also	  essential	   in	  mammal	  development:	  
ADAR-­‐/-­‐	   mice	   undergo	   liver	   disintegration	   and	   death	   by	   the	   twelfth	   day	   of	   embryonic	  development	  (Hartner	  et	  al.	  2004).	  Although	   there	   are	   many	   examples	   of	   A-­‐to-­‐I	   editing	   occurring	   in	   coding	   regions	  (Bass	  2002),	  the	  majority	  of	  discovered	  A-­‐to-­‐I	  edit	  sites	  occur	  in	  the	  untranslated	  regions	  (UTRs)	  of	  transcripts	  (Mingyao	  Li	  et	  al.	  2011;	  Carmi	  et	  al.	  2011;	  Bahn	  et	  al.	  2012;	  Peng	  et	  al.	  2012;	   Jin	  Billy	  Li	  et	  al.	  2009).	  More	   than	  80%	  of	   these	  UTR	  edits	  are	  associated	  with	  Alu	  elements,	   which	   are	   members	   of	   the	   Short	   Interspersed	   Nuclear	   Element	   (SINE)	   family	  (Batzer	   and	   Deininger	   2002).	   While	   Alu	   elements	   can	   insert	   into	   the	   genome	   in	   any	  direction	  relative	  to	  transcription,	  they	  are	  commonly	  found	  with	  an	  opposite-­‐oriented	  Alu	  element	  nearby.	  These	  pairs	  of	  inverted	  Alu	  elements	  are	  able	  to	  form	  the	  necessary	  dsRNA	  hairpin	  required	  for	  binding	  of	  the	  ADAR	  family	  of	  enzymes	  (Häsler	  and	  Strub	  2006).	  Of	  all	  the	  repetitive	  elements	  existing	  in	  the	  human	  genome,	  Alu	  elements	  are	  the	  most	  common,	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occurring	  in	  over	  1	  million	  copies	  and	  representing	  more	  than	  10%	  of	  the	  entire	  genome	  (Häsler	  and	  Strub	  2006).	  Although	  they	  were	  initially	  dismissed	  as	  self-­‐replicating	  genomic	  parasites,	   Alu	   elements	   have	   been	   observed	   to	   introduce	   regulatory	   elements	   such	   as	  promoters,	   enhancers,	   and	   polyadenylation	   signals	   into	   transcripts	   (Tomilin	   1999).	   In	  addition,	  Alu	  elements	  have	  been	  determined	  to	  be	  probable	  microRNA	  targets	  (Smalheiser	  and	   Torvik	   2006).	   Other	   3’	   UTR	   edits	   occur	   in	   the	   seed	   regions	   of	  miRNA	   binding	   sites,	  which	   can	   enable	   or	   abolish	  microRNA	   binding	   sites	   (Borchert	   et	   al.	   2009).	   Conversely,	  ADARs	  have	  been	   found	   to	  directly	   edit	  microRNAs	   in	   the	  mouse	  brain	   (Kawahara	   et	   al.	  2007;	  Shahar	  Alon	  et	  al.	  2012).	  The	   contribution	   of	   A-­‐to-­‐I	   editing	   in	   cancer	   is	   becoming	   increasingly	   appreciated.	  Recently,	  Chen	  et	  al.	   identified	  a	   single	  A-­‐to-­‐I	  editing	  position	   in	   the	  coding	  region	  of	   the	  
AZIN1	   gene	   (antizyme	   inhibitor	   1).	   Hyperediting	   of	   this	   position	   is	   observed	   in	  hepatocellular	  carcinoma	  (HCC)	  and	  significantly	  correlated	  with	  liver	  cirrhosis	  and	  tumor	  recurrence	   (Leilei	   Chen	   et	   al.	   2013).	   Sie	   et	   al.	   examined	   two	   editing	   positions	   in	   IGFBP7	  (insulin-­‐like	   growth	   factor	   binding	   protein	   7),	   and	   determined	   that	   the	   amino	   acid	  substitutions	  resulting	  from	  the	  edits	  decreased	  proteolytic	  cleavage	  of	  the	  protein	  (Sie	  et	  al.	  2012).	  In	  a	  follow-­‐up	  study,	  Hochberg	  et	  al.	  demonstrated	  that	  editing	  levels	  of	  IGFBP7	  are	  significantly	  decreased	  in	  basal	  cell	  and	  squamous	  cell	  carcinoma,	  and	  the	  edited	  form	  of	  the	  protein	  inhibits	  proliferation	  and	  promotes	  cell	  senescence	  in	  cultured	  keratinocytes	  (Hochberg	   et	   al.	   2013).	   Galeano	   et	   al.	   observed	   decreased	   editing	   percentages	   of	  BLCAP	  (bladder-­‐cancer	   associated	   protein)	   in	   cancerous	   tissues	   (Galeano	   et	   al.	   2010).	   A	   recent	  study	  examined	  editing	  levels	  in	  a	  range	  of	  gliomas	  and	  healthy	  astrocytes,	  and	  found	  that	  ADAR	   family	   expression	   is	   lower	   in	   the	   cancer	   tissue	   (Paz	   et	   al.	   2007).	   One	   gene	   in	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particular,	   ADARB2,	   exhibits	   decreased	   expression	   levels	   in	   direct	   correlation	   with	   the	  grade	  of	  the	  tumor:	  the	  highest	  expression	  levels	  were	  observed	  in	  healthy	  tissue,	  followed	  by	  low-­‐grade	  astrocytomas	  (grade	  I),	  oligodendoglioma	  (grade	  II),	  anaplastic	  astrocytoma	  (grade	   III),	   and	   the	   lowest	   expression	  was	   observed	   in	   glioblastoma	   (grade	   IV).	   Another	  study	  found	  that	  while	  ADARB2	  is	  downregulated,	  high-­‐grade	  astrocytomas	  express	  higher	  levels	  of	  ADAR	  than	  control	  samples	  (Cenci	  et	  al.	  2008).	  Whether	  expression	  dysregulation	  of	  the	  ADAR	  family	  of	  enzymes	  is	  a	  cause	  or	  an	  effect	  of	  the	  cancer	  is	  unknown.	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CHAPTER	  2:	  RELATIVE	  EXPRESSION	  ALGORITHMS	  
IMPLEMENTED	  ON	  THE	  GRAPHICS	  PROCESSING	  UNIT	  RESULT	  
IN	  DRAMATIC	  COMPUTATIONAL	  SPEEDUP1	  
	  
Abstract	  
	   The	   top-­‐scoring	   pair	   (TSP)	   and	   top-­‐scoring	   triplet	   (TST)	   algorithms	   are	   powerful	  methods	   for	   classification	   from	   expression	   data,	   but	   analysis	   of	   all	   combinations	   across	  thousands	  of	  human	  transcriptome	  samples	   is	  computationally	   intensive,	  and	  has	  not	  yet	  been	  achieved	  for	  TST.	  Implementation	  of	  these	  algorithms	  for	  the	  graphics	  processing	  unit	  results	  in	  dramatic	  speedup	  of	  two	  orders	  of	  magnitude,	  greatly	  increasing	  the	  searchable	  combinations	  and	  accelerating	  the	  pace	  of	  discovery.	  	  	  
	  
Introduction	  	   Rapidly	   improving	  technologies	  have	  made	   large	  amounts	  of	  gene	  expression	  data	  available	   for	   analysis	   and	   classification.	   The	   NCBI	   Gene	   Expression	   Omnibus	   (GEO)	  database	   contains	   hundreds	   of	   thousands	   of	   samples	   representing	   a	   wide	   range	   of	   dis-­‐eased	  and	  healthy	  tissue	  for	  which	  gene	  expression	  has	  been	  measured.	  As	  next-­‐generation	  RNA	  sequencing	  technology	  (Zhong	  Wang	  et	  al.	  2009)	  becomes	  ubiquitous,	  GEO	  and	  other	  databases	   will	   further	   increase	   in	   size	   and	   accuracy	   of	   information.	   Researchers	   have	  sought	   to	   use	   this	   expression	   data	   to	   identify	   distinct	   gene	   relationships	   that	   classify	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1This	  chapter	  uses	  previously	  published	  material	  with	  the	  following	  citation:	  Magis	  AT,	  Earls	  JC,	  Ko	  Y,	  Eddy	  JA,	  and	  Price,	  ND.	  2011.	  Graphics	  processing	  unit	  implementations	  of	  relative	  expression	  analysis	  algorithms	  enable	  dramatic	  computational	  speedup.	  Bioinformatics	  27:872–873.	  	  This	  article	  is	  reprinted	  with	  the	  permission	  of	  the	  publisher	  and	  is	  available	  using	  DOI:	  10.1093/bioinformatics/btr033.	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disease	  states,	  allowing	  for	  accurate	  diagnosis	  of	  diseases	  given	  the	  expression	  patterns	  of	  a	  few	  genes.	  Such	  methods	  include	  support	  vector	  machines	  (Brown	  et	  al.	  2000),	  decision	  trees	  (Zhang	  et	  al.	  2003),	  and	  neural	  networks	  (Khan	  et	  al.	  2001).	  The	  TSP	  algorithm	  and	  its	   variants	   have	   demonstrated	   similar	   accuracies	   to	   these	   methods	   while	   remaining	  relatively	   simple,	   resistant	   to	   overfitting,	   and	   consistent	   across	   data	   normalization	  methods	  (Geman	  et	  al.	  2004;	  Tan	  et	  al.	  2005;	  Price	  et	  al.	  2007;	  Lin	  et	  al.	  2009).	  Classifiers	  identified	   using	   these	   algorithms	   have	   been	   used	   to	   predict	   cancer	   outcomes	   and	  model	  disease	  progression	  (JA	  Eddy	  et	  al.	  2010).	  Despite	  these	  advantages,	  the	  TSP	  and	  especially	  the	   TST	   algorithm	   are	   computationally	   intensive	   and	   therefore	   slow.	   Because	   increasing	  the	   accuracy	   of	   predictions	  may	   require	   analysis	   of	   thousands	   of	   samples	   across	   tens	   of	  thousands	  of	   transcripts,	   it	   is	   important	   to	   improve	  the	  speed	  of	   these	  algorithms.	  Faster	  algorithms	   also	   enable	  more	   comparisons	   to	   be	  made,	   including	   automated	   data	  mining	  across	  many	  sample	  sets.	  While	  primarily	  known	  for	  gaming	  applications,	  the	  graphics	  processing	  unit	  (GPU)	  is	   increasingly	   applied	   to	   computationally-­‐challenging	   scientific	   problems	   including	  molecular	  dynamics	  simulations	  (John	  E	  Stone	  et	  al.	  2010)	  and	  medical	  imaging	  (S	  S	  Stone	  et	   al.	   2008).	   The	   GPU	   is	   designed	   for	   massive	   parallelism	   involving	   thousands	   of	  simultaneous	   executing	   threads,	   but	   requires	   different	   coding	   than	   that	   which	   runs	   on	  CPUs.	  Algorithms	  well	  suited	  for	  such	  parallelism	  can	  run	  tens	  to	  hundreds	  of	  times	  faster	  on	  GPUs	  than	  a	  corresponding	  CPU	  implementation.	  GPUs	  are	  also	  now	  widely	  available	  to	  researchers	   via	   National	   Center	   for	   Supercomputing	   Applications	   (NCSA)	   clusters	   and	  businesses	   such	   as	   Amazon	   Web	   Services	   EC2	   Cloud	   Computing.	   Here	   we	   present	  implementations	   of	   the	   TSP	   algorithm	   and	   the	   TST	   algorithm	   on	   the	   GPU.	   As	   the	   TST	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algorithm	  is	  particularly	  computationally	  demanding,	  this	  GPU	  implementation	  enables	  the	  first	  comprehensive	  search	  of	  all	  possible	  TSTs	  for	  classification.	  	  
Methods	  Given	  two	  classes	  of	  samples	  C	  =	  {C1,	  C2}	  with	  expression	  values	  for	  N	  genes	  {x1,...,xN},	  the	  TSP	  algorithm	  identifies	  the	  marker	  gene	  pair	  (xi,	  xj)	  in	  which	  the	  TSP	  score:	  ∆!,!= !" !! < !! ! = !! − !" !! < !! ! = !! , ! ≠ !	  is	  maximized.	  The	  algorithm	  performs	  all	  pairwise	  comparisons	  between	  the	  genes	  of	  the	  data	   set	   and	   calculates	   the	   TSP	   score	   for	   each,	   then	   selects	   the	   maximum	   or	   set	   of	  maximum	  scores.	  Multiple	  pairs	  may	  then	  be	  combined	  to	  improve	  classification	  (Tan	  et	  al.	  2005).	  The	  TSP	  algorithm	  exhibits	  O(N2)	  time	  complexity.	  	  The	   top-­‐scoring	   triplet	   (TST)	   algorithm	   extends	   the	   TSP	   algorithm	   to	   triplets	   of	  genes,	   instead	  of	  pairs.	   	  Because	   triplets	  allow	   for	  six	  possible	  permutations	  of	   the	  genes	  involved	   in	   the	   classifier	   (3!	   =	  6),	  more	   subtle	  differences	  between	  diseased	   and	  healthy	  tissue	  may	   be	   identified.	   	   The	   TST	   algorithm	   has	   been	   applied	   towards	   the	   discovery	   of	  gene	  triplets	  that	  identify	  BRCA1-­‐mutant	  breast	  cancers,	  achieving	  a	  classification	  accuracy	  of	  0.968,	  which	   is	  better	   than	  any	  existing	  classification	  method	  to	  date	  (Lin	  et	  al.	  2009).	  Because	  of	  computational	  limitations,	  the	  Lin	  et	  al.	  study	  was	  not	  able	  to	  comprehensively	  search	   all	   possible	   TSTs,	   but	   rather	   focused	   on	   those	   formed	   amongst	   the	   most	  differentially	  expressed	  genes.	  	  	  Given	  two	  classes	  of	  samples	  C	  =	  {C1,	  C2}	  with	  expression	  values	  for	  N	  genes	  across	  each	  sample,	   the	  TST	  algorithm	   identifies	   the	  marker	  gene	   triplet	   (xi,	  xj,	  xk)	   for	  which	   the	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observed	   permutations	   {π1,...,π6}	   differ	   the	   most	   between	   the	   two	   classes.	   	   The	  classification	  score	  is	  then:	  
∆!,!,!= 12 !" !! ! = !! − !" !! ! = !! , ! ≠ ! ≠ !!!!! 	  Because	  the	  TST	  algorithm	  relies	  on	  the	  relative	  expressions	  of	  all	  triplets	  of	   input	  genes,	  the	  algorithm	  exhibits	  O(N3)	  time	  complexity.	  In	  other	  words,	  the	  time	  required	  to	  execute	  the	   algorithm	   grows	   as	   the	   cube	   of	   the	   input	   size	   N.	   Cubic-­‐order	   algorithms	   are	   very	  computationally	   demanding	   and	   the	   authors	   of	   the	   TST	   paper	   state	   that	   searching	   the	  entire	   space	   of	   thousands	   of	   transcripts,	   e.g.	   the	   Affymetrix	   U133	   Human	   Genome	  microarray	   platform,	   is	   computationally	   infeasible.	   As	   a	   result,	   the	   authors	   restrict	   their	  searches	   to	   the	   top	  10	  most	  differentially-­‐expressed	  genes	   across	   the	  data	   set.	  However,	  this	  restriction	  ignores	  over	  99%	  of	  the	  potential	  classifiers.	  	  The	   physical	   architecture	   of	   the	   modern	   CUDA	   GPU	   (compute	   capability	   1.2	   and	  higher)	   consists	   of	   multiple	   (2-­‐30,	   depending	   on	   the	   particular	   model)	   streaming	  multiprocessors	   (SM),	   each	   of	   which	   consists	   of	   multiple	   cores.	   Each	   core	   can	   execute	  instructions	  in	  parallel	  with	  all	  other	  cores	  of	  that	  SM.	  The	  logical	  organization	  of	  the	  CUDA	  GPU	   architecture	   involves	   three	   paradigms:	   the	   thread,	   thread	   block,	   and	   grid.	  Multiple	  threads	   make	   up	   each	   thread	   block,	   and	   multiple	   thread	   blocks	   comprise	   a	   grid.	   Each	  thread	  executes	  on	  a	  single	  core,	  and	  thread	  blocks	  map	  loosely	  onto	  each	  multiprocessor.	  	  The	  grid	   then	   consists	  of	   code	   running	  on	   the	  multiple	   streaming	  multiprocessors	   in	   the	  GPU.	   The	   code	   that	   runs	   on	   the	   GPU	   device	   is	   known	   as	   the	   kernel.	   Kernel	   code	   can	   be	  written	   in	  several	  different	  programming	   languages	  (C,	  C++,	  Fortran)	  using	  special	  CUDA	  extensions	   to	   that	   language,	   which	   are	   compiled	   by	   the	   NVIDIA	   CUDA	   compiler	   (nvcc).	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Kernel	  code	   is	  executed	   in	  parallel	  across	  multiple	  threads	  within	  a	  thread	  block,	  making	  use	  of	  the	  single	  instruction,	  multiple	  data	  (SIMD)	  paradigm:	  each	  thread	  executes	  the	  same	  instruction	   simultaneously	   as	   all	   other	   threads	   in	   that	   thread	   block,	   but	   the	   data	   being	  operated	  on	  is	  different.	  Threads	  may	  have	  divergent	  execution	  patterns	  within	  a	  block,	  but	  all	   divergent	   threads	   execute	   serially	   until	   parallel	   execution	   can	   resume,	   resulting	   in	  decreased	  performance.	  	  	   Memory	  management	  is	  the	  other	  major	  concern	  of	  the	  GPU	  programmer.	  Memory	  on	   the	   GPU	   is	   divided	   up	   into	   a	   variety	   of	   different	   types,	   each	   having	   different	  characteristics.	   The	   primary	   memory	   storage	   on	   the	   GPU	   is	   device	   memory.	   	   This	   is	  analogous	   to	   the	  main	  memory	   of	   the	   CPU.	   	   Device	  memory	   is	   large	   (>4	   GB),	   but	   slow,	  requiring	  hundreds	  of	  GPU	  clock	  cycles	  to	  access.	  Shared	  memory	  is	  shared	  by	  all	  threads	  within	   a	   thread	   block,	   and	   is	   the	   primary	   method	   of	   communication	   between	   threads.	  Shared	   memory	   is	   fast	   (requiring	   1-­‐2	   clock	   cycles	   to	   access),	   but	   small	   (16-­‐48	   KB	   per	  thread	  block).	  There	  are	  also	  two	  fast	  caches	  available	  for	  device	  memory,	  the	  texture	  cache	  and	  the	  constant	  cache.	  Constant	  cache	  is	  immutable	  by	  the	  GPU	  threads	  and	  optimized	  for	  broadcast.	   In	  other	  words,	   constant	   cache	  works	  best	  when	  all	   threads	  of	  a	   thread	  block	  access	  the	  same	  memory	  location	  in	  constant	  cache	  simultaneously.	  In	  this	  case,	  accessing	  the	  constant	  cache	  requires	  1-­‐2	  clock	  cycles.	  The	   texture	  cache	  serves	  a	  slightly	  different	  purpose:	   it	   is	   optimized	   for	  2D	   spatial	   locality.	   	   In	   other	  words,	   the	   texture	   cache	  works	  best	   when	   threads	   within	   a	   thread	   block	   access	   data	   that	   is	   close	   together	   in	   device	  memory.	  	  	  The	  TSP	  algorithm	  is	  ideally	  suited	  for	  GPU	  implementation:	  because	  calculation	  of	  each	  TSP	  score	  is	  independent	  of	  all	  other	  scores,	  all	  scores	  may	  be	  calculated	  in	  parallel.	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All	   expression	  data	   is	   initially	   stored	   in	   the	  CPU	  main	  memory,	   either	   read	   in	   from	  a	   file	  (standalone	  software)	  or	  transferred	  from	  MATLAB.	  	  All	  expression	  data	  for	  the	  data	  set	  is	  first	   copied	   to	   the	  GPU	  device	  memory	   so	   each	   thread	   block	   can	   access	   it.	   	   As	   shown	   in	  Figure	   2.1,	   each	   thread	   on	   the	   device	   is	   assigned	   the	   task	   of	   computing	   one	   TSP	   score	  within	  the	  2D	  N	  x	  N	  matrix.	  	  Because	  the	  number	  of	  threads	  per	  block	  is	  limited,	  each	  sub-­‐block	  of	  the	  TSP	  matrix	  is	  calculated	  by	  a	  thread	  block.	  Threads	  are	  assigned	  2D	  indices	  to	  allow	  them	  to	  identify	  themselves	  within	  the	  matrix;	  therefore	  each	  thread	  ‘knows’	  which	  pairs	  of	  genes	  it	  should	  analyze	  and	  where	  it	  should	  store	  the	  result.	  Because	  every	  thread	  block	  within	  a	  kernel	  invocation	  is	  the	  same	  size,	  the	  output	  TSP	  matrix	  is	  padded	  to	  be	  a	  multiple	  of	   the	   thread	  block	  size,	   to	  avoid	   threads	  on	   the	  edge	  of	   the	  TSP	  matrix	  writing	  data	  to	  unallocated	  memory	  locations.	  	  This	  padding	  is	  discarded	  prior	  to	  the	  results	  being	  returned	   to	   the	  user.	   	  Within	   each	   thread	   there	   is	   no	  parallelization:	   each	   thread	   simply	  loops	  over	  each	  sample	  and	  performs	  the	  requisite	  comparisons	  to	  calculate	  the	  score,	  as	  described	   in	   the	   main	   text.	   	   The	   resulting	   TSP	   score	   is	   written	   directly	   back	   to	   device	  memory.	   	   After	   all	   thread	   blocks	   have	   finished,	   the	   TSP	   matrix	   is	   copied	   from	   the	   GPU	  device	  memory	  back	  to	  the	  CPU	  main	  memory	  and	  returned	  to	  the	  user.	  The	  TST	  algorithm	  requires	  computation	  of	  the	  probabilities	  of	  each	  of	  six	  different	  permutations	   of	   gene	   ranks	   for	   every	   triplet	   of	   genes	   in	   a	   data	   set.	   	   As	   with	   the	   TSP	  algorithm,	  all	  expression	  data	  is	  first	  copied	  from	  the	  CPU	  main	  memory	  to	  the	  GPU	  device	  memory.	  	  Because	  the	  output	  of	  the	  TST	  algorithm	  is	  a	  3D	  N	  x	  N	  x	  N	  matrix,	  there	  are	  now	  N	  kernel	  calls	  to	  the	  GPU,	  each	  of	  which	  calculates	  a	  single	  2D	  section	  of	  the	  3D	  output	  TST	  matrix	  (Figure	  2.2).	  	  As	  before,	  each	  thread	  block	  within	  each	  kernel	  invocation	  computes	  a	  sub-­‐block	  of	  the	  2D	  output	  matrix	  for	  that	  kernel	  call,	  and	  each	  2D	  section	  is	  padded	  to	  be	  a	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multiple	   of	   the	   thread	   block	   size.	   	   Within	   each	   thread	   there	   is	   no	   parallelization:	   each	  thread	  reads	  each	  sample	  triplet	  from	  device	  memory	  into	  the	  registers,	  and	  performs	  the	  multiple	   pairwise	   comparisons	   to	   identify	   the	   particular	   permutation	   for	   that	   sample.	  	  Probabilities	   for	   each	   permutation	   across	   all	   samples	   are	   stored	  within	   shared	  memory	  arrays	  within	  each	  thread	  block	  for	  speed.	  After	  all	  samples	  have	  been	  processed,	  the	  final	  TST	   score	   is	   computed	   as	   described	   in	   the	  main	   text	   and	   the	   resulting	   score	   is	   written	  directly	  back	   to	  device	  memory.	  After	  all	   thread	  blocks	   for	  a	  particular	  kernel	   invocation	  have	  finished,	  the	  2D	  portion	  of	  the	  TST	  matrix	  is	  copied	  back	  to	  the	  CPU	  main	  memory	  and	  the	  padding	  is	  discarded.	  	  Because	  there	  is	  a	  large	  memory	  requirement	  to	  store	  the	  entire	  3D	  output	  matrix	  if	  the	  number	  of	  genes	  is	  large,	  each	  2D	  portion	  of	  the	  matrix	  is	  analyzed	  and	  the	  top	  TST	  scores	  are	  stored	  prior	  to	  the	  invocation	  of	  the	  next	  kernel.	  	  If	  the	  entire	  3D	  matrix	  was	  kept	  in	  CPU	  memory,	  an	  input	  of	  only	  a	  few	  thousand	  genes	  could	  easily	  exceed	  the	   memory	   storage	   of	   a	   standard	   workstation.	   As	   a	   result,	   the	   size	   complexity	   of	   the	  algorithm	  is	  only	  O(N2),	  even	  though	  the	  time	  complexity	  is	  O(N3).	  The	  top	  TST	  scores	  from	  each	  2D	  subsection	  of	  the	  matrix	  are	  then	  sorted	  and	  returned	  to	  the	  user.	  	  	  	  
Results	  The	  algorithms	  described	  above	  have	  been	  implemented	  in	  C	  with	  CUDA	  extensions	  and	   compiled	   into	   MEX	   files	   for	   use	   with-­‐in	   the	   MATLAB	   computing	   environment;	   a	  standalone	   application	   is	   also	   available.	   Two	   existing	   CPU	   implementations	   of	   the	   TSP	  algorithm,	  tspair	  (Leek	  2009)	  and	  RXA	  (Lin	  et	  al.	  2009)	  were	  used	  for	  speed	  comparisons	  with	  the	  GPU	  code.	  One	  existing	  CPU	  implementation	  of	  the	  TST	  algorithm	  (RXA)	  was	  used	  for	   speed	   comparisons.	   Both	   CPU	   software	   packages	   are	   implemented	   in	   the	   C	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programming	   language	  as	  packages	   for	   the	  statistical	  environment	  R.	  All	  CPU	  speed	  tests	  were	  performed	  on	  an	  Intel	  Xeon	  x5680	  3.33	  processor.	  The	  GPU	  tests	  were	  performed	  on	  a	  NVIDIA	  Tesla	  T10	  and	  an	  NVIDIA	  GeForce	  GTX480.	  	  Figure	  2.3	  shows	  the	  results	  of	  the	  running	  time	  comparisons.	   	  The	  results	  for	  RXA	  and	   tspair	   are	  plotted	  separately	  due	   to	   the	   fact	   that	  RXA	   implements	   the	  Wilcoxon	  rank	  sum	  test	  to	  filter	  for	  only	  the	  most	  differentially	  expressed	  genes,	  whereas	  tspair	  does	  not.	  As	   the	   number	   of	   genes	   increases,	   the	   speedup	   on	   the	   GPU	   improves;	   therefore	   further	  speedup	  might	  be	  expected	  for	  larger	  tests.	  All	  GPU	  timings	  include	  the	  device	  data	  transfer	  as	  well	   as	   computation	   times.	  The	  Tesla	  T10	  executes	   the	  algorithms	  77X	   to	  255X	   faster	  than	   the	   corresponding	   CPU	   implementations,	   and	   the	   GTX480	   executes	   the	   algorithms	  228X	  to	  455X	  faster.	  An	  input	  size	  of	  10000	  genes	  takes	  nearly	  an	  hour	  using	  the	  CPU	  TSP	  implementation	   in	  RXA,	   while	   it	   is	   computed	   in	   about	   2.5	   seconds	   on	   the	   Fermi	   GPU.	   It	  should	   be	   noted	   that	   k-­‐fold	   cross	   validation	   of	   classifiers	   for	   a	   large	   dataset	   requires	  running	   many	   rounds	   of	   TSP,	   progressively	   omitting	   portions	   of	   the	   data	   in	   order	   to	  estimate	  classification	  accuracy.	  Using	  the	  GPU	  for	  such	  studies	  reduces	  the	  computational	  time	   from	   days	   to	   minutes.	   Processing	   10,000	   genes	   on	   the	   CPU	   version	   of	   the	   TST	  algorithm	  would	  take	  over	  6.5	  months,	  while	  the	  GPU	  implementation	  of	  the	  TST	  algorithm	  on	  this	  data	  set	  was	  completed	  in	  less	  than	  9	  hours.	  Using	  the	  GPU	  enables	  the	  discovery	  of	  accurate	  marker	  gene	  pairs	  and	  triplets	  that	  are	  infeasible	  with	  the	  CPU	  implementations,	  while	  also	  allowing	  more	  stringent	  error	  estimation	  methods	   than	  are	   currently	  possible	  due	  to	  previous	  computational	  time	  constraints.	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Figures	  and	  Tables	  
	  	  
Figure	   2.1:	   Logical	   organization	   of	   the	   TSP	   algorithm	   on	   the	   GPU.	   Each	   portion	   of	   the	  output	   TSP	  matrix	   is	   calculated	   independently	   of	   the	   others	   by	   each	   thread	  block.	   	   Each	  thread	  outputs	  a	  single	  element	  of	  the	  TSP	  matrix.	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Figure	   2.2:	   Logical	   organization	   of	   the	   TST	   algorithm	   as	  implemented	   on	   the	   GPU.	   Each	   block	   is	   calculated	   in	   a	   similar	  manner	  to	  the	  TSP	  algorithm,	  except	  all	  six	  possible	  permutations	  of	   each	   triplet	   are	   calculated	   within	   each	   thread.	   	   Each	   kernel	  invocation	   calculates	   a	   single	   2D	   section	   of	   the	   NxNxN	   output	  matrix.	  




























































Figure	  2.3:	  (Left)	  Plot	  of	  RXA	  TSP	  algorithm	  vs.	  GPU	  implementation.	  Both	  algorithms	  filter	  for	   most	   differentially	   expressed	   genes	   using	   the	   Wilcoxon	   Rank	   Sum	   test.	   Maximum	  speedup	  is	  255X	  (Tesla	  T10)	  and	  455X	  (GTX480).	  (Center)	  Plot	  of	  tspair	  TSP	  algorithm	  vs.	  GPU	  implementation.	  	  Maximum	  speedup	  is	  83X	  (Tesla	  T10)	  and	  228X	  (GTX480).	   	  (Right)	  Plot	  of	  RXA	  TST	  algorithm	  vs.	  GPU	  implementation.	  Maximum	  speedup	  is	  77X	  (Tesla	  T10)	  and	  301X	  (GTX480).	  The	  data	  set	  used	  had	  350	  samples	  in	  class	  1	  and	  306	  samples	  in	  class	  2.	   All	   data	   points	   are	   the	  mean	   of	   three	   independent	   runs	   of	   the	   software.	   	   Dotted	   lines	  indicate	   extrapolation	   from	   previous	   data	   points	   using	   a	   quadratic	   (TSP)	   or	   cubic	   (TST)	  polynomial	  fit.	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CHAPTER	  3:	  THE	  TOP-­‐SCORING	  ‘N’	  ALGORITHM:	  A	  
GENERALIZED	  RELATIVE	  EXPRESSION	  CLASSIFICATION	  
METHOD	  FROM	  SMALL	  NUMBERS	  OF	  BIOMOLECULES2	  
	  
Abstract	  Relative	   expression	   algorithms	   such	   as	   the	   top-­‐scoring	   pair	   (TSP)	   and	   the	   top-­‐scoring	  triplet	  (TST)	  have	  several	  strengths	  that	  distinguish	  them	  from	  other	  classification	  methods,	   including	   resistance	   to	   overfitting,	   invariance	   to	   most	   data	   normalization	  methods,	   and	   biological	   interpretability.	   The	   top-­‐scoring	   ‘N’	   (TSN)	   algorithm	   is	   a	  generalized	  form	  of	  other	  relative	  expression	  algorithms	  which	  uses	  generic	  permutations	  and	   a	   dynamic	   classifier	   size	   to	   control	   both	   the	   permutation	   and	   combination	   space	  available	  for	  classification.	  	  TSN	  was	  tested	  on	  nine	  cancer	  datasets,	  showing	  statistically	  significant	  differences	  in	   classification	   accuracy	   between	   different	   classifier	   sizes	   (choices	   of	   N).	   TSN	   also	  performed	   competitively	   against	   a	   wide	   variety	   of	   different	   classification	   methods,	  including	   artificial	   neural	   networks,	   classification	   trees,	   discriminant	   analysis,	   k-­‐Nearest	  neighbor,	   naïve	   Bayes,	   and	   support	   vector	   machines,	   when	   tested	   on	   the	   Microarray	  Quality	  Control	  II	  datasets.	  Furthermore,	  TSN	  exhibits	  low	  levels	  of	  overfitting	  on	  training	  data	   compared	   to	   other	   methods,	   giving	   confidence	   that	   results	   obtained	   during	   cross-­‐validation	  will	  be	  more	  generally	  applicable	  to	  external	  validation	  sets.	  TSN	  preserves	  the	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2This	  chapter	  uses	  previously	  published	  Open	  Access	  material	  with	  the	  following	  citation:	  Magis	  AT	  and	  Price	  ND.	  2012.	  The	  top-­‐scoring	  “N”	  algorithm:	  a	  generalized	  relative	  expression	  classification	  method	  from	  small	  numbers	  of	  biomolecules.	  BMC	  Bioinformatics	  
13:227.	  This	  article	  is	  reprinted	  with	  the	  permission	  of	  the	  publisher	  and	  is	  available	  using	  DOI:	  10.1186/1471-­‐2105-­‐13-­‐227.	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strengths	   of	   other	   relative	   expression	   algorithms	   while	   allowing	   a	   much	   larger	  permutation	   and	   combination	   space	   to	   be	   explored,	   potentially	   improving	   classification	  accuracies	  when	  fewer	  numbers	  of	  measured	  features	  are	  available.	  	  
	  
Introduction	  Relative	   expression	   algorithms	   such	   as	   the	   top-­‐scoring	   pair	   (TSP)	   (Geman	   et	   al.	  2004)	  and	  the	   top-­‐scoring	   triplet	   (TST)	  (Lin	  et	  al.	  2009)	  represent	  powerful	  methods	   for	  disease	  classification,	  primarily	  focused	  on	  the	  creation	  of	  simple,	  yet	  effective	  classifiers.	  These	   algorithms	   have	   several	   strengths	   that	   distinguish	   them	   from	   other	   classification	  methods.	  First,	  only	  the	  ranks	  of	  the	  expression	  data	  are	  used,	  rather	  than	  the	  expression	  values	   directly,	   therefore	   these	   algorithms	   are	   invariant	   to	   data	   normalization	   methods	  that	   preserve	   rank-­‐order.	   For	   example,	   quantile	   normalization	   is	   a	   rank-­‐preserving	  common	  practice	  in	  microarray	  analysis	  to	  remove	  technical	  sources	  of	  variance	  between	  arrays	   (Bolstad	  et	  al.	  2003).	   It	   is	   therefore	  preferable	   that	   the	  classification	  algorithm	  be	  insensitive	  to	  such	  normalization	  procedures,	  particularly	  in	  meta-­‐analyses	  combining	  data	  from	  multiple	   studies	  or	   in	  a	   clinical	   setting	  where	  additional	  measurements	  beyond	   the	  features	   used	   to	   build	   the	   classifier	   would	   be	   needed	   to	   apply	   the	   normalization	   step.	  Second,	   relative	   expression	   classifiers	   make	   use	   of	   only	   a	   few	   features	   to	   build	   each	  classifier,	   and	   require	   relatively	   little	   to	  no	  parameter	   tuning.	  As	   a	   result,	   the	   algorithms	  are	  generally	  resistant	  to	  overfitting,	   in	  which	  an	  algorithm	  learns	  to	  classify	  the	  noise	  of	  the	   training	   set	   rather	   than	   the	   true	   phenotypic	   signal	   of	   interest.	   Moreover,	   the	   small	  number	  of	  features	  in	  relative	  expression	  algorithms	  lends	  itself	  well	  to	  the	  development	  of	  inexpensive	  clinical	  tests	  (Price	  et	  al.	  2007).	  Third,	  an	  underappreciated	  aspect	  of	  relative	  
	  	   	  	   	   	  24	  
expression	  algorithms	  involves	  their	  potential	  for	  biological	   interpretation.	  The	  simplicity	  of	  these	  algorithms,	  in	  which	  the	  ranks	  of	  a	  few	  features	  shift	  positions	  in	  a	  predictable	  way	  between	   two	   phenotypic	   classes,	   suggests	   that	   the	   features	   participating	   in	   a	   highly	  accurate	  classifier	  may	  represent	  or	  reflect	  an	  underlying	  biological	  role	  for	  those	  features	  in	  the	  phenotypes	  being	  classified.	  Relative	  expression	  algorithms	  may	  therefore	  serve	  as	  hypothesis	   generators	   for	   additional	   study.	   This	   characteristic	   may	   become	   particularly	  relevant	   as	   classification	   methods	   move	   increasingly	   more	   into	   technologies	   such	   as	  secretomics	   and	   miRNA	   expression	   measurements	   that,	   at	   present,	   result	   in	   fewer	  measurements	  per	  samples	  than	  do	  transcriptomes.	  In	  this	  paper	  we	  present	  a	  new	  formulation	  of	  the	  relative	  expression	  classification	  algorithm	   that	   generalizes	   the	   idea	   of	   pairwise	   rank	   comparisons	   (TSP)	   and	   triplet	   rank	  comparisons	   (TST)	   into	   generic	   permutation	   rank	   comparisons,	   where	   the	   size	   of	   the	  classifier	  is	  not	  defined	  a	  priori.	  This	  algorithm	  is	  called	  the	  top-­‐scoring	  ‘N’	  (TSN),	  where	  N	  is	  a	  variable	  indicating	  the	  size	  of	  the	  classifier.	  As	  such,	  TSP	  and	  TST	  can	  be	  thought	  of	  as	  special	   cases	   of	   the	   general	   TSN	   algorithm	   (just	   with	   a	   fixed	  N=2	   or	  N=3,	   respectively).	  Because	   the	   classifier	   size	   is	   unconstrained,	   TSN	   can	   explore	   a	  much	   larger	   permutation	  and	  combination	  space	  than	  that	  available	  to	  either	  TSP	  or	  TST.	  All	  of	  the	  results	  presented	  in	  this	  paper	  used	  no	  more	  than	  sixteen	  features	  from	  any	  of	  the	  training	  sets.	  	  The	  classification	  accuracy	  of	   the	  existing	   relative	  expression	  algorithms	  has	  been	  demonstrated	  in	  several	  studies.	  Classifiers	  identified	  using	  relative	  expression	  algorithms	  have	   been	   used	   to	   distinguish	   multiple	   cancer	   types	   from	   normal	   tissue	   based	   on	  expression	  data	  (Geman	  et	  al.	  2004;	  Lin	  et	  al.	  2009;	  Price	  et	  al.	  2007;	  Tan	  et	  al.	  2005)	  as	  well	   as	   to	  predict	   cancer	  outcomes	  and	  model	  disease	  progression	   (JA	  Eddy	  et	  al.	  2010).	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Furthermore,	   relative	   expression	   algorithms	   perform	   competitively	   when	   compared	   to	  other,	   often	   more	   complex,	   classification	   methods,	   including	   support	   vector	   machines	  (Brown	  et	   al.	   2000),	   decision	   trees	   (Zhang	  et	   al.	   2003)	   and	  neural	  networks	   (Khan	  et	   al.	  2001).	   Relative	   expression	   algorithms	   have	   also	   been	   applied	   in	   a	   network	   context,	  illustrating	  the	  dysregulation	  of	  cellular	  pathways	  in	  disease	  phenotypes	  (James	  A	  Eddy	  et	  al.	  2010).	  We	  first	  demonstrate	  that	  both	  TSP	  and	  TST	  are	  special	  cases	  of	  the	  TSN	  algorithm.	  We	   illustrate	   the	   performance	   of	   a	   range	   of	   TSN	   classifier	   sizes	   on	   a	   set	   of	   nine	   cancer	  datasets.	   Finally,	  we	   demonstrate	   that	   TSN	   performs	   competitively	  when	   compared	   to	   a	  broad	   range	   of	   classification	   models,	   including	   artificial	   neural	   networks,	   classification	  trees,	   and	   support	   vector	   machines,	   using	   data	   and	   results	   from	   the	   FDA-­‐sponsored	  Microarray	  Quality	  Control	  II	  project	  (MAQC-­‐II)	  (Shi	  et	  al.	  2010).	  	  
Methods	  
Overview	  of	  relative	  expression	  algorithms	  TSP	  and	  TST	  Given	   two	   classes	   of	   samples	   C	   =	   {C1,	   C2},	   for	   which	   ranked	   expression	   data	   are	  available	  on	  M	   features	  X	  =	  {x1,…,xM},	   the	  TSP	  algorithm	  (Geman	  et	  al.	  2004)	  searches	   for	  the	  feature	  pair	  {xi,	  xj}	  that	  maximizes	  the	  TSP	  score	  Δi,j,	  defined	  as:	  ∆!,!= !" !! < !! ! = !! − !! !! < !! ! = !! , ! ≠ !	  The	  TSP	  algorithm	   identifies	   the	  best	  pair	  of	   features	   for	  which	   the	   rank	  of	  xi	   falls	   lower	  than	  the	  rank	  of	  xj	  in	  most	  or	  all	  samples	  in	  class	  C1,	  and	  the	  rank	  of	  xi	  falls	  lower	  than	  the	  rank	  of	  xj	  in	  few	  or	  no	  samples	  of	  class	  C2.	  The	  max	  (Δi,j	  =	  1)	  indicates	  a	  perfect	  classifier	  on	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the	  training	  set	  in	  which	  no	  samples	  deviate	  from	  this	  pattern.	  Classification	  is	  performed	  by	  comparing	  the	  ordering	  of	  features	  {xi,	  xj}	  in	  each	  sample	  of	  the	  test	  set	  to	  the	  orderings	  associated	  with	  the	  two	  classes.	  A	  variant	  on	  this	  algorithm	  known	  as	  k-­‐TSP	  makes	  use	  of	  multiple	  disjoint	  pairs	  to	  improve	  classification	  accuracy	  (Tan	  et	  al.	  2005).	  The	  top-­‐scoring	  triplet	  (TST)	  algorithm	  (Lin	  et	  al.	  2009)	  extends	  the	  TSP	  algorithm	  to	  triplets	  of	  features.	  The	  six	  unique	  permutations	  π1,…,π6	  of	  each	  feature	  triplet	  {xi,	  xj,	  xk,}	  are	  now	  considered	  explicitly,	  where:	  	  π1	  =	  {xi	  <	  xj	  <	  xk},	  π2	  =	  {xi	  <	  xk	  <	  xj},	  π3	  =	  {xj	  <	  xi	  <	  xk}	  π4	  =	  {xj	  <	  xk	  <	  xi},	  π5	  =	  {xk	  <	  xi	  <	  xj},	  π6	  =	  {xk	  <	  xj	  <	  xi}	  These	  permutation	  counts	  are	  accumulated	  for	  each	  sample	  of	  the	  training	  set,	  and	  the	  TST	  score	  Δi,j,k	  to	  be	  maximized	  is	  then	  calculated	  as	  follows:	  
∆!,!,!= 12 !" !! ! = !! − !" !! ! = !! , ! ≠ ! ≠ !!!!! 	  	  
The	  top-­‐scoring	  ‘N’	  algorithm	  The	  top-­‐scoring	  ‘N’	  algorithm,	  as	  the	  name	  implies,	  extends	  these	  relative	  expression	  algorithms	  to	  a	  generic	  permutation	  size.	  Within	  the	  context	  of	  feature	  permutations,	  TSP	  and	  TST	  can	  be	  thought	  of	  as	  special	  cases	  of	  the	  TSN	  algorithm,	  where	  a	  fixed	  N=2	  and	  N=3	  are	  used,	  respectively.	  The	  TSN	  algorithm	  uses	  a	  nonstandard	  counting	  system	  known	  as	  factoradics,	   or	   factorial-­‐radix	   numbers.	   Briefly,	   factoradics	   can	   be	   described	   as	   a	  mixed-­‐radix	   counting	   system	   in	   which	   the	   multiplicative	   factor	   for	   each	   digit	   placeholder	   is	  derived	  from	  the	  set	  of	  factorial	  numbers.	  An	  example	  of	  factoradics	  compared	  to	  two	  other	  common	   fixed-­‐radix	   counting	   systems	   is	   shown	   in	   Figure	   3.1.	   Given	   that	   the	   factoradic	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counting	  system	  is	  intimately	  related	  to	  the	  factorial	  numbers,	  it	  is	  perhaps	  not	  surprising	  that	   there	   is	   a	   relationship	   between	   factoradics	   and	   permutations.	   There	   exist	   n!	  permutations	   of	   a	   set	   of	   n	   objects,	   and	   therefore	   each	   permutation	   of	   n	   objects	  may	   be	  represented	   by	   an	   integer	   from	   0	   to	   n!-­‐1.	   Factoradics	   provide	   a	   mechanism	   by	   which	  permutations	  may	   be	   uniquely	   represented,	   and	   the	   translation	   between	   a	   permutation	  and	   its	   corresponding	   factoradic	   is	   known	   as	   the	   Lehmer	   code	   (Figure	   3.2).	   Using	  factoradics,	   every	  permutation	  has	  a	  one-­‐to-­‐one	  correspondence	  with	  a	  decimal	  number.	  Several	   examples	   of	   permutation-­‐to-­‐decimal	   translations	   via	   factoradics	   are	   shown	   in	  Figure	  3.3.	  	  	  The	  TSN	  algorithm	  works	  as	  follows:	  given	  two	  classes	  of	  samples	  C	  =	  {C1,	  C2}	  with	  rank	  values	  for	  M	  features	  {x1,...,xM},	  and	  a	  classifier	  size	  N,	  the	  TSN	  algorithm	  identifies	  the	  feature	   set	   X	   =	   {xi,xj,…xN}	   that	   maximizes	   the	   sum	   of	   the	   difference	   of	   the	   permutation	  probability	  density	  between	  the	  two	  classes:	  
∆!= 12 !" !! ! = !! − !" !! ! = !!!!!!! 	  where	   σm	   is	   the	  mth	   permutation	   of	   the	   classifier	   X.	   Recall	   that	   there	   are	   N!	   possible	  permutations	   of	   X.	   The	   permutation	   probability	   density	   for	   each	   class	   is	   determined	   by	  mapping	  the	  permutation	  of	  X	  for	  each	  training	  set	  sample	  to	  its	  corresponding	  factoradic,	  converting	   the	   factoradic	   to	   decimal	   representation,	   and	   using	   this	   as	   an	   index	   into	   a	  histogram	   of	   size	   N!.	   Once	   normalized	   by	   the	   number	   of	   samples	   in	   each	   class,	   the	  histogram	   represents	   the	   permutation	   probability	   density	   for	   that	   feature	   set	   on	   that	  training	   set	   class.	   When	   the	   two	   histograms	   are	   completely	   disjoint	   (i.e.,	   there	   are	   no	  overlapping	  permutations	  between	  the	  two	  classes),	  the	  TSN	  score	  ΔX	  =	  1.	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In	  addition	  to	  the	  primary	  TSN	  score,	  a	  secondary	  score	  γ	  is	  calculated	  in	  the	  event	  of	  ties	  between	  two	  classifiers.	  This	  is	  simply	  the	  distance	  in	  rank	  between	  the	  first	  and	  last	  element	  of	  the	  classifier	  X	  for	  each	  sample,	  summed	  over	  all	  the	  samples	  of	  the	  training	  set:	  
!! = !!(!),! − !!(!),!!!!! 	  where	  S	  is	  equal	  to	  the	  number	  of	  samples	  in	  the	  training	  set	  and	  N	  the	  size	  of	  the	  classifier	  
X.	  R	  refers	   to	   the	  rank,	  and	  X(1)	  and	  X(N)	  are	   the	   first	  and	   last	  elements	  of	   the	  classifier,	  respectively.	  In	  the	  case	  of	  ties	  in	  the	  primary	  TSN	  score,	  the	  classifier	  chosen	  will	  have	  the	  largest	  distance	  in	  rank	  between	  the	  upper	  and	  lower	  elements	  of	  the	  classifier.	  In	  the	  case	  where	  N=2,	  the	  TSN	  algorithm	  simply	  reduces	  to	  the	  TSP	  algorithm,	  since	  
X2	  =	  {xi,	  xj},	  and	  Pr(σm)	  =	  Pr(xi	  <	  xj).	  	  In	  the	  case	  where	  N=3,	  the	  TSN	  algorithm	  reduces	  to	  the	  TST	   algorithm,	   since	  X3	  =	   {xi,xj,xk}	   and	  Pr(σm)	   =	  Pr(πm).	   Because	   the	   TSN	   algorithm	   uses	  factoradics	  to	  uniquely	  represent	  any	  permutation	  of	  any	  size	  classifier,	  it	  allows	  TSP	  and	  TSP	   classifiers	   to	   be	   used	   in	   concert	   as	  well	   as	   allowing	   for	   even	   larger	   classifiers	   to	   be	  explored.	  	  The	   choice	   of	  N	   is	   clearly	   important	   in	   the	   determination	   of	   a	   new	   classifier	   for	   a	  training	  set.	  The	  simplest	  method	  is	  to	  choose	  the	  value	  of	  N	  with	  the	  greatest	  classification	  accuracy	  after	  iteration	  over	  a	  range	  of	  N.	  This	  method	  would	  reveal	  the	  apparently	  most	  effective	  classifier	  size.	  In	  this	  case	  the	  experimenter	  is	  artificially	  choosing	  the	  ‘best’	  value	  of	  N	  for	  a	  given	  data	  set.	  However,	  in	  fair	  comparisons	  with	  other	  classification	  methods	  it	  is	  important	  that	  the	  choice	  of	  N	  not	  be	  made	  a	  posteriori	  (once	  the	  best	  classifier	  and	  value	  of	  N	  have	  been	  determined)	  to	  avoid	  overly	  optimistic	  error	  estimates.	  We	  do	  not	  choose	  the	  value	  of	  N	  outside	  the	  cross	  validation	  loop,	  but	  rather	  dynamically	  select	  the	  value	  of	  N	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at	   each	   iteration	   of	   the	   cross	   validation	   loop;	   the	   choice	   is	  made	   based	   on	   the	   apparent	  accuracy	  of	  that	  value	  of	  N	  on	  the	  training	  set.	  We	  call	  this	  version	  of	  the	  algorithm	  dynamic	  
N.	   Apparent	   accuracy	   is	   calculated	   by	   first	   finding	   the	   highest	   scoring	   classifier	   on	   the	  training	   set	   for	  each	  value	  of	  N	   in	   a	   range	   specified	  by	   the	  user.	  The	  value	  of	  N	  with	   the	  highest	  apparent	  accuracy	  on	  the	  training	  set	  is	  then	  applied	  to	  the	  test	  set.	  In	  the	  case	  of	  ties	  in	  apparent	  accuracy	  for	  multiple	  values	  of	  N,	  the	  algorithm	  chooses	  the	  smallest	  tied	  value	   of	  N	   for	   the	   classifier	   at	   that	   iteration	   of	   the	   cross	   validation	   loop.	   This	   process	   is	  repeated	   at	   each	   iteration	   of	   the	   cross	   validation	   loop.	   	   Note	   that	   this	  method	   does	   not	  preclude	  the	  user	  from	  artificially	  choosing	  the	  best	  value	  of	  N	  (outside	  of	  cross	  validation)	  for	  other	  purposes,	  but	   is	   rather	  a	  mechanism	  to	  avoid	  bias	  during	  cross	  validation.	  This	  allows	  us	  to	  make	  fair	  comparisons	  of	  the	  TSN	  algorithm	  with	  other	  classification	  methods	  without	  potentially	  biasing	  the	  results	  in	  our	  favor.	  	  
Classification	  with	  TSN	  Once	  the	  highest	  scoring	  classifier	  X	  is	  identified	  using	  a	  training	  set,	  prediction	  on	  a	  test	  set	   is	  performed	  by	  comparing	   the	  classifier	  permutation	   for	  each	  sample	  of	   the	   test	  set	   to	   the	   permutation	   probability	   density	   of	   the	   classifier	   for	   each	   class.	   	   A	   class	   is	  predicted	  for	  each	  sample	  based	  on	  which	  permutation	  probability	  density	  is	  higher	  for	  the	  permutation	   of	   that	   sample.	   For	   example,	   given	   a	   classifier	   size	   of	   N=4,	   if	   a	   particular	  sample	  in	  the	  test	  set	  contains	  permutation	  16,	  that	  sample	  is	  classified	  as	  class	  1	  or	  class	  2	  based	  on	  which	  class	  has	  higher	  permutation	  probability	  density	  for	  permutation	  16	  in	  the	  training	  set.	  A	  special	  case	  may	  occur	  during	  classification,	  where	  the	  probability	  for	  a	  test	  set	   permutation	   is	   equal	   (or	   zero)	   for	   both	   classes.	   	   In	   this	   case,	   the	   algorithm	   adopts	   a	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maximum	  likelihood	  approach	  to	  classify	  the	  sample.	  	  First,	  all	  permutations	  are	  identified	  with	   an	   inversion	   distance	   of	   1	   from	   the	   original	   permutation.	   The	   inversion	   distance	   is	  defined	  as	  the	  number	  of	  adjacent	  swaps	  required	  to	  convert	  one	  permutation	  into	  another	  (Figure	  3.4,	  top	  panel).	  For	  example,	  given	  a	  classifier	  of	  size	  4,	  each	  permutation	  has	  a	  set	  of	  three	  permutations	  with	  an	  inversion	  distance	  of	  1.	  For	  permutation	  16,	  this	  set	  includes	  permutations	   13,	   17,	   and	   22	   (Figure	   3.4,	   bottom	   panel).	   Once	   the	   single-­‐inversion	  permutation	  set	  is	  identified,	  the	  permutation	  density	  for	  this	  set	  is	  summed	  for	  each	  class.	  The	   class	  with	   the	  higher	  probability	   is	   chosen.	   If	   the	   single-­‐inversion	  distance	   sums	  are	  the	   same	   between	   the	   two	   classes,	   the	   algorithm	   repeats	   the	   calculation	   for	   the	  permutations	  with	  inversion	  distance	  2,	  and	  so	  on.	  If	  a	  choice	  cannot	  be	  made,	  which	  only	  occurs	   if	  both	  classes	  have	   identical	  permutation	  probability	  distributions,	   that	  sample	   is	  considered	  an	  incorrect	  prediction	  for	  that	  iteration	  of	  the	  cross	  validation	  loop.	  	  
Implementation	  of	  TSN	  While	  the	  TSN	  algorithm	  can	  theoretically	  explore	  a	  very	  large	  permutation	  space,	  the	  computational	  requirements	  of	  the	  algorithm	  rise	  very	  quickly	  and	  to	  avoid	  overfitting	  the	  number	   of	   permutations	   explored	  must	   be	   scaled	   to	   what	   is	   reasonable	   given	   available	  sample	  numbers.	  The	  complexity	  of	  TSN	  is	  ! !! !! ,	  where	  M	   is	  the	  number	  of	   features	  and	  N	   is	   the	  size	  of	   the	  classifier.	  We	  have	  previously	  shown	  (Magis	  et	  al.	  2011)	   that	   the	  graphics	   processing	   unit	   (GPU)	   is	   highly	   efficient	   when	   applied	   to	   easily	   parallelizable	  algorithms	  such	  as	  TSP	  and	  TST.	  Given	  that	  TSN	  preserves	  the	  parallel	  nature	  of	  the	  other	  relative	  expression	  algorithms,	  it	  is	  also	  easily	  applied	  to	  the	  GPU.	  However,	  given	  that	  GPU	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hardware	  is	  not	  yet	  widely	  available	  to	  many	  researchers,	  we	  are	  releasing	  the	  source	  code	  for	  both	  GPU	  and	  CPU	  implementations	  of	  the	  TSN	  algorithm.	  TSN	  has	  been	  implemented	  for	  both	  the	  GPU	  and	  the	  CPU	  in	  the	  MATLAB	  computing	  environment.	  The	  GPU	  is	  a	  specialized	  hardware	  device	  normally	  used	  in	  graphics	  rendering.	  The	  nature	   of	   graphics	   rendering	   involves	   large	   numbers	   of	   vector	   and	   matrix	   operations	  performed	  in	  real-­‐time,	  thus	  the	  GPU	  architecture	  emphasizes	  massive	  parallelism.	  Driven	  by	  the	  billion-­‐dollar	  gaming	  industry,	  the	  GPU	  has	  developed	  into	  a	  powerful	  tool	  currently	  able	  to	  reach	  over	  1	  TFLOP	  (trillion	  floating	  point	  operations	  per	  second)	  on	  a	  single	  chip	  in	   single	   precision	   operations.	   With	   NVIDIA’s	   release	   of	   the	   Compute	   Unified	   Device	  Architecture	  (CUDA)	  in	  2007,	  general-­‐purpose	  computation	  on	  the	  GPU	  became	  accessible.	  GPUs	   are	   increasingly	   being	   applied	   to	   computationally	   intensive	   scientific	   problems,	  including	  molecular	  dynamics	   simulations	   (John	  E	  Stone	  et	   al.	   2010),	  weather	  prediction	  (Michalakes	   and	  Vachharajani	   2008),	   quantum	   chemistry	   (Ufimtsev	   and	  Martinez	   2008),	  bioinformatics	   (Schatz	   et	   al.	   2007),	   and	  medical	   imaging	   (S	   S	   Stone	   et	   al.	   2008).	   Plots	   of	  running	  times	  for	  N=2,	  N=3,	  and	  N=4	  over	  a	  wide	  range	  of	  input	  feature	  sizes	  are	  shown	  in	  Figure	  3.5.	  The	  speedup	  of	  the	  GPU	  over	  the	  CPU	  implementations	  of	  TSN	  improves	  as	  the	  value	   of	  N	   gets	   higher,	   ranging	   from	   2.3X	   for	  N=2	   to	   4.4X	   for	  N=4.	   Pseudocode	   for	   the	  operation	  of	  the	  core	  TSN	  algorithm	  is	  shown	  in	  Figure	  3.6.	  	  	  
Results	  and	  Discussion	  
Multiple	  Values	  of	  N	  TSN	  has	  been	  tested	  on	  nine	  cancer	  datasets	  that	  were	  used	  in	  the	  previous	  k-­‐TSP	  and	  TST	  papers	  (Lin	  et	  al.	  2009;	  Tan	  et	  al.	  2005)	  for	  comparison	  between	  different	  values	  of	  N.	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These	   datasets	   represent	   a	   wide	   range	   of	   cancers,	   including	   colon	   (U	   Alon	   et	   al.	   1999),	  leukemia	   (Golub	   et	   al.	   1999),	   central	   nervous	   system	   lymphoma	   (CNS)	   (Pomeroy	   et	   al.	  2002),	  diffuse	  large	  B-­‐cell	  lymphoma	  (DLBCL)	  (Shipp	  et	  al.	  2002),	  prostate	  (Dinesh	  Singh	  et	  al.	   2002;	   Stuart	   et	   al.	   2004;	  Welsh	   et	   al.	   2001),	   and	   a	   global	   cancer	  map	   (GCM)	   dataset	  (Ramaswamy	  et	  al.	  2001).	  As	  discussed	  in	  the	  methods	  section,	  the	  TSN	  algorithm	  can	  be	  used	   in	  two	  different	  ways:	   the	  choice	  of	  N	  can	  be	  made	  a	  posteriori	  after	  all	   fixed	  values	  have	  been	  tested,	  or	  the	  choice	  of	  N	  can	  be	  made	  at	  each	   iteration	  of	   the	  cross	  validation	  loop	  (dynamic	  N)	  using	  apparent	  accuracy.	  Apparent	  accuracy	  is	  calculated	  by	  first	  finding	  the	  highest	  scoring	  classifier	  on	  the	  training	  set	  for	  each	  value	  of	  N	  in	  a	  range	  specified	  by	  the	   user.	   The	   value	   of	  N	  with	   the	   highest	   apparent	   accuracy	   on	   the	   training	   set	   is	   then	  applied	  to	  the	  test	  set.	  In	  order	  to	  directly	  compare	  the	  accuracies	  based	  on	  the	  number	  of	  permutations	  of	  features,	  we	  chose	  16	  features	  for	  N=2,	  10	  features	  for	  N=3,	  and	  9	  features	  for	  N=4.	  This	  results	  in	  approximately	  120	  combinations	  for	  each	  value	  of	  N.	  The	  reason	  for	  choosing	  different	  numbers	  of	   features	  for	  each	  value	  of	  N	  is	   to	  equalize	  the	  combination	  space	   for	   each	   classifier	   size.	   For	   example,	   a	   classifier	   of	   size	  N=2	   given	   16	   features	   can	  explore	  2!	  =	  2	  permutations	  over	   !"! = 120  combinations.	  A	  classifier	  of	  size	  N=3	  given	  10	  features	  can	  explore	  3!	  =	  6	  permutations	  over	   !"! = 120  combinations.	  A	  classifier	  of	  size	  
N=4	   given	  9	   features	   can	   explore	  4!=24	  permutations	   over	   !! = 126  combinations.  	  As	   a	  result,	  any	  difference	   in	  accuracy	  between	  these	  two	  classifiers	  depends	  primarily	  on	  the	  permutation	  space	  being	  explored	  and	  not	  the	  combination	  space	  (which	  is	  held	  relatively	  constant).	  The	  features	  were	  chosen	  to	  be	  the	  most	  differentially	  expressed	  genes	  based	  on	  the	  Wilcoxon	  rank	  sum	  test,	  again	  selected	  within	  each	  iteration	  of	  the	  cross	  validation	  loop	  to	  avoid	  overly	  optimistic	  estimates.	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Shown	   in	   Figure	   3.7	   are	   the	   results	   of	   TSN	   being	   applied	   to	   three	   of	   the	   cancer	  datasets	   with	   fixed	   values	   of	   N	   as	   well	   as	   dynamic	   N	   using	   5-­‐fold	   cross	   validation.	   To	  determine	  statistically	  significant	  differences	  between	  values	  of	  N,	  we	  ran	  100	  iterations	  of	  5-­‐fold	   cross	   validation	   on	   each	   of	   the	   nine	   cancer	   datasets.	   Each	   iteration	   of	   cross	  validation	   randomly	   selected	  different	   training	   and	   test	   sets,	   allowing	  us	   to	  measure	   the	  distribution	  of	  accuracies	  for	  each	  value	  of	  N.	  This	  was	  done	  for	  fixed	  N=2,	  fixed	  N=3,	  fixed	  
N=4,	   and	   dynamic	   N={2,3,4}	   as	   described	   above.	   Because	   the	   resulting	   distributions	   of	  accuracies	   failed	   a	   Kolmogorov-­‐Smirnov	   normality	   test,	   we	   used	   the	   non-­‐parametric	  Kruskal-­‐Wallis	  one-­‐way	  analysis	  of	  variance	  by	  ranks	  to	  measure	  differences	  between	  the	  groups.	   	  A	  p-­‐value	  <	  0.05	  was	  considered	  significant.	  Significant	  differences	  are	   indicated	  by	   letters	   above	   each	   bar;	   if	   two	   bars	   share	   the	   same	   letter	   they	   are	   not	   statistically	  different.	  	  It	   is	   clear	   from	   Figure	   3.7	   that	   the	   value	   of	  N	   can	   have	   a	   significant	   effect	   on	   the	  resulting	   accuracy	   of	   the	   classifier,	   which	   indicates	   that	   the	   larger	   permutation	   space	  afforded	   by	   larger	   values	   of	  N	   can	   be	   useful	   in	   identifying	   an	   effective	   classifier.	   In	   the	  Leukemia	   data	   set,	   for	   example,	   N=2	   and	   N=3	   produced	   the	   apparently	   most	   effective	  classifiers;	   in	   the	  Lung	  data	  set,	  N=3	  and	  N=4	  were	  the	  apparent	  best.	   In	   four	  of	   the	  nine	  datasets	   (DLBCL,	   Prostate2,	   Prostate3,	   and	   GCM),	   dynamic	   N	   yielded	   no	   significant	  difference	  in	  accuracy	  with	  the	  highest-­‐scoring	  fixed	  value	  of	  N.	  In	  two	  additional	  datasets	  (Leukemia	  and	  Lung),	   the	  dynamic	  N	  accuracy	   is	  statistically	   in	  between	  the	  highest-­‐	  and	  lowest-­‐scoring	  values	  of	  N.	   	   In	   the	   remaining	   three	  datasets	   (Colon,	  CNS,	   and	  Prostate1),	  the	  dynamic	  N	  accuracy	  is	  not	  significantly	  different	  from	  the	  lowest-­‐scoring	  fixed	  value	  of	  
N.	   The	   dynamic	   N	   TSN	   result	   is	   the	   fair	   estimate	   of	   how	   well	   the	   algorithm	   would	   be	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expected	   to	   perform	   with	   optimization	   for	   N,	   without	   the	   bias	   that	   is	   introduced	   by	  choosing	  the	  apparently	  best	  N	  after	  the	  error	  estimate	  has	  been	  made.	  
	  
Microarray	  Quality	  Control	  II	  Datasets	  Published	   in	   2010,	   the	   Microarray	   Quality	   Control	   II	   dataset	   (MAQC-­‐II)	   (Shi	   et	   al.	  2010)	  was	  produced	  by	  the	  National	  Center	  for	  Toxicological	  Research	  at	  the	  United	  States	  Food	  and	  Drug	  Administration	   in	   collaboration	  with	  96	  universities	  and	  companies	   from	  around	  the	  world.	  One	  goal	  of	  the	  project	  was	  to	  build	  a	  set	  of	  microarray	  data	  that	  could	  be	  used	  to	  validate	  classification	  methods	  in	  a	  rigorous	  and	  systematic	  manner.	  To	  this	  end,	  six	   different	   microarray	   datasets	   representing	   a	   range	   of	   phenotypes,	   microarray	  platforms,	  and	  sample	  sizes	  were	  selected	  by	  the	  consortium.	  Each	  dataset	  was	  partitioned	  into	  one	  or	  more	  endpoints,	  where	  an	  endpoint	  represents	  a	  class	  partition	  to	  be	  predicted.	  A	  total	  of	  thirteen	  endpoints	  were	  represented	  by	  the	  six	  datasets.	  Each	  endpoint	  consisted	  of	  a	  training	  set	  as	  well	  as	  an	  independently	  collected	  validation	  set.	  A	  listing	  of	  the	  MAQC-­‐II	  datasets	  and	  endpoints	  used	  in	  this	  study	  is	  provided	  in	  Table	  3.1.	  Note	  that	  only	  five	  of	  the	  datasets	  representing	  nine	  endpoints	  are	  currently	  available	  for	  public	  download	  from	  the	  Gene	  Expression	  Omnibus	  (GSE16716).	  	  We	  tested	  TSN	  on	  all	  endpoints	  for	  which	  data	  was	   available.	   Thirty-­‐six	   independent	   groups	   using	   a	   variety	   of	   classification	   methods,	  including	   artificial	   neural	   networks,	   classification	   trees,	   discriminant	   analysis,	   k-­‐Nearest	  neighbor,	   naïve	   Bayes,	   and	   support	   vector	  machines,	   analyzed	   the	  MAQC-­‐II	   training	   sets	  and	   provided	   nearly	   20,000	   models	   to	   the	   MAQC-­‐II	   consortium.	   It	   should	   be	   noted	   the	  groups	   were	   not	   restricted	   to	   a	   single	   classification	   method,	   and	   many	   chose	   to	   use	  different	  methods	  for	  the	  different	  endpoints	  based	  on	  what	  they	  determined	  would	  be	  the	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most	   successful.	   As	   a	   result,	   our	   single	   classification	   method,	   TSN,	   is	   being	   compared	  against	   ensembles	   of	   methods	   by	   most	   MAQC-­‐II	   participants.	   Each	   group	   ultimately	  nominated	   a	   single	   model	   from	   each	   endpoint	   training	   set	   to	   be	   tested	   on	   the	  corresponding	   validation	   set,	   and	   these	   models	   were	   compiled	   into	   a	   list	   of	   final	  predictions.	  To	  further	  test	  the	  classification	  algorithms,	  the	  MAQC-­‐II	  consortium	  swapped	  the	   training	  and	  validation	  sets	   for	  each	  endpoint,	   and	  each	  group	  submitted	  predictions	  for	  the	  swapped	  datasets.	  TSN	  was	  tested	  against	  the	  groups	  that	  submitted	  validation	  set	  predictions	  for	  every	  available	  endpoint	  on	  both	  original	  and	  swapped	  data.	  A	  listing	  of	  the	  participants	  and	   their	   respective	   classification	  methods	  used	   in	   this	  paper	   is	  provided	   in	  Table	  3.2.	  The	  metric	  chosen	  by	  the	  MAQC-­‐II	  consortium	  to	  rate	  the	  classification	  models	  was	  the	   Matthew’s	   Correlation	   Coefficient	   (MCC).	   The	   MCC	   has	   several	   advantages	   over	   the	  accuracy/sensitivity/specificity	  standard,	  as	  it	  is	  able	  to	  detect	  inverse	  correlations	  as	  well	  as	  being	  sensitive	  to	  the	  overall	  size	  of	  the	  training	  sets.	  	  MCC	  values	  range	  from	  +1	  (perfect	  prediction)	   to	   -­‐1	   (perfect	   inverse	   prediction),	  with	   0	   indicating	   random	  prediction.	   Note	  that	  unbeknownst	  to	  the	  original	  study	  participants,	  endpoints	  H	  and	  I	  were	  replaced	  by	  a	  positive	   control	   (gender	   of	   the	   study	   participants)	   and	   a	   negative	   control	   (random	   class	  assignments),	  respectively.	  Therefore,	  it	  was	  expected	  that	  endpoint	  H	  would	  result	  in	  very	  high	   prediction	   MCC	   and	   endpoint	   I	   would	   result	   in	   MCC	   close	   to	   zero.	   	   The	   MCC	   is	  calculated	  as	  follows:	  
	  MCC = TP!TN "FP!FN(TP +FP)(TP +FN )(TN +FP)(TN +FN )
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If	  any	  of	  the	  sums	  in	  the	  denominator	  of	  the	  MCC	  are	  zero,	  the	  denominator	  is	  set	  to	  be	  one,	  resulting	  in	  an	  MCC	  equal	  to	  zero.	  As	  stated	  above,	  only	   five	  of	   the	  six	  MAQC-­‐II	  datasets	  are	  currently	  available	   from	  GEO,	   therefore	   we	   were	   only	   able	   to	   compare	   TSN	   to	   these	   datasets.	   All	   filtering	   and	  classification	  was	  performed	  using	  only	  the	  training	  data	  for	  each	  data	  set	  –	  the	  validation	  set	  was	   left	   completely	   out	   of	   these	   calculations.	  Where	   possible	   (Affymetrix	   platforms),	  the	  features	  of	  each	  training	  set	  were	  first	  filtered	  for	  a	  high	  percentage	  (66%)	  of	  present	  or	  marginal	  calls	  using	  a	  MATLAB	   implementation	  of	   the	  Affymetrix	  MAS5	  call	  algorithm	  (Liu	   et	   al.	   2002).	   The	   most	   differentially	   expressed	   probes	   for	   each	   training	   set	   were	  identified	   using	   the	   TSN	   implementation	   of	   the	   Wilcoxon	   rank	   sum	   test.	   	   Finally,	   the	  
dynamic	  N	  TSN	  algorithm	  was	  used	  to	  identify	  the	  highest-­‐scoring	  classifier	  on	  the	  training	  set	  over	  a	  range	  of	  N={2,3,4}	  and	  DEG={16,10,9}.	  As	  described	  in	  the	  methods	  section,	  the	  algorithm	  was	  allowed	  to	  select	  the	  best	  value	  of	  N	  using	  apparent	  accuracy	  of	  the	  training	  set.	  The	  highest	  scoring	  classifier	  was	  then	  applied	  to	  the	  validation	  set	  for	  each	  endpoint.	  The	   results	   of	   the	   TSN	   algorithm	  models	   applied	   to	   each	   endpoint	   validation	   set	   in	   the	  context	  of	  all	  analyzed	  participants	  are	  shown	  in	  Figure	  3.8.	  The	  mean	  MCC	  value	  across	  all	  endpoints	   (excluding	   endpoint	   I,	   the	   negative	   control)	   was	   also	   calculated	   for	   each	  participant,	   and	   is	   shown	   in	   Figure	   3.8.	   TSN	   performs	   competitively	   on	   these	   datasets,	  yielding	  a	  mean	  MCC	  value	  across	  all	  endpoints	  of	  0.444.	  	  The	  maximum	  mean	  MCC	  value	  achieved	  by	  any	  of	  the	  groups	  was	  SAI,	  with	  0.489.	  In	  addition	  to	  standard	  cross	  validation	  and	  validation	  set	  MCC,	  we	  also	  measured	  the	  statistical	  significance	  of	  different	  classifier	  sizes.	  As	  described	  with	  the	  cancer	  datasets	  above,	  we	   ran	  100	   iterations	  of	  TSN	  using	   fixed	  values	  of	  N=2,	  N=3,	   and	  N=4,	   as	  well	   as	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dynamic	  N={2,3,4}	  on	  all	  nine	  of	  the	  MAQC-­‐II	  training	  sets.	  For	  example,	  in	  endpoints	  A	  and	  B,	   N=4	   yields	   a	   statistically	   significant	   improvement	   over	   smaller	   classifier	   sizes.	   For	  endpoints	  C	  and	  E,	  N=2	  is	   the	  most	  effective	  classifier	   size.	  For	  endpoint	  G,	   there	  was	  no	  significant	   difference	   between	   any	   of	   the	   classifier	   sizes.	   In	   five	   out	   of	   the	   nine	   datasets	  (endpoints	  A,	  C,	  F,	  G,	  H,	  and	  I)	  there	  was	  no	  significant	  difference	  in	  MCC	  between	  dynamic	  
N	  and	  the	  highest-­‐scoring	  fixed	  value	  of	  N.	  	  In	  order	   to	   test	   the	  amount	  of	  overfitting,	  we	  calculated	   the	  difference	  of	   the	  MCC	  values	  from	  each	  validation	  set	  and	  the	  corresponding	  MCC	  values	  from	  training	  set	  cross	  validation	   for	   each	   group.	   The	   cross	   validation	   performed	   for	   TSN	   was	   5-­‐fold	   cross	  validation,	  repeated	  10	  times,	  as	  recommended	  by	  the	  MAQC-­‐II	  consortium.	  These	  results	  are	   presented	   in	   Figure	   3.9	   as	   boxplots	   showing	   the	   distribution	   of	   ΔMCC	   values.	   To	  prevent	  negative	  and	  positive	  values	  canceling	  each	  other	  out,	   the	  absolute	  value	  of	  each	  
ΔMCC	  was	  used.	  Both	  original	  and	  swap	  datasets	  were	  included	  in	  the	  calculation	  of	  ΔMCC.	  TSN	  has	  a	  mean	  ΔMCC	  =	  0.101,	  ranking	  second	  after	  SAS	  for	  the	  lowest	  ΔMCC	  of	  any	  of	  the	  MAQC-­‐II	   participants	   –	   demonstrating	   that	   TSN	   had	   a	   remarkably	   low	   overfitting	   to	   the	  data.	   For	   all	   analyses	   in	   this	   paper,	   up	   to	   sixteen	   differentially	   expressed	   genes	   were	  selected	  by	  the	  Wilcoxon	  rank	  sum	  test	  to	  input	  into	  the	  TSN	  algorithm.	  The	  fact	  that	  so	  few	  features	  were	   input	  to	  TSN	  in	  these	  analyses	  could	  explain	  the	   low	  levels	  of	  overfitting	   it	  exhibits.	   To	   test	   this,	   we	   ran	   all	   MAQC-­‐II	   training	   sets	   (except	   for	   the	   negative	   control	  endpoint	   I,	   which	   would	   bias	   the	   results	   of	  ΔMCC	   towards	   zero)	   over	   a	   range	   of	   input	  feature	  sizes.	  For	  N=2,	  we	  input	  a	  range	  of	  16	  to	  10,000	  input	  features.	  	  For	  N=3	  we	  input	  a	  range	   of	   10	   to	   670	   input	   features.	   For	  N=4	  we	   input	   a	   range	   of	   9	   to	   188	   input	   features.	  
	  	   	  	   	   	  38	  
These	   numbers	   were	   chosen	   to	   span	   approximately	   the	   same	   range	   of	   possible	   feature	  combinations	   for	   each	   value	   of	   N	   (approximately	   120	   combinations	   up	   to	   50	   million	  combinations).	   Finally	   we	   ran	   dynamic	   N	   for	   N={2,3,4}	   over	   the	   same	   ranges	   of	   input	  feature	  sizes.	  ΔMCC	  values	  were	  calculated	  for	  each	  input	  feature	  size,	  and	  boxplots	  of	  their	  distributions	   are	   shown	   in	   Figure	   3.10.	   While	   the	   mean	   ΔMCC	   values	   do	   increase	   as	   a	  function	  of	   input	   feature	  size,	  overall	   the	   levels	  of	  overfitting	  remain	   low	  for	  TSN	  despite	  the	   increase.	   The	   mean	   ΔMCC	   exhibited	   by	   dynamic	   N	   TSN	   at	   the	   largest	   input	   size	   of	  [10000,	  760,	  188],	  is	  0.148.	  This	  is	  still	  among	  the	  smallest	  mean	  ΔMCC	  value	  observed	  in	  any	  of	  the	  participating	  groups;	  only	  three	  groups	  are	  smaller	  (GHI,	  GSK,	  and	  SAS).	  	  	  
Discussion	  The	   goal	   of	   relative	   expression	   classification	   algorithms	   is	   to	   identify	   simple	   yet	  effective	   classifiers	   that	   are	   resistant	   to	   data	   normalization	   procedures	   and	   overfitting,	  practical	  to	  implement	  in	  a	  clinical	  environment,	  and	  potentially	  biologically	  interpretable.	  The	   top-­‐scoring	   ‘N’	   algorithm	   presented	   here	   retains	   these	   desirable	   properties	   while	  allowing	  a	  larger	  combination	  and	  permutation	  space	  to	  be	  searched	  than	  that	  afforded	  by	  earlier	  relative	  expression	  algorithms	  such	  as	  TSP	  and	  TST.	  TSN	  can	  also	  recommend	  the	  classifier	  size	  (N)	  most	  likely	  to	  result	  in	  effective	  classification	  based	  on	  the	  training	  set.	  Of	  course,	  more	  care	  must	  be	  taken	  to	  avoid	  overfitting	  with	  TSN,	  particularly	  on	  smaller	  data	  sets,	   given	   that	   the	   permutation	   space	   grows	   with	   the	   factorial	   numbers.	   However,	   the	  problem	   of	   overfitting	   can	   be	   well	   mitigated	   by	   choosing	   a	   suitably	   small	   number	   of	  features	   from	   which	   to	   build	   the	   classifier,	   or	   ensuring	   that	   the	   number	   of	   samples	  available	   is	   large	   enough	   to	   justify	   searching	   a	   larger	   combination	   space.	   All	   the	   results	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presented	   in	   this	   paper	  were	   performed	   using	   between	   nine	   and	   sixteen	   features	   of	   the	  microarray	   data	   sets.	   TSN	   is	   therefore	  well	   suited	   for	   datasets	   of	   emerging	   technologies	  that	  contain	  smaller	  numbers	  of	   features	  to	  begin	  with,	  such	  as	  secretomics	  and	  miRNAs.	  However,	   as	   Figure	   3.5	   demonstrates,	   it	   is	   still	   possible	   to	   search	   tens	   of	   thousands	   of	  permutations	  in	  a	  relatively	  short	  amount	  of	  time,	  when	  justified	  by	  large	  sample	  sizes.	  The	  statistical	   significance	   of	   the	   resulting	   classifiers	   can	   then	   be	   determined	   though	   e.g.	  permutation	  tests	  of	  the	  class	  labels.	  We	  have	  demonstrated	  the	  effectiveness	  of	  TSN	  in	  classification	  of	  the	  MAQC-­‐II	  data	  sets	   in	   comparison	   with	   many	   other	   classification	   strategies,	   including	   artificial	   neural	  networks,	  classification	  trees,	  discriminant	  analysis,	  k-­‐Nearest	  neighbor,	  naïve	  Bayes,	  and	  support	   vector	   machines,	   as	   implemented	   by	   several	   universities	   and	   companies	   from	  around	   the	   world.	   We	   do	   not	   claim	   that	   TSN	   is	   necessarily	   the	   best	   or	   most	   effective	  classifier	  for	  every	  circumstance.	  For	  example,	  TSN	  performs	  relatively	  poorly	  on	  endpoint	  H,	  which	  as	  the	  positive	  control	  in	  which	  classes	  were	  simply	  assigned	  as	  the	  gender	  of	  the	  study	   participants,	   should	   be	   among	   the	   easiest	   to	   classify.	   A	   major	   strength	   of	   the	  algorithm	   is	   the	   level	   to	  which	   the	  MCC	   values	   for	   cross	   validation	   agree	  with	   the	  MCC	  values	  on	  the	  independent	  validation	  set	  (ΔMCC).	  Importantly,	  these	  results	  indicate	  a	  very	  low	   level	  of	  overfitting,	  and	   increase	  our	  confidence	   that	  results	  generated	  through	  cross	  validation	   on	   future	   datasets	   will	   be	   effective	   classifiers	   on	   independent	   validation	   sets.	  	  That	  is,	  when	  TSN	  works	  on	  a	  dataset	  it	  is	  relatively	  more	  likely	  to	  be	  true,	  and	  conversely,	  when	   it	   is	  going	   to	   fall	   short	   in	   independent	  validation	   it	   typically	  does	  not	  work	  well	   in	  cross	   validation	   and	   so	   can	   be	   discarded	   as	   a	   candidate	   diagnostic	   early	   in	   the	   process.	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Analyses	   over	   a	   range	   of	   input	   sizes	   indicate	   that	   overfitting	   remains	   low	   even	   as	   input	  feature	  numbers	  increase,	  given	  sufficient	  sample	  sizes.	  	  Of	  all	   the	  MAQC-­‐II	  participants,	   including	  TSN,	  group	  SAS	  yielded	  the	   lowest	  mean	  
ΔMCC	   score	   (0.074),	   indicating	   low	   levels	   of	   overfitting.	   Group	   SAI	   yielded	   the	   highest	  mean	  MCC	  (0.4893)	  for	  original	  and	  swap	  datasets,	  indicating	  high	  levels	  of	  validation	  set	  accuracy	   based	   on	   the	   training	   set.	   Both	   of	   these	   groups	   utilized	   multiple	   classification	  strategies	   across	   all	   endpoints.	   For	   example,	   group	   SAS	   used	   logistic	   regression	   for	  endpoints	   A,	   E,	   and	   I,	   support	   vector	   machines	   for	   endpoints	   B,	   G,	   and	   H,	   partial	   least	  squares	  regression	   for	  endpoints	  D	  and	  F,	  and	  a	  decision	   tree	   for	  endpoint	  C.	   	  Group	  SAI	  used	   support	   vector	   machines	   for	   endpoints	   A,	   B,	   E,	   F,	   G,	   and	   I,	   k-­‐nearest	   neighbor	   for	  endpoints	  C	  and	  H,	  and	  a	  machine	  learning	  classifier	  for	  endpoint	  D.	  Group	  SAI	  also	  used	  a	  range	   of	   different	   feature	   selection	   methods	   for	   each	   endpoint.	   Both	   groups	   also	   used	  different	   classification	   strategies	   for	   the	   swap	   datasets.	   For	   example,	   group	   SAS	   used	  logistic	  regression	  for	  the	  original	  endpoint	  E	  data	  but	  partial	  least	  squares	  regression	  on	  swap	  endpoint	  E.	  Group	  SAI	  used	  a	  machine	  learning	  classifier	  for	  the	  original	  endpoint	  D,	  and	  discriminant	  analysis	  for	  swap	  endpoint	  D.	  As	  a	  result,	  TSN	  is	  not	  only	  being	  compared	  to	  different	  classification	  strategies,	  but	  the	  ensemble	  of	  classification	  strategies	  that	  were	  chosen	  in	  an	  attempt	  to	  maximize	  success	  for	  each	  endpoint	  across	  both	  original	  and	  swap	  datasets.	   Given	   its	   advantages	   of	   relative	   simplicity,	   biological	   interpretability,	   and	   low	  levels	  of	  overfitting,	  the	  TSN	  algorithm	  can	  serve	  as	  a	  useful	  tool	  for	  hypothesis	  generation,	  particularly	   as	   next	   generation	   sequencing	   and	   proteomics	   technologies	   yield	   increasing	  sensitivity	  in	  biomolecule	  measurements.	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Figures	  and	  Tables	  
	  
Figure	   3.1:	   Representation	   of	   a	   number	   (42)	   in	   three	   different	   counting	   systems:	  decimal	  (42),	  binary	  (101010),	  and	  factorial	  (13000).	  Note	  that	  decimal	  and	  binary	  are	  both	  fixed	  radix	  systems,	  in	  which	  the	  multiplicative	  distance	  between	  each	  digit	  place	  is	  the	  same,	  and	  the	  set	  of	  digits	  used	  for	  each	  place	  is	  the	  same.	  The	  factorial	  counting	  system	   (factoradics)	   uses	   a	   mixed-­‐radix	   system	   in	   which	   the	   multiplicative	   distance	  between	  each	  digit	  place	  is	  not	  the	  same,	  and	  the	  set	  of	  digits	  used	  for	  each	  place	  is	  also	  not	  the	  same.	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Convert  permutation  ı  =  3,  4,  1,  2  to  decimal  representation
Step  1:  Let  i DUJPLQı
Step  2:  Count  the  number  of  digits  to  the  left  of  digit  i  that
are  greater  than  ıL.  This  is  the  first  digit  of  the  factoradic.
3,  4,    1,    2
3,  4,  1,  2
Step  3:  Remove  ıLfrom  the  permutation.   3,  4,  2
Step  4:  Perform  steps  1-­3  until  no  digits  remain.  
3,  4,  2 3,  4,  2 Num  digits:  2
3,  4 3,  4 Num  digits:  0
4 4 Num  digits:  0
3,  4,  1,  2 Num  digits:  23,  4,  1,    2
Step  5:  Convert  factoradic  2,  2,  0,  0  to  decimal,  using  the  
factorial  numbers  as  the  place  for  each  digit.    
2 2 0 0
2x3!+2x2!+0x1!+0x0!  =  16
Place: 3! 2! 1! 0!
Factoradic:
The  unique  decimal  representation  of  permutation  
3,  4,  1,  2  is  16.    
Num  digits:  2
Figure	  3.2:	  A	  complete	  translation	  from	  permutation	  to	  decimal,	  by	  way	  of	  the	  factoradic,	  for	  a	  permutation	  of	  size	  4.	  Each	  permutation	  is	  mapped	  to	  a	  single	  unique	  decimal	  representation.	  	  Two	  additional	  translations	  from	  permutation	  to	  factoradic	  are	  shown	  in	  Figure	  3.3.	  	  	  
	  
	  	   	  	   	   	  43	   	  
Figure	   3.3:	   Three	   complete	   translations	   from	   permutation	   to	  decimal,	   by	   way	   of	   the	   factoradic,	   for	   a	   set	   of	   size	   4.	   The	  permutation	  to	  be	  translated	  is	  shown	  above	  the	  grid	  box,	  and	  the	  factoradic	   for	   that	   permutation	   is	   listed	   to	   the	   right	   of	   the	   grid	  box.	  Each	  row	  of	  the	  grid	  box	  determines	  a	  digit	  of	  the	  factoradic.	  The	   first	   row	   of	   the	   grid	   box	   is	   the	   complete	   sorted	   list.	   To	  perform	  the	  translation,	  consider	  the	  elements	  of	  the	  permutation	  progressively	  from	  1	  to	  4.	  The	  digit	  of	  the	  factoradic	  is	  equal	  to	  the	  number	   of	  elements	   of	   the	   sorted	   list	   to	   the	   left	   of	   this	   position.	  After	   each	   digit	   of	   the	   permutation	   is	   considered,	   the	  corresponding	   digit	   of	   the	   sorted	   list	   is	   removed.	   Note	   that	   the	  sorted	  permutation	   (Top)	   translates	   into	  decimal	   representation	  0.	   	   The	   reverse	   sorted	   permutation	   (Bottom)	   translates	   into	  decimal	  representation	  4!	  -­‐	  1	  =	  23,	  the	  maximum	  number	  that	  can	  be	  represented	  by	  a	  factoradic	  of	  size	  4.	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Permutation: 3 4 1 2
Factoradic: 2 2 0 0 Sum  =  4
1 2 3 4Sorted:
1 3 2 4Inversion  1:
3 1 2 4Inversion  2:
3 1 4 2Inversion  3:







1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 230
Figure	  3.4:	   (Top)	  There	  are	  four	  inversions	  required	  to	  translate	  the	  sorted	  list	   [1	   2	   3	   4]	   into	   the	   permutation	   [3	   4	   1	   2].	   The	   sum	   of	   the	   digits	   of	   the	  factoradic	   give	   the	   number	   of	   inversions	   required	   to	   translate	   one	  permutation	   into	   another.	   (Bottom)	   The	   grey	   squares	   indicate	   the	   set	   of	  permutations	   that	   have	   a	   single	   inversion	  distance	   from	   the	   original	   (black)	  permutations.	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N = 3 N = 2
N = 2
Figure	  3.5:	  Running	  times	  for	  N=2,	  N=3,	  and	  N=4	  over	  a	  range	  of	  input	  feature	   sizes.	   Each	  point	   is	   the	  mean	  of	   three	   independent	   runs	   of	   the	  software.	  The	  CPU	  running	  time	  for	  N=2	  over	  20,000	  features	  is	  similar	  to	   the	   running	   times	   for	   N=3	   over	   1000	   features	   and	   N=4	   over	   200	  features.	  The	  CPU	  version	  of	  TSN	  was	  run	  on	  a	   single	  core	  of	  a	  2.4GHz	  Intel	  Core	  2	  processor.	  The	  GPU	  version	  of	  TSN	  was	  run	  on	  an	  NVIDIA	  Tesla	   C2050.	   The	   speedup	   due	   to	   the	   GPU	   improves	   as	   the	   value	   of	  N	  gets	   higher:	   for	  N=2,	   the	  speedup	   is	   2.3X,	   for	  N=3	   the	   speedup	   is	   2.8X,	  and	  for	  N=4	  the	  speedup	  is	  4.4X.	  Running	  times	  reflect	  a	  single	  iteration	  of	   the	   algorithm	   and	   do	   not	   include	   multiple	   iterations	   such	   as	   cross	  validation.	  Note	  that	  running	  times	  are	  also	  a	  function	  of	  the	  number	  of	  samples	  in	  the	  dataset;	  there	  were	  70	  samples	  in	  this	  dataset.	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    1.  INPUTS:  C1,C2  =  Ranked  feature  expression  data
    2.                                M  =  num  features  of  C1,C2
    3.                                N  =  classifier  size
    4.  copy  C1,C2  to  GPU
    5.  hist1,hist2  =  allocate  zeroed-­out  N!  size  histograms  on  GPU
    6.  num_combinations  =  (M  choose  N)
    7.  num_iterations  =  num_combinations  /  GPU  memory
    8.  foreach  iteration  in  num_iterations  (CPU)
    9.          combs  =  combinations  for  this  iteration
10.          copy  combs  to  GPU
11.          parallel  foreach  combination  C  in  combs  (GPU)
12.                  foreach  sample  S  in  C1
13.                          fact  =  factoradic  for  permutation  of  C  in  S
14.                          hist1[decimal(fact)]  =  hist1[decimal(fact)]  +  1
15.                  foreach  sample  S  in  C2
16.                          fact  =  factoradic  for  permutation  of  C  in  S
17.                          hist2[decimal(fact)]  =  hist2[decimal(fact)]  +  1
18.                  hist1  =  normalize(hist1);;    hist2  =  normalize(hist2)
19.                  scores  =  sum(hist1  -­  hist2)    
20.          copy  scores,hist1,hist2  to  CPU
21.          sort  scores  and  save  (CPU)
22.  classifiers  =  top  combs  over  all  iterations
23.  OUTPUTS:  top  classifiers,  scores,  hist1,  hist2
Figure 3.6: Pseudocode for the core operation of the TSN algorithm on 
the GPU. This pseudocode does not include code to choose the value of N 
using apparent accuracy or determine classification accuracy using cross 
validation. Lines 11 through 19 are computed in parallel on the GPU. The 
GPU is called multiple times depending on the number of combinations 
requested and the size of the GPU device memory. 
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Figure	   3.7:	   Results	   of	   100	   rounds	   of	   5-­‐fold	   cross	   validation	   over	   a	   range	   of	  N={2,3,4}	  where	   the	   number	   of	   differentially	   expressed	   probes	   is	   different	   for	   each	   value	   of	   N	  {16,10,9}.	  This	  yields	  approximately	  the	  same	  number	  of	  possible	  combinations	  for	  each	  value	   of	   N	   (~120),	   illustrating	   how	   classification	   accuracy	   can	   be	   determined	   by	   the	  permutation	  itself,	  not	  just	  the	  number	  of	  combinations	  available.	  	  Results	  shown	  include	  accuracies	   of	   fixed	   values	   of	   N	   as	   well	   as	   the	   dynamic	   N	   algorithm	   described	   in	   the	  methods	  section.	  	  Statistical	  differences	  were	  calculated	  using	  the	  nonparametric	  Kruskal-­‐Wallis	   one-­‐way	   analysis	   of	   variance	   by	   ranks,	   and	   a	   p-­‐value	   <	   0.05	   was	   considered	  significant.	  If	  bars	  share	  the	  same	  letter	  they	  are	  not	  statistically	  different.	  	  The	  data	  sets	  are	  derived	  from	  	  (Lin	  et	  al.	  2009)	  and	  represent	  a	  wide	  range	  of	  cancers.	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A B C D E F G H I ALL
Figure	   3.8:	  MCC	   of	   MAQC-­‐II	   endpoints	   A	   through	   I,	   based	   on	   models	   learned	   on	   the	  training	   set	   and	   then	   applied	   to	   the	   validation	   set.	  MCC	   values	   range	   from	  +1	   (perfect	  prediction)	   to	   -­‐1	   (perfect	   inverse	   prediction),	   with	   0	   indicating	   random	   prediction.	  Boxplots	   show	   the	  MCC	  distribution	   of	   the	  models	   from	   the	   15	   groups,	   including	  TSN,	  that	  predicted	  all	  original	  and	  swap	  endpoints	  from	  the	  MAQC-­‐II.	  The	  original	  and	  swap	  MCC	  values	  are	  averaged	  for	  each	  group.	  In	  addition	  to	  endpoints	  A	  through	  I,	  a	  boxplot	  showing	  the	  mean	  MCC	  over	  endpoints	  A	  through	  H	  is	  shown	  (ALL).	  We	  exclude	  endpoint	  I	  from	  this	  final	  boxplot	  because	  it	  is	  a	  negative	  control.	  The	  bottom	  and	  top	  of	  each	  box	  indicate	   the	   lower	   and	   upper	   quartiles	   of	   the	   data,	   respectively.	   The	   middle	   line	  represents	   the	   median.	   The	   whiskers	   indicate	   the	   extreme	   values.	   The	   asterisk	  represents	  the	  performance	  of	  TSN	  on	  that	  data	  set.	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Figure	  3.9:	  Boxplots	  showing	  the	  distribution	  of	  ΔMCC	  values	  on	  the	  original	  data	  for	  each	  group,	   where	   ΔMCC	   =	   Cross	   Validation	   MCC	   –	   Validation	   Set	   MCC.	   This	   illustrates	   the	  amount	   of	   overfitting	   present	   during	   cross	   validation.	   The	   absolute	   value	   of	   each	   ΔMCC	  value	  was	  used	  in	  the	  calculations.	  The	  cross	  validation	  performed	  for	  TSN	  was	  5-­‐fold	  cross	  validation,	   repeated	  10	   times,	   as	   recommended	  by	   the	  MAQC-­‐II	   consortium.	  Boxplots	   are	  sorted	  by	  the	  mean	  ΔMCC	  for	  each	  group	  (asterisk).	  	  
	  





































¨MCC for N=4 Over A Range of Feature Sizes
Figure	   3.10:	  TSN	  algorithm	   is	   tested	  in	  the	  paper	  with	  very	  small	   input	  sizes	   (up	   to	  16	  features).	  When	  the	  cross	  validation	  MCC	  is	  compared	  with	  the	  test	  set	  MCC,	  the	  average	  difference	  is	  very	  small	   (Figure	  3.9),	   indicating	   that	   the	  level	  of	  overfitting	  with	  the	  TSN	  algorithm	   is	   low.	   	  To	  determine	   if	   the	   low	  overfitting	  of	   the	  TSN	  algorithm	  is	  due	   to	  the	  small	   number	   of	   input	   features	  we	   tested	   all	   the	   MAQC-­‐II	   datasets	   again	   using	   a	   large	  range	  of	  input	  sizes.	  This	  process	  was	  performed	  for	  fixed	  values	  of	  N=2,	  N=3,	  and	  N=4,	  as	  well	  as	  dynamic	  N.	  The	  number	  of	   features	  was	  chosen	   to	  yield	  approximately	   the	  same	  number	  of	  combinations	  for	  each	  classifier	  size.	  	  The	  feature	  sizes	  were	  chosen	  to	  span	  a	  range	  of	   combinations	   from	  120	   to	  50,000,000.	  The	   top	  panel	   shows	   the	  distribution	  of	  ΔMCC	  scores	  for	  dynamic	  N,	  and	  the	  2nd,	  3rd,	  and	  4th	  panels	  show	  the	  same	  calculations	  for	  fixed	  N=2,	  N=3,	  and	  N=4,	   respectively.	  Despite	  the	  wide	  range	  of	   input	  feature	  sizes,	   the	  mean	  (asterisk)	  and	  median	  (middle	  line)	  ΔMCC	  scores	  stay	  low,	  among	  the	  lowest	  of	  any	  of	   the	  MAQC-­‐II	  participants.	  The	  distance	  between	   the	   lower	  and	  upper	   quartiles	  of	   the	  data	  also	  remains	  fairly	  constant,	  as	  indicated	  by	  the	  top	  and	  bottom	  of	  the	  box.	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Table	   3.1:	   The	   five	   MAQC-­‐II	   datasets,	   representing	   endpoints	   A	   through	   I	   that	   are	  available	  from	  the	  Gene	  Expression	  Omnibus.	  
Dataset	   Endpoint	   Description	   Platform	  
Hamner	   A	   Lung	  tumorigen	  vs.	  non-­‐tumorigen	   Affymetrix	  Mouse	  430	  2.0	  
Iconix	   B	   Non-­‐genotoxic	  liver	  carcinogens	  vs.	  non-­‐carcinogens	   Amersham	  Uniset	  Rat	  1	  Bioarray	  
NIEHS	   C	   Liver	  toxicants	  vs.	  non-­‐toxicants	   Affymetrix	  Rat	  230	  2.0	  
Breast	  
Cancer	  
D	   Pre-­‐operative	  treatment	  response	   Affymetrix	  Human	  U133A	  E	   Estrogen	  receptor	  status	  
Multiple	  
Myeloma	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Table	  3.2:	   The	  participants	  that	  submitted	  models	  for	  every	  endpoint	  (original	  and	  swap)	  in	  the	  MAQC-­‐II	  study,	  and	  the	  classification	  methods	  used.	  Participants	  were	  not	  required	  to	  use	   the	   same	  classification	  method	   for	   each	  endpoint,	   and	  most	   chose	   to	  use	  multiple	  methods.	  
Code	   Name	   Classification	  Algorithm(s)	  Used	  
CAS	   Chinese	  Academy	  of	  Sciences	   Naïve	  Bayes,	  Support	  Vector	  Machine	  
CBC	   CapitalBio	  Corporation,	  China	   k-­‐Nearest	  Neighbor,	  Support	  Vector	  Machine	  
Cornell	   Weill	  Medical	  College	  of	  Cornell	  University	   Support	  Vector	  Machine	  
FBK	   Fondazione	  Bruno	  Kessler,	  Italy	   Discriminant	  Analysis,	  Support	  Vector	  Machine	  
GeneGo	   GeneGo,	  Inc.	   Discriminant	  Analysis,	  Random	  Forest	  
GHI	   Golden	  Helix,	  Inc.	   Classification	  Tree	  
GSK	   GlaxoSmithKline	   Naïve	  Bayes	  
NCTR	  
National	  Center	  for	  Toxicological	  Research,	  FDA	   k-­‐Nearest	  Neighbor,	  Naïve	  Bayes,	  Support	  Vector	  Machine	  
NWU	   Northwestern	  University	   k-­‐Nearest	  Neighbor,	  Classification	  Tree,	  Support	  Vector	  Machine	  
SAI	   Systems	  Analytics,	  Inc.	   Discriminant	  Analysis,	  k-­‐Nearest	  Neighbor,	  Machine	  Learning,	  Support	  Vector	  Machine,	  Logistic	  Regression	  
SAS	   SAS	  Institute,	  Inc.	   Classification	  Tree,	  Discriminant	  Analysis,	  Logistic	  Regression,	  Partial	  Least	  Squares,	  Support	  Vector	  Machine	  
Tsinghua	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CHAPTER	  4:	  SNAP-­‐RNA:	  A	  BIOINFORMATICS	  PIPELINE	  FOR	  
ACCURATE	  RNA-­‐SEQ	  ALIGNMENT	  AND	  ANALYSIS	  
	  
Abstract	  The	  growth	  of	  next-­‐generation	  sequencing	  data	  now	  exceeds	  the	  growth	  rate	  of	  storage	  capacity.	  Researchers’	  ability	  to	  process	  and	  analyze	  these	  data	  depends	  upon	  bioinformatics	  tools	  that	  are	  fast,	  accurate,	  and	  easy	  to	  use—especially	  when	  multiple	  large	  data	  sets	  are	  available	  for	  processing	  and	  additional	  analyses	  beyond	  standard	  mapping	  are	  required.	  We	  present	  SNAP-­‐RNA,	  a	  new	  RNA-­‐seq	  alignment	  and	  analysis	  pipeline	  designed	  to	  handle	  datasets	  involving	  hundreds	  or	  thousands	  of	   RNA-­‐seq	   libraries,	   while	   maintaining	   high	   alignment	   accuracy.	   SNAP-­‐RNA	   is	  capable	  of	  natively	  reading	  gzipped	  FASTQ	  and	  BAM	  formats,	  and	  directly	  writing	  to	  sorted	   BAM	   formats	   for	   immediate	   visualization,	   without	   any	   need	   for	   external	  software	  packages	  such	  as	  SAMtools.	  Quality	  filtering	  of	  input	  reads	  is	  incorporated	  directly	  into	  the	  alignment	  process.	  SNAP-­‐RNA	  can	  automatically	  identify	  and	  report	  contaminants	  or	  viral/bacterial	  infections	  in	  samples,	  and	  it	  automatically	  generates	  read	   counts	   suitable	   for	   downstream	   analysis	   with	   popular	   statistical	   programs	  such	  as	  DESeq,	  edgeR,	  or	  baySeq,	  with	  no	  running	  time	  penalty.	  Finally,	  SNAP-­‐RNA	  automatically	   identifies	   intra-­‐	   and	   inter-­‐chromosomal	   gene	   fusions	   with	   high	  accuracy,	  reporting	  the	  results	  automatically,	  while	  maintaining	  speeds	  competitive	  with	   the	   fastest	   available	   aligners.	  We	   demonstrate	   the	   capabilities	   of	   SNAP-­‐RNA	  through	   the	   analysis	   of	   nearly	   1300	   high-­‐quality	   RNA-­‐seq	   samples	   from	   four	  different	   cancer	   types	   derived	   from	   The	   Cancer	   Genome	   Atlas	   (TCGA),	   using	  recently	  published	  studies	  as	  our	  benchmarks.	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Introduction	  RNA	  sequencing	  (RNA-­‐seq)	  is	  one	  of	  the	  most	  common	  technologies	  in	  use	  today	  for	  the	  analysis	  of	  gene	  expression	  and	  transcriptome	  variation	   in	  biological	  samples	  (Zhong	  Wang	   et	   al.	   2009).	   As	   of	   2013,	   the	   NCBI	   Sequence	   Read	   Archive	   contains	   over	   500	  terabases	   of	   short	   read	   sequencing	  data,	  with	   a	   projected	  doubling	   time	  of	   22.3	  months.	  The	   explosive	   growth	   of	   next-­‐generation	   sequence	   data	   now	   exceeds	   the	   growth	   rate	   of	  storage	  capacity	  (Kodama	  et	  al.	  2012).	  Furthermore,	  the	  complexity	  of	  the	  transcriptome,	  defined	  as	  the	  set	  of	  expressed	  RNA	  species	  in	  a	  biological	  sample,	  presents	  challenges	  for	  short-­‐read	   alignment	   algorithms.	   Pseudogenes,	   noncoding	   and	   coding	   paralogs	   with	  sequence	  similarity,	  as	  well	  as	  low	  complexity	  and	  repetitive	  regions,	  can	  all	  contribute	  to	  misaligned	  reads.	  The	  GENCODE	  project	  estimates	  14,112	  pseudogenes	  exist	  in	  the	  human	  genome	  (Pei	  et	  al.	  2012).	  Repetitive	  sequences	  such	  as	  Alu	  elements	  comprise	  over	  10%	  of	  the	   human	   genome	   and	   tend	   to	   cluster	   around	   genes	   (Batzer	   and	   Deininger	   2002).	  Alignment	  accuracy	  is	  not	  only	  important	  in	  quantification	  of	  transcript	  expression;	  just	  as	  misaligned	   genomic	   reads	   can	   lead	   to	   false	  positives	   in	   variant	   identification,	  misaligned	  RNA	   reads	   can	   introduce	   false	   positives	   in	   RNA-­‐editing	   discovery.	   As	   the	   most	   recent	  papers	  have	  identified	  upwards	  of	  one	  million	  editing	  events	  in	  the	  human	  transcriptome	  (Ramaswami	  et	  al.	  2013),	  the	  risk	  of	  false	  positives	  is	  high,	  considering	  the	  relative	  size	  of	  the	  genome	  to	  the	  transcriptome.	  Compounding	  the	  problem	  is	  the	  fact	  that	  new	  species	  of	  RNA	   continue	   to	   be	   discovered,	   including	   circular	   RNAs	   (Jeck	   et	   al.	   2013),	   novel	   fusion	  genes	   (Salzman	   et	   al.	   2011)	   and	   trans-­‐splicing	   events	   (Hu	   et	   al.	   2013).	   While	   DNA	  sequencing	   is	   more	   commonly	   used	   to	   identify	   genomic	   translocations	   and	  rearrangements,	   RNA-­‐seq	   used	   for	   this	   purpose	   can	   readily	   identify	   functional	   aberrant	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species	   with	   a	   more	   easily	   identifiable	   role	   in	   pathology	   (Ozsolak	   and	   Milos	   2011).	  Researchers’	   ability	   to	   process	   and	   analyze	   RNA-­‐seq	   data	   depends	   upon	   bioinformatics	  tools	   that	   are	   fast,	   accurate,	   and	   easy	   to	   use—especially	   when	   multiple	   data	   sets	   are	  available	   for	   processing	   and	   additional	   analyses	   beyond	   standard	   mapping	   for	   new	  discovery	  are	  required.	  Here	  we	  present	  a	  new	  RNA-­‐seq	  alignment	  algorithm	  based	  on	  the	  Scalable	   Nucleotide	   Alignment	   Program	   (SNAP).	   We	   call	   this	   new	   alignment	   algorithm	  SNAP-­‐RNA.	  	  	  
Methods	  SNAP-­‐RNA	   incorporates	   the	   annotation	   directly	   into	   the	   alignment	   process	   to	  improve	  alignment	  accuracy.	  Each	  mate	  (one	  for	  single-­‐end,	  two	  for	  paired-­‐end)	  is	  aligned	  to	  both	  the	  genome	  and	  the	  transcriptome	  independently,	  creating	  a	  set	  of	  unique	  putative	  alignment	   positions	   for	   mate(s)	   to	   both	   indices.	   The	   final	   alignment	   position	   and	  subsequent	  mapping	   score	   is	   determined	   based	   on	   criteria	   described	   below.	   Aligning	   to	  both	  the	  transcriptome	  and	  the	  genome	  simultaneously	  serves	  a	  dual	  purpose:	   it	  ensures	  that	   all	   possible	   alignment	  positions	   for	   a	  mate	   are	   considered,	   and	   it	   allows	  paired	   end	  reads	   to	   cross	   transcriptome/genome	   boundaries.	  While	   an	   annotation	   provides	   critical	  prior	   knowledge	   about	   the	   likelihood	   of	   alignment	   positions,	   gene	   boundaries	   are	   often	  truncated	  at	   the	  5’	  and	  3’	  ends.	  SNAP-­‐RNA	  can	  also	  align	  paired	  end	  reads	   for	  which	  one	  mate	  occurs	  in	  an	  intron	  and	  the	  other	  in	  an	  exon,	  a	  situation	  resulting	  from	  unannotated	  exons	  or	  sequenced	  pre-­‐mRNA.	  The	  current	  version	  of	  SNAP-­‐RNA	  is	  designed	  for	  genomes	  with	  curated	  annotations,	  and	  does	  not	  attempt	  to	  find	  novel	  splice	  junctions.	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The	  mapping	  quality	  (MAPQ)	  field	  in	  the	  SAM	  file	  format	  specification	  is	  defined	  as	  −10 log!" !	  where	  X	  is	  the	  probability	  that	  the	  mapping	  position	  is	  incorrect.	  This	  value	  is	  rounded	  off	  to	  the	  nearest	  integer	  in	  the	  SAM	  file.	  Accurately	  calculating	  MAPQ	  necessitates	  the	   identification	   of	   all	   alternative	   alignment	   positions	   for	   a	   read	   to	   a	   given	   assembly.	  Genomic	   read	   aligners	   such	   as	   BWA	   (Heng	   Li	   and	   Durbin	   2009)	   estimate	   this	   value	   by	  finding	   as	   many	   alternative	   alignments	   positions	   as	   possible	   in	   a	   reasonable	   amount	   of	  time	  while	  reporting	  the	  highest	  quality	  alignment.	  Other	  factors	  such	  as	  repetitiveness	  of	  the	  genome	  and	  base	  qualities	  are	  also	  taken	  into	  account.	  SNAP	  effectively	  calculates	  the	  MAPQ	   value	   for	   genomic	   alignments	   such	   that	   Area	   Under	   the	   Receiver	   Operator	  Characteristic	   (AUROC)	   is	   among	   the	   highest	   of	   all	   aligners	   tested	   (Zaharia	   et	   al.	   2011).	  This	  accuracy	  is	  enabled	  by	  SNAP’s	  ability	  to	  rapidly	  find	  alternative	  alignments	  using	  the	  hash	  index.	  Transcriptomic	  alignments	  present	  greater	  difficulty	  in	  estimating	  MAPQ,	  due	  to	   the	   fact	   that	   reads	   can	   be	   spliced	   in	   many	   different	   ways	   and	   therefore	   accurately	  estimating	   alternative	   alignment	   positions	   is	   difficult.	   TopHat2	   (Kim	   et	   al.	   2013),	   for	  example,	  only	  reports	  five	  values	  for	  MAPQ	  in	  the	  output	  SAM	  file:	  0,	  1,	  2,	  3	  and	  50.	  	  If	  two	  alignments	   are	   identified	   for	   a	   read,	   the	   probability	   of	   any	   one	   of	   the	   alignments	   being	  correct	   is	   assumed	   to	   be	   0.5,	   irrespective	   of	   mismatches,	   yielding	   a	   MAPQ	   value	   of	  −10 log!" 0.5	  =	  3,	  rounded	  off	  to	  the	  nearest	  integer.	  A	  MAPQ	  value	  of	  50	  is	  reported	  if	  an	  alignment	   is	   unique.	   As	   such,	   the	   MAPQ	   value	   is	   not	   particularly	   useful	   in	   determining	  whether	   a	   given	   read	   is	   accurately	   aligned.	   Ultimately,	  most	   end	   users	   are	   interested	   in	  mapping	   uniqueness,	   but	   alignment	   uniqueness	   is	   not	  well	   defined	  when	   one	   allows	   for	  mismatches	   between	   reads	   and	   their	   target.	  Without	   allowing	   for	  mismatches,	   any	   read	  containing	  a	  sequencing	  error	  or	  derived	  from	  a	  transcript	  containing	  any	  form	  of	  a	  single	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nucleotide	  variant	   (SNV)	  will	  be	  discarded	  as	  an	   imperfect	  match.	  Alternatively,	  allowing	  for	  N	  mismatches	  in	  a	  read	  of	  length	  N	  enables	  the	  alignment	  of	  any	  read	  to	  any	  position,	  regardless	   of	   sequence.	   Aligners	   must	   therefore	   strike	   a	   balance	   between	   these	   two	  extremes,	   allowing	   for	   a	   reasonable	   number	   of	  mismatches	   that	   preserves	   the	   ability	   to	  identify	  variation	  while	   constraining	  alignments	  enough	   to	  yield	  meaningful	   information.	  Compounding	  the	  problem	  is	  the	  repetitiveness	  of	  the	  target	  genome,	  which	  leads	  to	  high	  sequence	  similarity	  in	  distal	  regions,	  potentially	  confounding	  even	  conservative	  alignment	  algorithms.	  SNAP-­‐RNA	  makes	  use	  of	  an	  error	  model	  in	  which	  the	  uniqueness	  of	  a	  particular	  alignment	   is	   determined	   through	   a	   confidence	   threshold	   that	   is	   defined	   by	   the	   user.	   All	  alignments	   are	   identified	  within	   a	   user-­‐specified	   edit	   distance	  between	   the	   read	   and	   the	  reference,	  and	  reverse	  sorted	  by	   the	  number	  of	  mismatches.	   If	   the	   top-­‐scoring	  alignment	  has	   at	   least	   n	   fewer	   mismatches	   than	   the	   second-­‐best	   scoring	   alignment,	   where	   n	   is	   a	  confidence	   interval	   specified	   by	   the	   user,	   the	   alignment	   is	   considered	   unique	   and	   is	  reported	   with	   the	   SNAP-­‐computed	   MAPQ	   value.	   Otherwise,	   the	   alignment	   is	   considered	  non-­‐unique	  and	  is	  reported	  with	  a	  MAPQ	  value	  of	  1.	  	  A	  major	  feature	  of	  the	  SNAP-­‐RNA	  pipeline	  is	  the	  manner	  in	  which	  the	  annotation	  is	  incorporated	   into	   the	  categorization	  of	  putative	  alignments.	  All	  valid	  alignments	   for	  each	  read	  are	  compared	  to	  the	  list	  of	  annotated	  genes.	  If	  both	  mates	  align	  within	  the	  boundaries	  of	   an	   annotated	   gene,	   that	   alignment	   is	   categorized	   as	   an	   intra-­‐gene	   alignment.	   Putative	  alignments	  that	  are	  not	   intra-­‐gene	  but	  occur	  on	  the	  same	  chromosome	  are	  categorized	  as	  
intra-­‐chromosomal.	   Finally,	   putative	   alignments	   that	   cross	   chromosome	   boundaries	   are	  categorized	  as	   inter-­‐chromosomal.	  Each	  read	  may	  have	  valid	  alignments	  that	  occur	  in	  one	  or	  more	  of	  these	  categories.	  SNAP-­‐RNA	  prioritizes	  alignments	  in	  the	  following	  order:	  intra-­‐
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gene,	  intra-­‐chromosomal,	  and	  inter-­‐chromosomal.	  If	  a	  read	  generates	  an	  alignment	  that	  is	  categorized	  as	  intra-­‐gene	  within	  the	  user-­‐specified	  error	  model,	  no	  alignments	  in	  any	  of	  the	  other	  categories	  are	  considered	  valid,	  even	  if	  those	  alignments	  contain	  fewer	  mismatches	  with	   the	  reference	  genome.	  Similarly,	   if	   a	   read	  generates	  no	  valid	  alignment	   in	   the	   intra-­‐gene	   category,	   but	   a	   valid	   alignment	   in	   the	   intra-­‐chromosomal	   category	   exists,	   no	  alignments	   are	   considered	   from	   the	   inter-­‐chromosomal	   category.	   This	   categorization	  scheme	   is	   designed	   to	   leverage	   the	   likelihood	   of	   alignments	   occurring	  within	   annotated	  genes	  while	  biasing	  the	  algorithm	  against	   inter-­‐chromosomal	  alignments.	  As	  a	  result,	  any	  intra-­‐	  or	  inter-­‐chromosomal	  alignments	  that	  do	  pass	  through	  these	  filters	  are	  subsequently	  more	  likely	  to	  result	  from	  real	  biological	  events.	  	  	  	  
Results	  To	   demonstrate	   the	   performance	   and	   accuracy	   of	   SNAP-­‐RNA,	   we	   generated	  simulated	   RNA-­‐seq	   datasets	   with	   Mason	   (Holtgrewe	   2010),	   each	   of	   which	   contained	  2.5x106	   paired-­‐end	   reads	   with	   standard	   IlluminaTM	   sequencing	   error	   rates.	   Reads	   were	  simulated	   with	   homozygous	   and	   heterozygous	   variants/indels	   present	   in	   the	   Venter	  genome	  (Levy	  et	  al.	  2007).	  In	  the	  first	  dataset,	  80%	  of	  the	  reads	  were	  generated	  from	  the	  Ensembl	   v68	   transcriptome	   (e.g.	   crossing	   splice	   junctions)	   and	   20%	   were	   generated	  directly	  from	  the	  genome	  with	  no	  splicing:	  a	  representation	  of	  a	  true	  RNA-­‐seq	  sequenced	  library.	   For	   the	   second	  dataset,	   80%	  of	   the	   reads	  were	   generated	   from	   the	  Ensembl	   v68	  transcriptome	   as	   before,	   but	   the	   remaining	   20%	   were	   generated	   only	   from	   27,606	  annotated	  pseudogene	  transcripts.	  This	  dataset	  was	  used	  to	  estimate	  mapping	  and	  variant-­‐calling	  accuracies	  in	  a	  worst-­‐case	  scenario.	  In	  addition	  to	  SNAP-­‐RNA,	  we	  chose	  three	  of	  the	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most	   recently	   published	   aligners	   to	   compare	   performance	   and	   mapping	   accuracy:	  TopHat2/Bowtie2	   (Kim	   et	   al.	   2013),	   STAR	   (Dobin	   et	   al.	   2013),	   and	   Subjunc	   (Liao	   et	   al.	  2013).	  The	  Genome	  Analysis	  Toolkit	  v2.5	  (DePristo	  et	  al.	  2011)	  was	  used	  for	  variant	  calling	  in	  order	   to	  estimate	  read	  mapping	  accuracies;	   incorrectly	  mapped	  reads	  should	  generate	  spurious	  variants	  while	  missing	  real	  variants.	  The	  Receiver	  Operating	  Characteristic	  (ROC)	  curves	  for	  variant	  calling	  are	  shown	  in	  Figure	  4.1.	  SNAP-­‐RNA	  is	  the	  most	  accurate	  aligner	  on	   both	   datasets,	  most	   notably	   in	   the	  worst-­‐case	   scenario.	   SNAP-­‐RNA	   is	   also	   the	   fastest	  aligner	  when	  BAM	  conversion	  is	  taken	  into	  account:	  nearly	  twice	  as	  fast	  as	  STAR	  and	  25X	  faster	  than	  TopHat2/Bowtie2.	  	  To	   maximize	   efficiency	   of	   disk	   usage,	   which	   is	   a	   critical	   issue	   in	   the	   analysis	   of	  growing	  amounts	  of	  RNA-­‐seq	  data,	  we	  designed	  SNAP-­‐RNA	  so	  that	  it	  is	  capable	  of	  natively	  reading	   gzipped	   FASTQ	   and	   BAM	   formats	   without	   requiring	   any	   external	   software	  packages	   such	   as	   SAMtools	   (Heng	   Li	   et	   al.	   2009).	   SNAP-­‐RNA	   can	   also	   write	   directly	   to	  sorted	  BAM	  format	  for	  immediate	  visualization	  or	  downstream	  analysis	  (e.g.	  variant	  calling	  or	  RNA	  editing	  identification).	  	  Sample	  quality	  is	  of	  paramount	  importance	  in	  RNA-­‐seq	  analysis,	   including	  filtering	  of	   low-­‐quality	   reads	   generated	   by	   the	   sequencer	   as	   well	   as	   identification	   of	   sample	  contaminants.	   While	   software	   packages	   such	   as	   the	   FASTX	   Toolkit	  [http://hannonlab.cshl.edu/fastx_toolkit/]	  have	  been	  developed	  to	  filter	  low	  quality	  reads	  from	   FASTQ	   files,	   SNAP-­‐RNA	   performs	   this	   task	   automatically,	   with	   no	   running	   time	  penalty,	  and	   it	   is	   completely	  configurable	  via	   the	  command	   line.	  Sequenced	  samples	  may	  contain	  products	  of	  viral	  infections	  and/or	  bacterial	  or	  fungal	  species,	  either	  expected	  or	  as	  a	   result	   of	   contamination.	   SNAP-­‐RNA	   allows	   the	   user	   the	   option	   of	   providing	   an	   input	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‘contaminant	   database’	   to	   which	   unaligned	   reads	   are	   tested	   after	   all	   other	   alignment	  options	   have	   failed.	  When	   a	   contaminant	   database	   is	   provided,	   SNAP-­‐RNA	   automatically	  writes	  a	  report	  of	  all	  putative	  contaminants	  and	  their	  respective	  read	  counts.	  All	  analyses	  in	   this	   paper	   were	   performed	   using	   a	   prepared	   contaminant	   database	   containing	   all	  sequenced	   viral	   genomes	   from	  NCBI	   (1376	  genomes),	   all	   sequenced	   fungal	   genomes	   (35	  genomes),	   and	   one	   representative	   genome	   from	   each	   sequenced	   bacterial	   genus	   (1145	  genomes).	   This	   contaminant	   database	   is	   freely	   available,	   along	  with	   all	   source	   code	   and	  compiled	   executables,	   via	   an	   Amazon	   EC2	   snapshot.	   Approximately	   10%	   of	   gastric	  carcinomas	   are	   associated	   with	   the	   presence	   of	   Epstein-­‐Barr	   Virus	   (EBV,	   Human	  herpesvirus	   4)	   (Strong	   et	   al.	   2013).	   We	   analyzed	   312	   RNA-­‐seq	   samples	   of	   stomach	  adenocarcinoma	   (STAD)	   from	   TCGA	   using	   SNAP-­‐RNA,	   and	   identified	   70	   with	   detectable	  (>10)	   and	   24	   with	   appreciable	   (>1000)	   numbers	   of	   reads	   mapping	   to	   the	   EBV	   type	   1	  genome.	   Of	   these,	   17	   samples	   contained	   EBV	   type	   1	   as	   the	   strongest	   identifiable	  contaminant	  in	  the	  report.	  All	  of	  these	  17	  samples	  also	  contained	  detectable	  levels	  of	  EBV	  type	   2.	   Additionally,	   41	   samples	   contained	   detectable	   levels	   of	   cytomegalovirus	   (CMV,	  Human	   herpesvirus	   5),	   with	   one	   sample	   containing	   CMV	   as	   the	   strongest	   identifiable	  contaminant.	   The	   distribution	   of	   read	   counts	   for	   each	   of	   these	   three	   viral	   genomes	   is	  shown	  in	  Figure	  4.1.	  We	  note	  that	  among	  the	  1295	  TCGA	  samples	  processed	  for	  this	  paper,	  only	   stomach	   adenocarcinoma	   exhibited	   any	   appreciable	   amounts	   of	   EBV.	   However,	   48	  samples	  of	  LAML	  and	  one	  sample	  of	  OV	  contained	  detectable	  levels	  of	  CMV.	  RNA-­‐seq	   is	   commonly	   used	   for	   the	   analysis	   of	   differentially	   expressed	   genes	   and	  transcripts.	   The	   most	   widely	   accepted	   method	   for	   estimating	   statistically	   significant	  variation	   in	   read	   counts	   is	  based	  on	   the	  negative	  binomial	  distribution.	  This	  method	  has	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been	  adopted	  by	  the	  R	  packages	  DESeq	  (Anders	  and	  Huber	  2010),	  edgeR	  (Robinson	  et	  al.	  2010),	   and	   baySeq	   (Hardcastle	   and	   Kelly	   2010),	   as	   well	   as	   the	   most	   recent	   version	   of	  CuffDiff	   (Trapnell	   et	   al.	   2010),	   among	   others.	   The	   standard	   protocol	   for	   generating	   such	  read	   counts	   is	   to	   process	   an	   existing	   BAM	   file	   with	   an	   annotation	   using	   one	   of	   several	  scripts,	  such	  as	  the	  Python-­‐based	  htseq-­‐count	  or	  BEDTools.	  This	  process	  of	  generating	  read	  counts	   can	   add	   substantial	   processing	   time	   per	   sample.	   Because	   SNAP-­‐RNA	   uses	   the	  genome	   annotation	   as	   part	   of	   the	   alignment	   process,	   it	   automatically	   reports	   all	   read	  counts	   for	   immediate	  statistical	  analysis,	  with	  no	  running	   time	  penalty	  and	  no	  additional	  software	   required.	   Of	   the	   four	   aligners	   tested,	   SNAP-­‐RNA	   and	   Subjunc	   are	   able	   to	  automatically	   generate	   read	   counts.	   We	   generated	   a	   third	   RNA-­‐seq	   dataset	   with	   Mason	  (Holtgrewe	   2010)	   that	   contained	   2x106	   paired-­‐end	   reads	   with	   standard	   IlluminaTM	  sequencing	  error	  rates	  from	  the	  Ensembl	  v68	  annotation.	  As	  before,	  reads	  were	  simulated	  with	  homozygous	  and	  heterozygous	  variants/indels	  present	  in	  the	  Venter	  genome	  (Levy	  et	  al.	   2007).	   This	   dataset	  was	   processed	   using	   all	   four	   aligners	   and	   gene	   read	   counts	  were	  generated.	  SNAP-­‐RNA	  and	  Subjunc	  are	  able	  to	  generate	  gene	  read	  counts	  internally,	  while	  read	  counts	  for	  STAR	  and	  TopHat2/Bowtie2	  were	  generated	  using	  htseq-­‐count	  .	  Calculated	  gene	  read	  counts	  were	  compared	  to	  the	  exact	  gene	  read	  counts	  calculated	  from	  the	  SAM	  file	  output	   by	   Mason.	   The	   scatterplot	   comparisons	   are	   presented	   in	   Figure	   4.2.	   SNAP-­‐RNA	  calculates	  reads	  counts	  the	  most	  accurately	  out	  of	  all	  four	  aligners	  tested.	  	  	   For	  the	  identification	  of	  fusion	  genes	  or	  trans-­‐splicing	  events,	  SNAP-­‐RNA	  makes	  use	  of	  both	  mate	  pair	  information	  and	  spliced	  reads	  to	  filter	  out	  false	  positives.	  Reads	  that	  fail	  to	   align	   to	   either	   the	   transcriptome	   or	   the	   genome	   are	   searched	   for	   inter-­‐	   and	   intra-­‐	  chromosomal	  splicing.	  The	  hash	   index	   is	  able	   to	  quickly	   identify	  all	  places	   in	   the	  genome	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where	   partial	   alignments	   of	   a	   read	   occur.	   Only	   intra-­‐	   and	   inter-­‐chromosomal	   spanning	  paired	  end	  alignments	  that	  are	  supported	  by	  intra-­‐	  and	  inter-­‐chromosomal	  splicing	  events	  are	   reported	   as	   putative	   fusion	   events	   (Figure	   4.3).	   SNAP-­‐RNA	   automatically	   reports	   all	  putative	  fusion	  events	  in	  GTF	  format,	  for	  easy	  visualization	  in	  an	  environment	  such	  as	  the	  UCSC	   Genome	   Browser	   (Kent	   et	   al.	   2002)	   or	   the	   Integrative	   Genomics	   Viewer	  (Thorvaldsdóttir	   et	   al.	   2013).	   A	   novel	   gene	   fusion	   was	   recently	   identified	   between	   the	  genes	   FGFR3	   and	   TACC3	   in	   approximately	   3%	   of	   the	   studied	   glioblastoma	   multiforme	  (GBM)	  samples	  (Devendra	  Singh	  et	  al.	  2012).	  This	  discovery	  necessitated	  the	  realignment	  of	  unaligned	  reads	  using	  a	  combined	  BWA/BLAST	  pipeline	  developed	  specifically	  for	  that	  project	  by	  the	  authors.	  We	  applied	  SNAP-­‐RNA	  to	  the	  fusion	  samples	  (TCGA-­‐27-­‐1835,	  TCGA-­‐76-­‐4925)	  identified	  in	  Singh	  et	  al.,	  and	  it	  reported	  the	  TACC3-­‐FGFR3	  fusion	  as	  the	  top	  intra-­‐chromosomal	   fusion	   candidate	   for	   both	   samples,	   with	   over	   20,000	   evidentiary	   reads	   in	  sample	  TCGA-­‐27-­‐1835	  and	  nearly	  600	  evidentiary	  reads	  in	  sample	  TCGA-­‐76-­‐4925.	  We	  next	  applied	   SNAP-­‐RNA	   to	   a	   chronic	   myelogenous	   leukemia	   (CML)	   sample	   from	   dbGaP	  (SRR607562),	   identifying	   the	   canonical	   BCR-­‐ABL1	   fusion	   gene	   product	   as	   the	   top	   inter-­‐chromosomal	  fusion	  event	  with	  nearly	  100	  evidentiary	  reads	  (Figure	  4.3).	  Recently	  Frattini	  et	   al.	   reported	   the	   landscape	   of	   gene	   fusions	   in	   58	   glioblastoma	   RNA-­‐seq	   samples	   from	  TCGA(Frattini	   et	   al.	   2013).	   We	   ran	   SNAP-­‐RNA	   on	   the	   same	   58	   samples,	   partially	   or	  completely	  identifying	  93%	  of	  the	  fusions	  reported	  in	  Frattini	  et	  al.	  (Figure	  4.3).	  	  In	  total,	  we	  have	  processed	  312	  stomach	  adenocarcinoma	  (STAD),	  58	  glioblastoma	  multiforme	   (GBM),	   117	   acute	   myeloid	   leukemia	   (LAML),	   and	   808	   ovarian	   serous	  cystadenocarcinoma	  (OV)	  samples	  from	  TCGA,	  quality	  filtering	  all	   input	  reads,	  generating	  read	  counts	  for	  each	  sample	  suitable	  for	  immediate	  statistical	  analysis,	  identifying	  putative	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fusion	   events	   and	   contaminant	   information	   for	   all	   samples,	   and	   finally	   writing	   the	   new	  alignments	   directly	   to	   compressed	   BAM	   format.	   No	   step	   of	   this	   analysis	   required	   any	  external	  software	  package	  and	  was	  completed	  using	  a	  single	  command	  for	  each	  sample.	  As	  discussed	   in	   Frattini	   et	   al.	   (Frattini	   et	   al.	   2013),	  we	   find	  many	   fusions	   in	   GBM	   involving	  
EGFR,	  LANCL2,	  and	  SEPT14.	  In	  addition	  to	  the	  viral	  infections	  identified	  in	  STAD,	  SNAP-­‐RNA	  finds	  evidence	  for	  fusions	  with	  ERBB2	  (Park	  et	  al.	  2012;	  Jong	  Woo	  Lee	  et	  al.	  2005)	  (HER2)	  and	  IGF2	  (Pavelić	  et	  al.	  2003),	  which	  are	  commonly	  mutated,	  amplified,	  and	  overexpressed	  in	   gastric	   cancers.	   Few	   cancer	   types	   are	  more	   canonically	   associated	  with	   translocations	  than	  leukemia,	  and	  SNAP-­‐RNA	  identifies	  the	  canonical	  fusions	  in	  the	  LAML	  samples:	  BCR-­‐
ABL1	  (Ren	  2005),	  CBFB-­‐MYH11	  (Castilla	  et	  al.	  1999),	  RUNX1-­‐RUNX1T1	  (Tonks	  et	  al.	  2006),	  and	  PML-­‐RARA	  (Yoshida	   et	   al.	   1996).	   Furthermore,	   SNAP-­‐RNA	   identifies	   10	   of	   the	   LAML	  samples	   with	   very	   high	   read	   counts	   mapping	   to	   genus	   Acinetobacter	   (~6x106	   reads),	  species	   of	   which	   are	   commonly	   associated	   with	   hospital-­‐acquired	   infections	   in	  immunocompromised	  patients.	  Finally,	  in	  OV	  samples	  SNAP-­‐RNA	  finds	  evidence	  for	  fusions	  involving	  IGF2	  (Murphy	  et	  al.	  2006;	  Sayer	  et	  al.	  2005),	  H19	  (Murphy	  et	  al.	  2006),	  GPX3	  (Hee	  Joong	   Lee	   et	   al.	   2011;	   Agnani	   et	   al.	   2011),	  MUC16	   (Thériault	   et	   al.	   2011),	   and	  WNT7A	  (Yoshioka	  et	  al.	  2012).	  	  	  
Conclusions	  The	  promise	  of	  discovery	  through	  RNA	  sequencing	  is	  constrained	  by	  our	  ability	  to	  analyze	  the	  rapidly	  growing	  quantity	  of	  data,	  and	  the	  rate	  of	  data	  generation	  continues	  to	  accelerate.	  Databases	  such	  as	  The	  Cancer	  Genome	  Atlas	  (http://cancergenome.nih.gov),	  the	  NCBI	  Database	  of	  Genotypes	  and	  Phenotypes	  (Mailman	  et	  al.	  2007),	  and	  the	  Sequence	  Read	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Archive	   (Kodama	   et	   al.	   2012)	   are	   accumulating	   petabytes	   of	   data,	  most	   of	  which	  will	   be	  analyzed	  once	  and	  for	  a	  single	  purpose,	  despite	  periodic	  updates	  of	  genome	  assemblies	  and	  annotations.	  SNAP-­‐RNA	  enables	  researchers	  to	  leverage	  hundreds	  to	  thousands	  of	  samples	  to	  accurately	  identify	  statistically	  rare	  patterns	  of	  gene	  expression	  or	  other	  transcriptomic	  perturbations,	   while	   also	   providing	   automatic	   additional	   detection	   of	   contaminants	   and	  fusion	  events.	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Figures	  and	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Figure	   4.1:	   (A)	   ROC	   curve	   for	   variant	   calling	   with	   GATK	   using	   2.5x107	  100bp	   paired-­‐end	  reads	  generated	  by	  Mason	  with	  IlluminaTM	  sequencing	  errors	  using	  the	  Venter	  genome.	  80%	  of	   reads	   were	   generated	   from	   the	   Ensembl	   v68	   annotation,	   while	   20%	   were	   generated	  directly	  from	  the	  genome.	  (B)	  ROC	  curve	   for	  variant	  calling	  with	  GATK	  using	  2.5x107	  100bp	  paired-­‐end	   reads	   generated	   by	   Mason	   with	   IlluminaTM	   sequencing	   errors	   using	   the	   Venter	  genome.	   80%	  of	   reads	  were	   generated	   from	   the	   Ensembl	   v68	   annotation,	  while	   20%	  were	  generated	   from	   annotated	  pseudogenes.	   (C)	  Running	   times	   for	   all	   four	   aligners	   on	   2.5x107	  paired-­‐reads	   of	   varying	   lengths	   (50,	   75,	   100,	   125bp).	   All	   processing	   was	   performed	   on	   16	  cores	  using	  an	  Amazon	  EC2	  cr1.8xlarge	  instance.	  (D)	  Distribution	  of	  reads	  aligning	  to	  Epstein-­‐Barr	   virus	   Type	   1,	   Epstein-­‐Barr	   virus	   Type	   2,	   and	   cytomegalovirus	   genomes	   from	   312	  processed	   TCGA	   stomach	   adenocarcinoma	   samples	   by	   SNAP-­‐RNA.	   Read	   counts	   were	  automatically	   generated	   using	   the	   contamination	   database	   functionality	   implemented	   in	  SNAP-­‐RNA.	  Samples	  with	  zero	  counts	  are	  not	  shown.	  Note	  the	  x-­‐axis	  is	  on	  a	  logarithmic	  scale.	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Figure	   4.2:	   Aligned	   gene	   read	   counts	   for	   2x107	   paired-­‐end	   reads	   generated	   by	   Mason	   with	  IlluminaTM	  sequencing	  errors	  using	  the	  Venter	  genome.	  100%	  of	  reads	  were	  generated	  from	  the	  Ensembl	  v68	  annotation,	  and	  aligned	  using	  each	  of	  the	  four	  tested	  aligners.	  ‘Correct’	  read	  counts	  (x-­‐axis)	   for	   each	   gene	   were	   generated	   from	   the	   Mason	   SAM	   file.	   (A)	   SNAP-­‐RNA	   automatically	  generates	  gene	  read	  counts.	  (B)	  Read	  counts	   for	  STAR	  alignments	  were	  generated	  using	  htseq-­‐count.	   (C)	  Read	  counts	   for	  Subjunc	  alignments	  were	  generated	  using	   the	  built-­‐in	   featureCounts	  functionality.	   (D)	   Read	   counts	   for	   TopHat2/Bowtie2	   alignments	   were	   generated	   using	   htseq-­‐count.	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Figure	   4.3:	   (A)	   SNAP-­‐RNA	   only	   considers	  fusion	   events	   that	   are	   supported	   by	   spanning	  reads	   as	   well	   as	   spliced	   reads.	   (B)	   SNAP-­‐RNA	  finds	   the	   FGFR3-­‐TACC	   fusion	   event	   in	   GBM	  sample	   TCGA-­‐27-­‐1835	   with	   thousands	   of	  evidentiary	   reads,	   and	   the	  BCR-­‐ABL1	   fusion	   in	  the	   CML	   sample	   SRR607562	   with	   nearly	   100	  evidentiary	  reads	  (C)	  In	  an	  analysis	  of	  58	  GBM	  RNA-­‐seq	   samples	   from	   TCGA,	   SNAP-­‐RNA	  partially	  or	  completely	  identified	  93%	  of	  the	  82	  fusions	   from	   Frattini	   et	   al.	   A	   partial	   fusion	   is	  where	  one	  or	  both	  of	  the	  genes	  from	  Frattini	  et	  al.	   participate	   in	   a	   fusion	   event,	   just	   not	   with	  each	  other.	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CHAPTER	  5:	  TRANSCRIPTOME-­‐WIDE	  DIFFERENTIAL	  RNA	  
EDITING	  IN	  HUMAN	  BRAIN	  AND	  GLIOMA	  
	  
Abstract	  Glioblastoma	  multiforme	   (GBM)	   is	   the	   deadliest	   and	  most	   common	   form	   of	   brain	  cancer.	  	  Recent	  developments	  in	  next-­‐generation	  sequencing	  have	  revealed	  unprecedented	  levels	   of	   RNA	   editing	   of	   expressed	   transcripts,	   the	  majority	   of	  which	   occur	   in	   the	   brain.	  Alterations	   in	   expression	   of	   editing	   enzymes	   have	   been	   associated	   with	   increased	   cell	  proliferation	   and	  migration	   in	   GBM	   cell	   lines,	   and	   differential	   editing	   has	   been	   linked	   to	  tumor	  growth	   in	  hepatocellular	   carcinoma.	  This	   study	   represents	   the	   first	   global	   view	  of	  differential	   editing	   across	   multiple	   healthy	   brain	   regions	   and	   low-­‐	   and	   high-­‐grade	  astrocytoma.	   We	   identify	   broad	   changes	   in	   expression	   of	   editing	   enzymes	   across	  phenotypes	   that	   are	   correlated	   with	   changes	   in	   editing	   levels	   of	   specific	   transcripts,	  highlighting	  the	  editing	  positions	  most	  likely	  to	  be	  clinically	  relevant	  in	  GBM.	  	  
Introduction	  RNA	   editing	   is	   the	   enzymatic	   modification	   of	   bases	   within	   expressed	   RNA	  transcripts.	   The	   most	   well	   studied	   RNA	   editing	   event	   occurs	   when	   adenosine	   (A)	   is	  deaminated	  to	  form	  inosine	  (I)	  a	  process	  known	  as	  A-­‐to-­‐I	  editing.	  This	  reaction	  is	  catalyzed	  by	   the	   ADAR	   (adenosine	   deaminase	   acting	   on	   RNA)	   family	   of	   enzymes,	   which	   includes	  
ADAR,	   ADARB1,	   and	   ADARB2	   (Bass	   2002).	   RNA	   editing	   has	   been	   shown	   to	   decrease	   in	  malignant	  gliomas	   (Maas	  et	  al.	  2001).	  Recent	   studies	  have	  characterized	  A-­‐to-­‐I	  editing	   in	  U87MG	   glioblastoma	   cell	   lines	   (Bahn	   et	   al.	   2012),	   immortalized	   B-­‐lymphocyte	   cell	   lines	  (Mingyao	  Li	  et	  al.	  2011),	  and	  cells	  derived	  from	  single	  individuals	  (Jin	  Billy	  Li	  et	  al.	  2009;	  
	  	   	  	   	   	  69	  
Peng	   et	   al.	   2012).	   These	   studies	   and	   others	   provide	   evidence	   that	   RNA	   editing	   is	   much	  more	   widespread	   than	   previously	   thought.	   The	   Database	   of	   RNA	   Editing	   (DARNED)	  currently	  lists	  over	  333,000	  editing	  positions	  in	  the	  hg19	  assembly	  of	  the	  human	  genome	  (Kiran	  et	  al.	  2013),	  and	  a	  recent	  paper	  increases	  this	  number	  to	  well	  over	  a	  million	  editing	  positions,	  most	  of	  which	  were	  identified	  in	  the	  brain	  (Ramaswami	  et	  al.	  2013).	  	  	  The	  functional	  consequences	  of	  edits	  in	  the	  protein-­‐coding	  regions	  for	  several	  genes	  have	  been	  well	  characterized.	  One	  of	  the	  most	  well	  studied	  RNA	  editing	  events	  is	  found	  in	  the	  AMPA-­‐selective	  glutamate	  receptor	  family,	  where	  editing	  of	  the	  pre-­‐mRNA	  results	  in	  a	  non-­‐synonymous	  amino	  acid	  substitution	  for	  several	  of	  the	  family	  members	  (Sommer	  et	  al.	  1991).	   The	   importance	   of	   RNA	   editing	   has	   also	   been	   demonstrated	   through	   knockout	   of	  ADAR	  family	  proteins	  in	  mice.	  ADAR-­‐/-­‐	  mice	  undergo	  liver	  disintegration	  and	  death	  by	  the	  twelfth	   day	   of	   embryonic	   development	   (Hartner	   et	   al.	   2004).	  ADARB1-­‐/-­‐	  mice	   die	   shortly	  after	   birth	   due	   to	   excess	   Ca2+	   influx	   in	   neuronal	   cells	   (Seeburg	   et	   al.	   2001).	   The	   vast	  majority	  of	   reported	  edits	  are	   in	   introns	  and	  3’	  untranslated	   regions	   (UTRs).	  These	  edits	  mostly	  originate	   from	  inverted	  Alu	   repeats	   that	  combine	   to	   form	  double-­‐stranded	  RNA—the	  requisite	  substrate	  for	  ADAR	  binding	  and	  editing	  (Athanasiadis	  et	  al.	  2004).	  Though	  a	  few	   functional	   consequences	   of	   Alu-­‐mediated	   editing	   for	   specific	   transcripts	   have	   been	  identified,	  it	  is	  unclear	  what,	  if	  any,	  function	  exists	  for	  the	  majority	  of	  these	  edits.	  Editing	  of	  
Alu	   regions	   in	   the	   3’UTR	   for	   a	   handful	   of	   genes	   has	   been	   shown	   to	   influence	   splicing	  (Athanasiadis	  et	  al.	  2004).	  Another	  report	  describes	  how	  the	  3’	  UTR	  of	  CTN-­‐RNA	  is	  edited	  and	  retained	  in	  the	  nucleus,	  possibly	  through	  its	  association	  with	  inosine-­‐binding	  protein	  P54NRB.	  Other	  3’	  UTR	  edits	  occur	   in	   the	  seed	  regions	  of	  miRNA	  binding	  sites,	  which	  can	  enable	  or	  abolish	  microRNA	  binding	  sites	  (Borchert	  et	  al.	  2009).	  Conversely,	  ADARs	  have	  
	  	   	  	   	   	  70	  
been	  found	  to	  directly	  edit	  microRNAs	   in	  the	  mouse	  brain	  (Kawahara	  et	  al.	  2007;	  Shahar	  Alon	  et	  al.	  2012).	  	  The	   contribution	   of	   A-­‐to-­‐I	   editing	   in	   cancer	   is	   becoming	   increasingly	   appreciated.	  Recently,	  Chen	  et	  al.	  reported	  on	  a	  single	  A-­‐to-­‐I	  editing	  position	  in	  the	  coding	  region	  of	  the	  
AZIN1	   gene	   (encoding	   antizyme	   inhibitor	   1)	   in	   the	   context	   of	   hepatocellular	   carcinoma	  (HCC)	  (Leilei	  Chen	  et	  al.	  2013).	  Remarkably,	  the	  non-­‐synonymous	  amino	  acid	  substitution	  resulting	  from	  this	  edit	  is	  significantly	  correlated	  with	  liver	  cirrhosis	  and	  tumor	  recurrence.	  	  Sie	   et	   al.	   examined	   two	   editing	   positions	   in	   IGFBP7	   (insulin-­‐like	   growth	   factor	   binding	  protein	   7),	   and	   determined	   that	   the	   amino	   acid	   substitutions	   resulting	   from	   the	   edit	  decreased	  proteolytic	  cleavage	  of	  the	  protein	  (Sie	  et	  al.	  2012).	  Hochberg	  et	  al.	  followed	  up	  on	   this	   study,	   demonstrating	   that	   editing	   levels	   of	   IGFBP7	   are	   significantly	   decreased	   in	  basal	   cell	   and	   squamous	   cell	   carcinoma,	   and	   the	   edited	   form	   of	   the	   protein	   inhibits	  proliferation	   and	   promotes	   cell	   senescence	   in	   cultured	   keratinocytes	   (Hochberg	   et	   al.	  2013).	  Galeano	  et	  al.	  examined	  multiple	  editing	  sites	  of	  BLCAP	  (bladder-­‐cancer	  associated	  protein)	   in	  coding	  and	  non-­‐coding	  regions	  of	   the	  expressed	  transcript,	  and	  demonstrated	  decreased	  editing	  percentages	  in	  cancerous	  tissues,	  although	  no	  specific	  functions	  have	  yet	  been	  associated	  with	  these	  edits	  (Galeano	  et	  al.	  2010).	  From	  a	  more	  global	  perspective	  of	  RNA	  editing,	  overexpression	  of	  ADAR	  and	  ADARB1	  in	  U87	  glioblastoma	  cell	  lines	  decreases	  cell	  proliferation	  and	  alters	  cell	  morphology	  (Paz	  et	  al.	  2007;	  Cenci	  et	  al.	  2008).	  	  	  Central	   to	   the	   discovery	   and	   characterization	   of	   widespread	   RNA	   editing	   is	   the	  development	  of	  next	  generation	  sequencing	  (NGS)	  and	  analysis.	  The	  challenge	  of	  accurately	  mapping	  reads	  generated	  from	  RNA-­‐seq	  experiments	  to	  identify	  differences	  between	  RNA	  and	   DNA	   has	   inherent	   challenges	   that	   directly	   tie	   to	   the	   accuracy	   and	   sensitivity	   of	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identifying	   RNA	   edits.	   A	   common	   approach	   for	   identifying	   RNA	   editing	   events	   is	   to	  compare	   the	   transcriptomic	  and	  genomic	  sequence	  data	   from	   the	  same	   individual	  or	   cell	  line.	  Without	  genomic	  sequence	  data,	  mapping	  RNA-­‐seq	  to	  a	  reference	  genome	  can	  result	  in	  spurious	   variants.	   However,	   a	   recent	   study	   (Ramaswami	   et	   al.	   2013)	   demonstrates	   that	  high	   levels	   of	   accuracy	   can	   be	   achieved	   in	   the	   absence	   of	   matched	   genome	   information	  through	   the	   comparison	   of	   multiple	   RNA-­‐seq	   samples	   with	   databases	   such	   as	   dbSNP	  (Sherry	  et	  al.	  2001)	  and	  the	  1000	  Genomes	  Project	  (1000	  Genomes	  Project	  Consortium	  et	  al.	  2012)	  to	  filter	  out	  common	  genetic	  variants.	  Any	  genome-­‐wide	  characterization	  of	  A-­‐to-­‐I	  editing	  must	   consider	   and	   take	  measures	   to	  minimize	   false	   positives	   due	   to	   sequencing	  error,	   PCR	   error,	   alignment	   error,	   and	   discrepancies	   between	   the	   reference	   genome	   and	  the	  sample	  genome	  (Pachter	  2012).	  Indeed,	  the	  very	  sites	  where	  RNA	  edits	  are	  found	  to	  be	  most	   common,	   within	   the	   low-­‐complexity,	   GC-­‐rich	   Alu	   sequences	   commonly	   found	   in	  introns	  and	  3’	  UTRs,	  can	  be	  problematic	  areas	  for	  NGS	  analysis.	  	  We	  have	  developed	  an	  RNA	  editing	  discovery	  pipeline	   and	  used	   it	   to	   identify	   and	  characterize	  differences	  in	  A-­‐to-­‐I	  editing	  events	  in	  nearly	  400	  primary	  tumor,	  normal	  brain,	  and	  cell	  line	  samples	  without	  the	  need	  for	  matched	  genomic	  samples.	  While	  the	  importance	  of	   identifying	  all	   instances	  of	   editing	   is	   an	   important	  aspect	   in	  deciphering	   the	  biological	  role	  of	  RNA	  editing	  in	  healthy	  and	  diseased	  tissue,	  identification	  of	  those	  edits	  that	  change	  between	  disease	  and	  healthy	  states	  is	  of	  equal	  interest	  and	  importance.	  Our	  large	  number	  of	   samples	   yields	   the	   necessary	   statistical	   power	   to	   effectively	   perform	   a	   comparative	  analysis	  of	  RNA	  editing	  in	  the	  brain	  (where	  editing	  has	  been	  shown	  to	  be	  more	  prominent	  than	  any	  other	  tissue),	   in	  which	  we	  characterize	  the	  change	  in	  editing	  percentage	  at	  each	  base	   across	   different	   brain	   regions	   and	   across	   two	   disease	   states—low	   and	   high	   grade	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astrocytoma—for	  the	  entire	  transcriptome.	  This	  focus	  on	  phenotypic	  variation	  rather	  than	  static	  editing	  positions	  allows	  the	  identification	  of	  biologically	  relevant	  editing	  sites.	  	  
Methods	  
RNA-­‐seq	  for	  primary	  tumor	  samples	  We	  obtained	  50	  grade	  II	  and	  III	  astrocytoma	  (AST)	  primary	  tumor	  and	  142	  grade	  IV	  glioblastoma	   (GBM)	   primary	   tumor	   RNA-­‐seq	   samples	   from	   The	   Cancer	   Genome	   Atlas	  	  (TCGA)	   via	   the	   Cancer	   Genomics	   Hub	   (CGHub).	   	   Available	   samples	   were	   first	   identified	  using	   the	   CGQuery	   tool	   with	   the	   filters	   “disease_abbr=GBM”	   (glioblastoma)	   or	  “disease_abbr=”LGG”	   (astrocytoma),	   “platform=Illumina”,	   “center_name=UNC-­‐LCCC”,	   and	  “library_strategy=RNA-­‐Seq”.	   The	   resulting	   files	   were	   downloaded	   using	   the	   CGHub	  GeneTorrent	   program.	  While	   other	   cancer	   types	   are	   included	   in	   the	   TCGA	   LGG	   category	  (oligoastrocytoma	  and	  oligodendroglioma),	  only	  astrocytoma	  samples	  were	  included	  in	  the	  downstream	  analysis.	  All	  processed	  TCGA	  GBM	  data	  are	  76-­‐bp	  paired-­‐end	  reads	  sequenced	  on	   an	   IlluminaTM	   HiSeq	   2000.	   All	   processed	   TCGA	   AST	   data	   are	   50-­‐bp	   paired-­‐end	   reads	  sequenced	   on	   an	   IlluminaTM	  HiSeq	   2000.	   All	   TCGA	   samples	  were	   sequenced	   at	   the	  UNC-­‐Chapel	  Hill	  Lineberger	  Comprehensive	  Cancer	  Center.	  All	  files	  obtained	  from	  TCGA	  were	  in	  the	   SAMtools	   BAM	   format	   (Heng	   Li	   et	   al.	   2009)	   from	  which	   the	   raw	   FASTQ	   reads	  were	  extracted	  using	  a	   custom	  script.	  159	  normal	  brain	  RNA-­‐seq	   samples	  were	  obtained	   from	  the	   NIH	   Database	   of	   Genotypes	   and	   Phenotypes	   Genotype-­‐Tissue	   (dbGaP)	   Expression	  Common	   Fund	   Project	   (phs000424.v3.p1).	   All	   available	   samples	  were	   selected	   using	   the	  SRA	  RUN	  selector	  for	  the	  following	  brain	  regions:	  amygdala,	  anterior	  cingulate	  cortex,	  basal	  ganglia,	   cerebellar	   hemisphere,	   cerebellum,	   cortex,	   frontal	   cortex,	   hippocampus,	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hypothalamus,	   substantia	   nigra.	   The	   selected	   files	   were	   downloaded	   using	   the	   Aspera	  program.	  Fourteen	  of	  the	  processed	  dbGaP	  normal	  brain	  samples	  were	  101-­‐bp	  paired-­‐end	  reads;	  the	  remaining	  samples	  were	  76-­‐bp	  paired-­‐end	  reads.	  All	  processed	  dbGaP	  samples	  were	  sequenced	  on	  an	  IlluminaTM	  HiSeq	  2000	  at	  the	  Broad	  Institute.	  All	  files	  obtained	  from	  dbGaP	  were	  in	  an	  encrypted	  SRA	  format,	  from	  which	  the	  raw	  FASTQ	  reads	  were	  extracted	  using	  the	  fastq-­‐dump	  tool	  in	  the	  NCBI	  SRA	  Toolkit	  v2.2.2b.	  	  	  	  
U87	  cell	  line	  preparation,	  library	  construction,	  and	  sequencing	  The	  four	  isogenic	  U87	  cell	  lines	  were	  obtained	  from	  Paul	  Mischel	  (Ludwig	  Institute,	  UCSD).	   Expression	   of	   EGFR,	   PTEN,	   and	   EGFR+PTEN	   was	   enabled	   through	   the	   stable	  integration	  of	  the	  genes	  using	  a	  retroviral	  vector	  (Riemenschneider	  et	  al.	  1999;	  Mellinghoff	  et	  al.	  2005).	  Cells	  were	  maintained	  in	  DMEM	  containing	  10%	  FBS,	  supplemented	  with	  1mM	  sodium	  pyruvate	  and	  HEPES	  buffer.	  Cells	  were	  seeded	   in	  maintenance	  media	  on	  Corning	  Cellgro	   10cm	   dishes	   at	   sub-­‐confluent	   amounts	   prior	   to	   being	   washed	   with	   HBSS	   upon	  which	   they	  were	  grown	   for	  ~36	  hours	   in	  Neurobasal	  media	  containing	  B-­‐27	  supplement	  (both	   from	  Life	  Technologies).	   	  5mM	  EGF	  (LONG	  EGF,	  Sigma-­‐Aldrich)	  or	  vehicle	   (10nM	  HCl	   in	  water)	  was	  added	   to	  samples	  24	  hours	  prior	   to	  harvest.	  Cells	  were	  harvested	  and	  total	  RNA	  was	  isolated	  using	  the	  miRVana	  PARIS	  kit	  (Life	  Technologies).	  A	  companion	  dish	  of	  cells	  was	  grown	  under	  identical	  conditions	  and	  used	  to	  count	  cells	  at	  the	  time	  of	  harvest.	  Though	  the	  cell	  lines	  grow	  at	  slightly	  different	  rates,	  the	  number	  of	  cells	  with	  which	  to	  seed	  was	  empirically	  determined	  so	  that	  all	  cell	  lines	  contained	  approximately	  the	  same	  number	  of	   cells	   per	   plate	   (8.0x105)	   at	   the	   time	   of	   harvest.	   Libraries	   were	   created	   using	   the	  IlluminaTM	   TruSeq	   kit,	   following	   the	   protocol	   outlined	   from	   November	   2010	   including	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polyA	  enrichment.	  All	  U87	  cell	  line	  libraries	  were	  sequenced	  on	  an	  IlluminaTM	  HiSeq	  2000	  at	  the	  University	  of	  Illinois	  Core	  Facilities	  using	  the	  100-­‐bp	  paired-­‐end	  protocol.	  	  	  	  
Quality	  and	  unique	  filtering	  Raw	  RNA-­‐seq	  paired-­‐end	   reads	  were	   filtered	   for	   a	   Phred	   score	   >	   20	   over	   at	   least	  90%	  of	  the	  bases	  of	  each	  read.	  If	  only	  one	  mate	  failed	  this	  cutoff,	  the	  entire	  paired-­‐end	  read	  was	  discarded.	  After	  being	  filtered	  for	  Phred	  quality,	  the	  remaining	  paired-­‐end	  reads	  were	  filtered	   for	   uniqueness.	   If	   the	   sequence	   of	   both	  mates	   of	   two	   or	  more	   paired-­‐end	   reads	  were	  identical	  within	  a	  sample,	  only	  one	  of	  the	  paired-­‐end	  reads	  was	  retained	  in	  the	  output	  file.	   The	   paired-­‐end	   read	   retained	   had	   the	   highest	   average	   Phred	   score	   over	   all	   reads	  considered.	  Because	  the	  assembled	  RNA-­‐seq	  libraries	  were	  prepared	  using	  an	  unstranded	  library	  protocol,	  all	  paired-­‐end	  reads	  were	  checked	  against	  the	  original	  sequence	  as	  well	  as	  the	  reverse	  complement	  of	  all	  other	  reads	  to	  determine	  uniqueness.	  All	  quality	  and	  unique	  filtering	  was	  performed	  using	  custom	  C++	  scripts.	  	  
Alignment	  to	  reference	  assembly	  genome	  and	  transcriptome	  We	  obtained	  the	  Genome	  Reference	  Consortium	  h37	  assembly	  (GRCh37/hg19)	  from	  the	   NCBI	   (ftp://ftp.ncbi.nlm.nih.gov/genomes).	   The	   Ensembl	   human	   genome	   annotation	  version	  68	  was	  used	   to	   extract	   the	   sequences	  of	   all	   spliced	   transcripts	   from	   the	  GRCh37	  assembly	  using	  a	  custom	  Python	  script,	  with	  the	  resulting	  data	  hereafter	  referred	  to	  as	  the	  transcriptome.	  Both	  the	  genome	  and	  transcriptome	  sequence	  files	  were	  used	  to	  build	  index	  files	  for	  the	  SNAP	  aligner	  (Zaharia	  et	  al.	  2011)	  using	  the	  default	  seed	  size	  of	  20.	  Each	  mate	  was	  aligned	  to	  the	  genome	  and	  transcriptome	  independently	  using	  the	  SNAP	  aligner	  with	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the	  following	  command:	  “snap	  single	  index_directory	  input.fastq	  -­‐m	  2000	  –d	  8	  –c	  0	  –C++	  -­‐n	  50	  –h	  500	  –x	  –o	  output.sam”.	   	  This	  commands	  the	  SNAP	  aligner	  to	  search	  for	  up	  to	  2000	  alignment	  positions	  for	  each	  mate	  using	  up	  to	  50	  20-­‐nt	  seeds	  for	  each	  read	  and	  up	  to	  500	  hits	  for	  each	  seed,	  clipping	  low-­‐quality	  bases	  from	  the	  5’	  and	  3’	  ends,	  and	  allowing	  up	  to	  8	  mismatches	  to	  the	  reference	  genome.	  All	  alignments	  were	  reported	  to	  the	  output	  SAM	  file	  sorted	  by	  read	  identifier.	  Four	   independent	  runs	  of	   the	  SNAP	  aligner	  were	  performed	  for	  each	  sample:	  mate1	  to	  the	  genome,	  mate2	  to	  the	  genome,	  mate1	  to	  the	  transcriptome,	  and	  mate2	  to	  the	  transcriptome.	  In	  this	  manner	  four	  SAM	  files	  were	  generated	  for	  each	  sample.	  These	  four	  SAM	  files	  were	  then	  processed	  simultaneously	  using	  a	  custom	  Python	  script	  to	  identify	  the	  highest	  quality	  alignment	  position	  for	  each	  read.	  	  All	  alignments	  for	  each	  mate	  were	  converted	  into	  genomic	  coordinates	  and	  splice	  junctions	  were	  added	  where	  required	  for	   transcriptome	   alignments	   based	   on	   the	   Ensembl	   annotation	   version	   68.	   Identical	  alignments	   for	   each	  mate	  were	   combined	   (e.g.	   if	   a	  mate	   aligned	   to	   the	   genome	   and	   the	  equivalent	  position	  in	  the	  transcriptome,	  both	  alignments	  were	  merged).	  In	  this	  manner	  all	  unique	  alignments	  for	  each	  mate	  were	  identified	  to	  both	  the	  transcriptome	  and	  genome.	  If	  exactly	  2000	  alignment	  positions	  were	  reported	  for	  either	  mate,	  that	  read	  was	  discarded,	  because	  additional	  valid	  alignments	  could	  exist	  that	  were	  not	  explored	  by	  the	  aligner.	  Next,	  all	  mate	  pairs	  were	  identified	  for	  each	  read	  using	  all	  reported	  alignment	  positions	  for	  both	  mates.	  These	  pairs	  were	  filtered	  using	  the	  following	  criteria:	  1)	  Each	  mate	  of	  a	  pair	  must	  be	  aligned	   in	   at	   least	   one	   position,	   2)	   Each	   mate	   of	   a	   pair	   must	   be	   aligned	   to	   the	   same	  chromosome,	  3)	  One	  of	  the	  mates	  of	  a	  pair	  must	  be	  aligned	  to	  the	  forward	  strand,	  and	  the	  other	   to	   the	   reverse	   strand,	  4)	  The	  paired-­‐end	  distance	  between	   the	  mates	   for	   each	  pair	  must	   be	   less	   than	   100,000	   bases.	   All	   valid	   paired-­‐end	   alignments	  were	   identified	   in	   this	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manner	   for	   each	  paired-­‐end	   read.	  The	   following	   rules	  were	  used	   to	   identify	   high	  quality	  alignments:	  	  1)	  If	  a	  single	  paired-­‐end	  alignment	  remained	  after	  filtering,	  this	  alignment	  was	  considered	  high	  quality	  and	  written	  to	  the	  output	  file,	  2)	  If	  multiple	  paired-­‐end	  alignments	  remained,	  those	  alignments	  were	  sorted	  by	  their	  total	  number	  of	  mismatches.	  If	  the	  ‘best-­‐scoring’	  alignment	  (the	  one	  with	  the	  fewest	  number	  of	  mismatches)	  had	  at	  least	  two	  fewer	  mismatches	  than	  the	  ‘second-­‐best’	  scoring	  alignment,	  that	  alignment	  was	  considered	  high	  quality	   and	   written	   to	   the	   output	   file.	   Only	   high	   quality	   alignments	   were	   used	   for	  downstream	  analysis.	  
	  
Post-­‐processing	  of	  alignment	  files	  Following	  genome/transcriptome	  alignments	  and	  strict	  read	   filtering,	  all	  SAM	  files	  were	  converted	  to	  BAM	  format,	  sorted	  by	  alignment	  position,	  and	  indexed	  using	  SAMtools	  version	  0.1.18.	  	  In	  order	  to	  correlate	  gene	  expression	  of	  the	  ADAR	  family	  of	  enzymes	  with	  editing	   levels	   at	   each	   position,	   it	   was	   necessary	   to	   estimate	   gene	   expression	   for	   each	  sample.	   The	   htseq-­‐count	   package	   in	   the	   HTSeq	   framework	   version	   0.5.3p3	   (Anders	   and	  Huber	  2010)	  was	  used	  with	  the	  Ensembl	  annotation	  version	  68	  to	  count	  alignments	  to	  each	  gene.	   Only	   alignments	   overlapping	   exons	   were	   included	   in	   read	   counts.	   Finally,	   raw	  alignment	   counts	   for	   all	   samples	  were	   loaded	   into	   edgeR	   version	  2.6.12	   (Robinson	   et	   al.	  2010)	   in	   the	   statistical	   environment	   R.	   The	   edgeR	   TMM	   method	   (trimmed	   mean	   of	   M-­‐values)	  was	   used	   to	   normalize	   all	   alignment	   counts	   by	   adjusted	   library	   sizes	   in	   order	   to	  estimate	  normalized	  counts	  per	  million	  (CPM)	  for	  each	  gene.	  Differential	  gene	  expression	  tests	  were	  performed	   in	  edgeR	  using	   tagwise	  dispersions	  and	  FDR-­‐corrected	  p-­‐values.	  P-­‐values	  <	  0.01	  were	  considered	  significant.	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Identification	  of	  RNA-­‐DNA	  differences	  and	  SNV	  filtering	  The	  UnifiedGenotyper	   tool	   from	   the	  Genome	  Analysis	  Toolkit	   (GATK)	   (DePristo	  et	  al.	   2011)	   was	   used	   for	   identifying	   RNA-­‐DNA	   differences,	   using	   the	   following	   options:	   “-­‐stand_call_conf	   0.0	   –stand_emit_conf	   0.0”.	   All	   results	  were	   output	   in	   Variant	   Call	   Format	  v4.1	  (VCF).	  RNA-­‐DNA	  differences	  were	   filtered	   for	  a	  minimum	  QUAL	  field	  of	  10.0	  using	  a	  custom	  Python	  script.	  The	  KAVIAR	  package	  (queryable	  database	  of	  Known	  VARiants)	  was	  used	   to	   filter	   known	   genomic	   variants	   from	   all	   quality-­‐filtered	   RNA-­‐DNA	   differences	   for	  each	   sample	   (Glusman	   et	   al.	   2011).	   KAVIAR	  makes	   use	   of	   a	   comprehensive	   database	   of	  known	   variants	   derived	   from	   dbSNP,	   The	   1000	   Genomes	   Project,	   the	   ESP6500	   NHLBI	  exomes	  and	  25	  other	  data	  sources,	  encompassing	  a	  total	  of	  53	  million	  variant	  sites.	  Because	  the	  assembled	  RNA-­‐seq	   libraries	  were	  prepared	  using	  an	  unstranded	   library	  protocol,	  all	  putative	  editing	  positions	  were	  assigned	  to	  a	  strand	  using	  the	  Ensembl	  annotation	  version	  68	  using	  a	  custom	  Python	  script.	  Prior	  to	  assigning	  strandedness,	  all	  genes	  were	  buffered	  on	   the	   3’	   end	   by	   3	   kilobases.	   This	   buffering	   allowed	   the	   assignment	   of	   strandedness	   for	  edits	  occurring	  beyond	  the	  annotated	  3’	  UTR	  of	  each	  transcript.	  Putative	  editing	  positions	  for	   which	   the	   strand	   was	   ambiguous	   (in	   the	   case	   that	   buffered	   genes	   overlapped	   on	  opposite	  strands)	  were	  not	  considered	  in	  any	  downstream	  analysis.	  	  
Calculation	  of	  editing	  percentage	  While	  editing	  positions	  can	  in	  principle	  be	  identified	  using	  low	  depth	  of	  coverage,	  an	  accurate	   estimation	   of	   editing	  percentage	   across	   phenotypes	   requires	   a	   greater	   depth	   of	  coverage	  for	  each	  site.	  As	  a	  result,	  we	  required	  a	  minimum	  depth	  of	  coverage	  of	  10	  reads	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for	  any	  putative	  editing	  position	  considered	  in	  this	  analysis.	  All	  putative	  editing	  positions	  from	  each	  sample	  were	  therefore	  filtered	  for	  depth	  of	  coverage	  using	  the	  VCF	  ‘allelic	  depth’	  field	  (AD),	  in	  which	  the	  sum	  of	  all	  allelic	  depths	  was	  used	  as	  the	  total	  depth	  of	  coverage	  at	  that	  position	  as	  measured	  by	  RNA-­‐seq.	  Any	  putative	  editing	  position	  with	  more	  than	  two	  alleles	  was	   discarded.	   The	   editing	   percentage	  was	   calculated	   by	   dividing	   the	   ALT	   allelic	  depth	  by	  the	  total	  depth	  at	  that	  position.	  Each	  putative	  edit	  was	  required	  to	  be	  present	  in	  at	  least	   five	   samples	   to	   be	   considered	   for	   downstream	   analysis.	   All	   editing	   percentage	  calculations	  were	  performed	  using	  custom	  Python	  scripts.	  	  
Identification	  of	  differentially	  edited	  bases	  All	   samples	   containing	   each	   edited	   position	   were	   grouped	   into	   the	   following	  categories:	   astrocytoma,	   glioblastoma,	   amygdala,	   anterior	   cingulate	   cortex,	   basal	   ganglia,	  cerebellar	   hemisphere,	   cerebellum,	   cortex,	   frontal	   cortex,	   hippocampus,	   hypothalamus,	  substantia	   nigra,	   U87	   parental,	   U87	  EGFR+,	   U87	  PTEN+,	   U87	  EGFR/PTEN+.	   Differentially	  edited	   bases	   were	   identified	   using	   the	   non-­‐parametric	   Kruskal-­‐Wallis	   test	   to	   identify	  statistically	   significant	   differences	   in	   mean	   editing	   levels	   across	   multiple	   groups.	   The	  statistical	  tests	  were	  performed	  with	  the	  Python	  package	  SciPy	  (http://www.scipy.org).	  P-­‐values	   were	   adjusted	   for	   multiple	   hypothesis	   testing	   (false	   discovery	   rate)	   using	   the	  method	  of	  Storey	  (Storey	  2002).	  A	  minimum	  of	  five	  samples	  containing	  a	  valid	  edit	  (having	  a	  depth	  of	  coverage	  of	  at	   least	  10	  reads)	  within	  each	  group	  were	  required	  to	  include	  that	  group	  in	  the	  statistical	  test	  for	  each	  editing	  position.	  Groups	  with	  fewer	  than	  the	  requisite	  five	   samples	  were	   omitted	   from	   the	  Kruskal-­‐Wallis	   test	   for	   that	   editing	  position	   and	  not	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considered	  in	  any	  downstream	  analysis,	  due	  to	  the	  significant	  likelihood	  of	  deviation	  from	  the	  chi-­‐squared	  distribution.	  P-­‐values	  <	  0.01	  were	  considered	  significant.	  	  	  
Computational	  resources	  All	   high-­‐throughput	   analysis,	   including	   read	   filtering,	   alignment,	   and	   post-­‐processing,	  was	  performed	  on	  the	  Amazon	  Web	  Services	  Elastic	  Cloud	  using	  instance	  type	  
m2.4xlarge.	   All	   software	   and	   custom	  scripts	  used	   in	   this	   study	  are	  publicly	   available	   and	  pre-­‐configured	   via	   our	   custom	   Amazon	   Machine	   Image:	   ami-­‐fe35ab97.	   Configuration	   of	  EC2	  clusters	  was	  performed	  with	  StarCluster	  (star.mit.edu/cluster).	  
	  
Results	  
Expression	  of	  editing	  enzymes	  is	  dysregulated	  in	  gliomas	  and	  cerebellum	  Because	  A-­‐to-­‐I	  editing	  is	  catalyzed	  by	  the	  ADAR	  family	  of	  enzymes,	  we	  investigated	  the	  expression	  of	  ADAR1,	  ADARB1,	  and	  ADARB2	  across	  all	  available	  brain	  regions	  as	  well	  as	  AST	  and	  GBM	  (Figure	  5.1).	  We	  observe	  no	  significant	  difference	  in	  ADAR	  expression	  across	  any	   normal	   brain	   regions,	   with	   the	   exception	   of	   cerebellum,	   which	   exhibits	   a	   small	   but	  statistically	   significant	   decrease	  with	   respect	   to	   some	   other	   brain	   tissues.	   In	   contrast	   to	  normal	  brain,	  both	  AST	  and	  GBM	  primary	  tumor	  samples	  show	  a	  marked	  increase	  in	  mean	  expression	  of	  ADAR	  and	  decreased	  ADARB1	  expression,	  consistent	  with	  the	  observations	  of	  previous	  studies	  (Cenci	  et	  al.	  2008;	  Paz	  et	  al.	  2007).	  Cerebellum	  and	  cerebellar	  hemisphere	  exhibit	   a	   striking	   increase	   in	   expression	   of	   ADARB1	   compared	   to	   all	   other	   tissues.	  Expression	   of	   ADARB2	   is	   almost	   completely	   absent	   in	   GBM,	   although	   its	   expression	   is	  similar	  to	  that	  of	  normal	  brain	  tissue	  in	  lower	  grade	  AST.	  The	  U87	  cell	  lines	  exhibit	  lower	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expression	  of	  ADAR	  with	  respect	  to	  GBM	  and	  AST	  primary	  tumor	  samples,	  and	  expression	  of	  ADAR	  is	  increased	  in	  the	  EGFR+	  cells.	  	  	  
Allele	  distributions	  differ	  between	  SNVs	  and	  putative	  edits	  In	  order	  to	  maximize	  statistical	  power	  for	  downstream	  analyses	  (e.g.	  Kruskal-­‐Wallis	  tests),	  we	  grouped	  the	  samples	  into	  four	  major	  categories	  based	  on	  phenotype	  and	  ADAR	  gene	  family	  expression	  (Figure	  5.1).	  Because	  cerebellum	  and	  cerebellar	  hemisphere	  exhibit	  such	   striking	  differences	   in	   expression	  of	  ADARB1	  compared	   to	   the	   rest	   of	   the	   brain,	  we	  combined	  these	  samples	   into	  a	  single	  group	  (cerebellum),	  keeping	  all	  other	  normal	  brain	  samples	  in	  a	  separate	  group	  (normal).	  The	  AST	  and	  GBM	  samples	  remained	  as	  two	  distinct	  groups.	  Assuming	  copy	  number	  variation	  (CNV)	  is	  rare,	  SNVs	  will	  occur	  most	  commonly	  as	  homozygous	   (present	   on	   both	   sister	   chromatids)	   or	   heterozygous	   (present	   on	   a	   single	  chromatid).	   In	   the	  case	  of	  homozygous	  SNVs,	  we	  expect	  all	  RNA-­‐seq	  reads	   to	  contain	   the	  variant.	   In	   the	   case	   of	   heterozygous	   SNVs,	   roughly	   50%	   of	   the	   reads	   should	   contain	   the	  variant	  allele,	  depending	  on	  the	  level	  of	  expression	  (and	  in	  rare	  cases	  mappability)	  of	  the	  allele.	   Deviations	  will	   also	   occur	   due	   to	   random	   sampling	  within	   the	   sequencer	   of	   lowly	  expressed	   transcripts.	   Figure	   5.2	   shows	   the	   probability	   distribution	   for	   alternate	   SNVs	  present	   in	   KAVIAR	   (top)	   as	  well	   as	   RNA-­‐DNA	   differences	   that	  were	   not	   filtered	   and	   are	  therefore	   probable	   editing	   positions	   (bottom).	   The	   SNVs	   identified	   by	   KAVIAR	   show	   the	  expected	  enrichment	  of	  alternate	  allele	  probability	  at	  50%	  and	  100%	  of	  sequenced	  reads,	  which	   is	   largely	  unaffected	  by	  differences	   in	  phenotype.	   Interestingly,	  both	  AST	  and	  GBM	  deviate	  upwards	   from	   the	   expected	  50%	  probability,	   likely	  due	   to	   tumor	  CNV.	   Identified	  editing	   positions	   differ	   not	   only	   from	   the	   characteristic	   SNV	   distribution	   but	   also	   differ	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among	   the	   four	   categories,	   as	  might	   be	   expected	   due	   to	   the	   differences	   in	   expression	   of	  ADAR	  enzymes.	  These	  results	  are	  consistent	  with	  previous	  observations	  that	  A-­‐to-­‐I	  editing	  is	  suppressed	  in	  GBM	  and	  AST	  (Cenci	  et	  al.	  2008;	  Paz	  et	  al.	  2007)	  compared	  to	  normal	  brain	  tissue,	  though	  the	  contribution	  of	  each	  individual	  ADAR	  enzyme	  is	  not	  well	  understood.	  	  
Editing	  in	  gliomas	  exhibits	  altered	  correlations	  with	  expression	  of	  editing	  enzymes	  We	   next	   explored	   the	   relationship	   between	   editing	   profiles	   in	   the	   different	   brain	  tissues	  and	  phenotypes	  in	  order	  to	  better	  understand	  the	  contribution	  of	  the	  three	  ADAR	  family	  enzymes	  to	  the	  editing	  profiles.	  GBM	  exhibits	  an	  increase	  in	  expression	  of	  ADAR,	  yet	  a	  decrease	  in	  average	  editing	  percentage	  relative	  to	  normal	  brain	  tissue.	  ADARB1	   is	  more	  highly	   expressed	   in	   cerebellum	   relative	   to	   other	   tissues,	   and	   it	   exhibits	   a	   concordant	  increase	  in	  editing	  percentages	  –	  suggesting	  that	  ADARB1	  may	  play	  a	  significant	  role	  in	  A-­‐to-­‐I	   editing	   in	   the	   cerebellum	   (Figure	   5.1).	   We	   examined	   the	   correlation	   between	  expression	   of	   the	   editing	   enzymes	   and	   the	   corresponding	   editing	   percentages	   for	  differentially	  edited	  bases.	  Using	  significantly	  differentially	  edited	  positions,	  we	  calculated	  the	  Pearson	  correlation	  between	  editing	  percentage	  with	  the	  corresponding	  expression	  of	  each	   of	   the	   ADAR	   family	   of	   enzymes	   over	   all	   samples	   at	   each	   edit	   position.	   In	   order	   to	  ensure	   a	   sufficient	   number	   of	   samples	   to	   estimate	   correlation,	   we	   required	   all	   edits	   to	  contain	   at	   least	   40	   samples	   from	   each	   group.	   Due	   to	   the	   fact	   that	   cerebellum	   does	   not	  contain	  a	  sufficient	  number	  of	  samples	  to	  accurately	  estimate	  correlations,	  we	  merged	  this	  group	   with	   the	   normal	   samples	   for	   this	   analysis.	   Expression	   of	   ADARB1	   is	   most	   highly	  correlated	  with	  editing	  percentage	  in	  normal	  brain	  (! = 0.245),	  while	  expression	  of	  ADAR	  is	  barely	  correlated	   (! = 0.056),	   and	  ADARB2	  uncorrelated	   (! = −0.004)	   (Figure	  5.3).	   In	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contrast,	  in	  AST	  only	  expression	  of	  ADAR	  is	  correlated	  with	  editing	  percentage	  (! = 0.148),	  whereas	   ADARB1	   (! = −0.043)	   and	   ADARB2	   (! = 0.001)	   are	   no	   longer	   correlated.	  Similarly,	  in	  GBM	  only	  ADAR	  expression	  is	  correlated	  with	  editing	  percentage	  (! = 0.208),	  while	   ADARB1	   (! = −0.022)	   and	   ADARB2	   (! = −0.014)	   are	   no	   longer	   correlated.	   This	  suggests	  that	  in	  the	  normal	  brain,	  ADARB1	  is	  the	  primary	  editing	  enzyme,	  whereas	  in	  AST	  and	  GBM	  expression	  of	  ADARB1	  has	  become	  uncoupled	  from	  editing.	   In	  this	  environment	  
ADAR	  performs	  a	  greater	  level	  of	  editing,	  particularly	  since	  its	  expression	  is	  upregulated	  in	  both	  AST	  and	  GBM.	  	  
	  
Previously	  characterized	  editing	  positions	  in	  non-­‐repetitive	  regions	  As	  discussed	  in	  the	  previous	  sections,	  the	  distributions	  of	  editing	  percentages	  vary	  widely	   by	   phenotype	   in	   our	   dataset,	   and	   different	   editing	   enzymes	   are	   correlated	   with	  editing	   percentage	   in	   normal	   brain	   tissue	   (ADARB1)	   vs.	   AST	   and	   GBM	   (ADAR).	   We	   next	  examined	   specific	   editing	   positions	   in	   more	   detail,	   to	   identify	   those	   bases	   differentially	  edited	   across	  phenotypes	   (see	  Methods).	  We	   identified	  240	  differentially	   edited	  bases	   in	  non-­‐repetitive	   regions	   of	   expressed	   transcripts,	   and	   an	   additional	   7278	   differentially	  edited	  bases	   in	  Alu	   regions	   (FDR	  <	  0.01)	   as	  defined	  by	  RepeatMasker	   (Smit	   et	   al.	   2006).	  Supporting	   the	   validity	   and	   breadth	   of	   our	   approach,	   several	   of	   the	   differentially	   edited	  bases	  we	  found	  were	  previously	  identified	  in	  other	  studies	  (Table	  5.1).	  Additionally,	  many	  identified	   sites	   are	   novel	   and	   are	   discussed	   in	   the	   next	   section.	   Among	   the	   best-­‐characterized	  edits	  we	  identified	  are	  two	  differentially	  edited	  bases	  in	  GRIA2,	  a	  subunit	  of	  the	   ionotropic	   AMPA	   selective	   glutamate	   receptor	   (GluR-­‐B).	   The	   first	   position	  (chr4:158257875	   [GRCh37/hg19,	   base	   1])	   occurs	   in	   exon	   11	   and	   results	   in	   a	   non-­‐
	  	   	  	   	   	  83	  
synonymous	  amino	  acid	  substitution	  of	  glutamine	  to	  arginine	  (Q/R)	  in	  the	  transmembrane	  domain	  of	   the	  channel.	  The	  Q/R	  site	   is	  edited	  between	  92.6%	   in	  non-­‐cerebellar	   tissue	   to	  99.3%	  editing	   in	   cerebellum.	  We	  observe	   approximately	  75%	  editing	   at	   this	   position	   for	  both	  AST	  and	  GBM,	  consistent	  with	  what	  has	  been	  reported	  using	  Sanger	  sequencing	  (69-­‐88%	   in	   GBM	   tissues)	   (Maas	   et	   al.	   2001).	   The	   second	   edited	   position	   (chr4:158281294)	  occurs	  in	  exon	  13,	  resulting	  in	  an	  amino	  acid	  substitution	  of	  arginine	  to	  glycine	  (R/G).	  This	  base	  is	  edited	  at	  a	  substantially	  higher	  amount	  in	  cerebellum	  compared	  to	  non-­‐cerebellum	  tissue	  (71.6%	  vs.	  34.4%),	  and	  exhibits	  decreased	  editing	  in	  gliomas.	  We	  performed	  a	  linear	  regression	   with	   editing	   percentage	   as	   the	   response	   variable	   for	   the	   R/G	   site	   using	   log	  expression	  of	  ADAR	  and	  ADARB1	  as	  regressors	  (Figure	  5.4).	  In	  normal	  samples,	  expression	  of	   ADAR	   is	   not	   predictive	   of	   editing	   percentage	   (R2=0.02),	   but	   expression	   of	  ADARB1	   is	  predictive	  (R2=0.51).	  ADARB1	  has	  previously	  been	  identified	  as	  the	  enzyme	  responsible	  for	  editing	   the	   Q/R	   and	   R/G	   sites	   in	   the	   GluR-­‐B	   subunit	   (Seeburg	   et	   al.	   1998).	   In	   contrast,	  expression	   of	   neither	   ADAR	   nor	   ADARB1	   is	   predictive	   of	   editing	   percentage	   in	   GBM	  samples.	  We	   identified	  differentially	  edited	  positions	   in	   two	  additional	  subunits	  of	   the	  GluR	  AMPA	   receptor	   complex:	  GRIA3	  (GluR-­‐C)	  and	  GRIA4	  (GluR-­‐D),	   both	   of	  which	  occur	   at	   an	  R/G	  site	  similar	  to	  GRIA2.	  The	  GRIA3	  R/G	  site	  is	  edited	  at	  78%	  in	  normal	  brain	  tissue,	  lower	  than	  the	  observed	  editing	  percentage	  of	  approximately	  95%	  in	  the	  adult	  rat	  brain,	  and	  the	  R/G	  site	  of	  GRIA4	  is	  edited	  at	  55%,	  close	  to	  what	  is	  observed	  in	  the	  adult	  rat	  brain	  (~50%)	  (Lomeli	  et	  al.	  1994).	  A	  subunit	  of	  the	  ionotropic	  kainate	  selective	  glutamate	  receptor	  GRIK2	  (GluR-­‐6)	  was	  also	  edited	   in	  three	  positions.	  The	  first	  position	  (chr6:102372589)	   is	  a	  Q/R	  site	   in	   exon	   13,	   the	   second	   (chr6:102337702)	   is	   a	   Y/C	   site	   in	   exon	   11,	   and	   the	   third	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(chr6:102337689)	  is	  an	  I/V	  site	  in	  exon	  11.	  	  All	  three	  of	  the	  editing	  positions	  in	  GluR-­‐6	  are	  differentially	   edited	   and	  exhibit	   reduced	  editing	   in	  GBM	  and	  AST.	  We	  observe	   the	  GRIK2	  Q/R,	   Y/C,	   and	   I/V	   sites	   to	   be	   edited	   at	   mean	   levels	   of	   69.8%,	   59.5%,	   and	   41.7%,	  respectively.	  The	  mean	  editing	  percentages	  of	  normal	  brain	  samples	  from	  a	  previous	  study	  using	  direct	  sequencing	  are	  67.0%	  for	  the	  Q/R	  site,	  62.5%	  for	  the	  Y/C	  site,	  and	  56.6%	  for	  the	   I/V	  site	  (Cenci	  et	  al.	  2008).	  Cenci	  et	  al.	  also	  presents	  editing	  percentages	   for	  multiple	  grades	  of	  AST	  and	  GBM.	  Our	  estimated	  editing	  percentage	  of	  24.3%	  for	  the	  Q/R	  site	  in	  AST	  is	   consistent	   with	   the	   authors’	   estimate	   of	   28%	   for	   grade	   III	   AST.	   However,	   our	   editing	  percentage	  of	  22.8%	  in	  GBM	  is	  significantly	  higher	  than	  the	  authors’	  estimate	  of	  4.5%	  for	  GBM	   at	   the	   Q/R	   site	   of	   GRIK2.	   We	   observe	   editing	   in	   the	   α3	   subunit	   of	   the	   GABA(A)	  receptor	   (GABRA3)	   at	   an	   I/M	   site	   in	   exon	   9,	  which	   has	   previously	   been	   observed	   in	   the	  mouse	  brain	  using	  direct	  sequencing	  at	  an	  editing	  percentage	  close	  to	  100%	  (Ohlson	  et	  al.	  2007).	  Our	  estimated	  editing	  percentage	  for	  normal	  human	  brain	  is	  71.3%.	  The	   transcript	   for	   Bladder	   cancer-­‐associated	   protein	   (BLCAP)	   was	   differentially	  edited	  across	  AST,	  GBM,	  and	  normal	  brain	   tissue.	  The	   first	   edit	   (20:36147572)	  occurs	   in	  exon	   2	   and	   yields	   a	   non-­‐synonymous	   amino	   acid	   substitution	   from	   tyrosine	   to	   cysteine	  (Y/C).	  The	  editing	  percentage	  of	  19.0%	  in	  our	  normal	  brain	  tissue	   is	  comparable	  to	  what	  was	  previously	  observed	  using	  direct	  sequencing	  in	  brain	  white	  matter	  (16.1%)	  (Galeano	  et	   al.	   2010).	   The	   second	   edit	   (20:36147563)	   occurs	   in	   exon	   2	   and	   results	   in	   a	   non-­‐synonymous	  substitution	  of	  glutamine	  to	  arginine	  (Q/R).	  Galeano	  et	  al.	  reported	  an	  editing	  percentage	  of	  19.4%	  at	  this	  position	  in	  white	  matter,	  close	  to	  our	  calculated	  percentage	  of	  17.2%.	  We	  note	  that	  Galeano	  et	  al.	  reports	  0%	  editing	  for	  both	  of	  these	  positions	  in	  GBM,	  disagreeing	  with	  our	  positive	  estimates,	  though	  it	  should	  be	  noted	  that	  their	  observation	  is	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from	   a	   single	   individual.	   Insulin-­‐like	   growth	   factor-­‐binding	   protein	   7	   (IGFBP7)	   has	  previously	   been	   studied	   in	   the	   context	   of	   basal	   cell	   and	   squamous	   cell	   carcinoma.	   Our	  estimated	   editing	   levels	   at	   the	   K/R	   position	   (4:57976234)	   of	   IGFBP7	   in	   GBM	   primary	  tumors	  (30.2%)	  are	  similar	  to	  those	  observed	  in	  basal	  cell	  carcinoma	  (32.5%)	  using	  mass	  spectrometry.	  However,	  normal	  epidermis	  exhibits	  an	  average	  editing	  level	  (61.4%)	  higher	  than	   that	  observed	   in	  normal	  brain	   tissue	   (38.5%).	  This	  edit,	  which	  occurs	   in	   the	   coding	  region	  of	  the	  gene,	  has	  been	  shown	  to	  modulate	  the	  protein’s	  susceptibility	  to	  proteolysis	  (Hochberg	   et	   al.	   2013).	   Editing	   levels	   of	   the	   splicing	   factor	   neuro-­‐oncological	   ventral	  antigen	  1	  (NOVA1)	  at	  a	  S/G	  position	  (14:26917530)	  have	  been	   investigated	   in	  the	  mouse	  brain	  by	  Sanger	  sequencing,	  and	  are	  also	  consistent	  with	  our	  results.	  The	  authors	  observe	  26%	  editing	  in	  the	  hypothalamus	  of	  the	  mouse	  brain,	  close	  to	  what	  we	  observe	  in	  human	  samples	   (26.5%)	   Similar	   to	   IGFBP7,	   editing	   of	   NOVA1	   has	   been	   observed	   to	   increase	  protein	  half-­‐life	  (Irimia	  et	  al.	  2012).	  Finally,	  we	  also	   identified	  an	  S/G	  edit	  position	   in	  the	  Antizyme	  inhibitor	  1	  (AZIN1)	  transcript	  (8:103841636),	  which	  was	  recently	  implicated	  in	  hepatocellular	  carcinoma	  (HCC)	  (Leilei	  Chen	  et	  al.	  2013).	  In	  the	  case	  of	  HCC,	  hyperediting	  at	  this	  position	  contributes	  to	  tumor	  development.	  Normal	  liver	  tissue	  exhibits	  an	  average	  editing	   percentage	   of	   approximately	   20%	   at	   this	   position,	   close	   to	   what	   we	   observe	   in	  normal	   brain	   (18.4%).	  Unlike	   in	  HCC,	   however,	   the	   editing	  percentage	   at	   this	   position	   is	  statistically	   unchanged	   between	   GBM	   and	   normal	   brain	   tissue,	   being	   edited	   at	   16.9%	   in	  glioblastoma,	  at	  a	  non-­‐significant	  adjusted	  p-­‐value	  of	  0.29.	  In	  contrast,	  hyperediting	  at	  this	  position	   is	  associated	  with	  HCC,	  defined	  by	   the	  authors	  as	  an	   increase	  of	  at	   least	  10%	   in	  editing	  percentage.	   In	  conclusion,	  we	  have	   identified	  several	  A-­‐to-­‐I	  edit	  positions	   in	  non-­‐repetitive	  regions	  of	  the	  human	  transcriptome	  that	  have	  been	  independently	  characterized	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in	   previous	   studies,	   the	  majority	   of	   which	  measured	   editing	   percentages	   through	   direct	  sequencing	   of	   edited	   transcripts.	   Where	   possible,	   we	   compared	   our	   estimated	   editing	  percentages	   to	   those	  previously	  observed,	   and	   in	   the	  majority	  of	   cases	   the	  estimates	   are	  consistent,	   supporting	   our	   claim	   that	   RNA-­‐seq	   data	   alone	   can	   be	   used	   to	   accurately	  estimate	  editing	  percentages	  in	  normal	  brain	  and	  primary	  tumor	  samples.	  	  	  
Novel	  differentially	  edited	  bases	  in	  non-­‐repetitive	  regions	  Application	  of	  our	  computational	  pipeline	  to	  nearly	  400	  RNA-­‐seq	  samples	  enabled	  us	  to	  identify	  many	  previously	  unreported	  edits	  that	  are	  also	  differentially	  edited	  between	  normal	   brain	   and	   GBM	   (Table	   5.2).	   The	  most	   significantly	   differentially	   edited	   base	   in	   a	  non-­‐repetitive	   region	   not	   previously	   characterized	   occurs	   in	   the	   3’	   untranslated	   region	  (UTR)	  of	  the	  calcium/calmodulin-­‐dependent	  protein	  kinase	  kinase	  1α	  (CAMKK1).	  While	  the	  functional	  consequence	  of	  this	  edit	  is	  presently	  unknown,	  it	  is	  interesting	  that	  the	  calcium-­‐dependent	   activity	   of	   its	   protein	   product	   is	   likely	   affected	   by	   editing	   of	   the	   well-­‐characterized	   GluR	   subunits	   that	  modulate	   Ca2+	   permeability	   (Seeburg	   et	   al.	   2001).	   The	  
CAMKK1	   transcript	   is	   edited	   at	   an	   average	   of	   51.9%	   in	   normal	   brain	   regions,	   but	   in	  cerebellum	  the	  editing	  percentage	  drops	  to	  an	  average	  of	  26.4%.	  Similarly,	  in	  AST,	  CAMKK1	  is	  edited	  approximately	  the	  same	  as	  for	  normal	  brain,	  50.0%,	  but	  in	  GBM	  the	  average	  drops	  to	  29.8%	  (Figure	  5.5).	  The	  pattern	  of	  editing	  of	  this	  position	  in	  CAMKK1	   is	  unusual,	  given	  that	   other	   non-­‐repetitive	   edit	   positions	   exhibit	   increased	   editing	   percentages	   in	  cerebellum,	  whereas	  this	  one	  is	  significantly	  decreased.	  Furthermore,	  GBM	  exhibits	  a	  very	  different	   editing	   percentage	   than	   AST,	   suggesting	   this	   edit	   is	   GBM-­‐specific.	   The	   FDR-­‐corrected	  p-­‐value	  of	  1e-­‐19	   indicates	  a	  highly	  significant	  change	   in	  editing	   levels	  between	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phenotypes,	  close	  to	  the	  order	  of	  changes	  for	  glutamate	  receptor	  subunits	  GRIA2	  and	  GRIA3	  (Table	  5.1).	  While	  this	  editing	  position	  does	  not	  yet	  exist	  in	  the	  Database	  of	  RNA	  Editing,	  a	  recent	  study	  confirms	  it	  as	  an	  A-­‐to-­‐I	  editing	  position	  (Ramaswami	  et	  al.	  2013).	  	  Phosphofructokinase,	  platelet	  (PFKP)	  is	  another	  gene	  that	  is	  differentially	  edited	  in	  GBM	  when	   compared	   to	   normal	   brain,	   and	   particularly	   cerebellum	   (FDR=4.3e-­‐11).	   This	  edit	  occurs	  in	  what	  is	  likely	  an	  unannotated	  5’UTR	  of	  the	  gene	  (chr10:3168694),	  although	  it	  is	  annotated	  as	  an	  intronic	  region.	  Regression	  analysis	  indicates	  that	  expression	  of	  ADARB1	  is	  highly	  predictive	  of	  editing	  percentage	  (R2=0.728)	  (Figure	  not	  shown).	  Ramaswami	  et	  al.	  independently	   identifies	   this	   position	   as	   a	   site	   for	   A-­‐to-­‐I	   RNA	   editing	   (Ramaswami	   et	   al.	  2013).	   PFKP	   encodes	   the	   platelet	   isozyme	   of	   phosphofructokinase,	   which	   catalyzes	   the	  phosphorylation	  of	  fructose-­‐6-­‐phosphate	  to	  fructose-­‐1,6-­‐bisphosphate,	  an	  irreversible	  and	  therefore	  key	  regulatory	  step	  in	  glycolysis.	  	  BCL2-­‐related	  ovarian	  killer	  (BOK)	  is	  differentially	  edited	  in	  the	  3’	  UTR,	  exhibiting	  an	  average	   editing	   percentage	   of	   29%	   in	  GBM	  and	  39.1%	   in	   normal	   brain	   tissue.	  While	   the	  magnitude	  of	   this	   change	   is	  not	   as	  great	   as	   some	  other	  edits	  discussed,	  we	  note	   that	   the	  
AZIN1	  hyperediting	  observed	  in	  HCC	  was	  of	  a	  similar	  magnitude	  (Leilei	  Chen	  et	  al.	  2013).	  Although	  the	  specific	  function	  of	  BOK	  is	  unclear,	  it	  is	  thought	  to	  be	  a	  pro-­‐apoptotic	  member	  of	   the	  BCL2	   family	   that	   is	   cell-­‐cycle	   regulated	   (Rodriguez	  et	   al.	  2006).	   	   Interestingly,	   this	  edit	   position	   (chr2:242512138)	   overlaps	   with	   a	   predicted	   microRNA	   binding	   site	   as	  predicted	   by	   TargetScan	   (Grimson	   et	   al.	   2007).	   The	   edit	   occurs	   specifically	   in	   the	   ‘seed’	  region	   of	   the	   binding	   site	   that	   confers	   binding	   specificity;	   therefore	   the	   binding	   of	   this	  microRNA	  (hsa-­‐miR-­‐661)	  to	  edited	  transcripts	  would	  be	  disrupted.	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As	  mentioned	  above,	  we	  identified	  the	  splicing	  factor	  NOVA1	  as	  edited	  in	  our	  data,	  although	  not	  significantly	  differentially	  edited	  (Table	  5.1).	  Editing	  of	  NOVA1	  occurs	   in	  the	  coding	  region	  of	  the	  transcript,	  increasing	  the	  protein	  half-­‐life	  (Irimia	  et	  al.	  2012).	  We	  now	  report	   significant	   differential	   editing	   (FDR=2.1e-­‐8)	   in	   the	   related	   gene	   neuro-­‐oncological	  ventral	   antigen	  2	   (NOVA2).	   This	  position	   (chr19:46438778)	  exhibits	  decreased	   editing	   in	  GBM	  (19.7%)	  compared	  to	  normal	  brain	  (28.0%)	  and	  especially	  cerebellum	  (46.3%),	  and	  is	  confirmed	  as	  an	  A-­‐to-­‐I	  editing	  position	  by	  the	  Database	  of	  RNA	  Editing	  (Kiran	  et	  al.	  2013;	  2013).	   	   NOVA2	   is	   a	   neuron-­‐specific	   RNA-­‐binding	   protein	   highly	   homologous	   to	   NOVA1	  (Ueki	  et	  al.	  1997),	  and	  is	  known	  to	  affect	  splicing	  of	  the	  neuronal	  sodium	  channel	  subunit	  
SCN1A	   (Heinzen	   et	   al.	   2007).	   The	   SON	   gene,	   encoding	   a	   Ser/Arg	   (SR)-­‐related	   protein,	   is	  differentially	  edited	  in	  the	  coding	  region	  of	  exon	  3.	  This	  particular	  edit	  (chr21:34923319)	  is	   confirmed	   as	   an	   A-­‐to-­‐I	   editing	   position	   by	   the	   Database	   of	   RNA	   Editing	   (Kiran	   et	   al.	  2013).	  SON	  modulates	  cell-­‐cycle	  progression	  through	  regulation	  of	  weak	  splice	  sites	  (Bahn	  et	  al.	  2012;	  2012;	  Ahn	  et	  al.	  2011).	  While	   this	  edit	  does	  occur	   in	  the	  coding	  region	  of	   the	  gene,	  it	  is	  a	  synonymous	  (silent)	  change	  that	  does	  not	  result	  in	  an	  amino	  acid	  substitution	  (L/L).	  Finally,	  the	  coatomer	  protein	  complex,	  subunit	  alpha	  (COPA)	  is	  differentially	  edited	  in	   the	   coding	   region	   of	   the	   transcript,	   near	   the	   3’	   end	   of	   exon	   6.	   	   This	   particular	   edit	  (chr1:160302244)	   results	   in	   a	   non-­‐synonymous	   amino	   acid	   substitution	   of	   isoleucine	   to	  valine	  (I/V),	  similar	  to	  that	  observed	  in	  the	  glutamate	  receptor	  subunit	  GRIK2.	  The	  edit	  is	  confirmed	  as	  an	  A-­‐to-­‐I	  editing	  position	  by	  the	  Database	  of	  RNA	  Editing	  (Kiran	  et	  al.	  2013).	  	  Like	  CAMKK1,	  this	  position	  is	  hyperedited	  in	  GBM	  with	  respect	  to	  normal	  brain	  tissue	  and	  AST.	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Differentially	  edited	  bases	  in	  Alu	  elements	  While	   many	   A-­‐to-­‐I	   edits	   occur	   in	   non-­‐repetitive	   regions,	   as	   discussed	   above,	   the	  majority	  of	  edited	  sites	  are	  associated	  with	  Alu	  elements,	  which	  are	  members	  of	  the	  Short	  Interspersed	  Nuclear	  Element	  (SINE)	  family	  (Batzer	  and	  Deininger	  2002).	  Alu	  elements	  are	  frequent	   targets	   of	   editing,	   due	   to	   their	   high	   conservation	   and	   ability	   tendency	   to	   form	  dsRNA	   secondary	   structures	   when	   found	   as	   inverted	   repeats,	   forming	   energetically	  favorable	  hairpins	  that	  act	  as	  substrates	  for	  the	  ADAR	  family	  of	  enzymes	  (Athanasiadis	  et	  al.	   2004).	  Alu-­‐based	   secondary	   structures	   are	   commonly	   promiscuously	   edited,	  meaning	  several	   adenosines	   are	   deaminated	  within	   a	   short	   span	   of	   the	   transcript.	   This	   stands	   in	  contrast	   to	   the	   site-­‐specific	   deamination	   that	   occurs	   in	   non-­‐repetitive	   regions	   of	   the	  transcriptome.	  Alu	   elements	   are	   very	   common	   in	   the	   human	   genome,	   occurring	   in	  more	  than	  one	  million	  copies	   (Häsler	  and	  Strub	  2006),	   and	  are	  known	   to	   introduce	   regulatory	  elements	   such	   as	   promoters,	   enhancers,	   and	   polyadenylation	   signals	   into	   transcripts	  (Tomilin	  1999).	  In	  addition,	  Alu	  elements	  are	  probable	  microRNA	  targets	  (Smalheiser	  and	  Torvik	  2006).	  Significant	   differential	   editing	   in	   Alu	   regions	   was	   observed	   at	   7278	   positions	  throughout	   the	   transcriptome	   (FDR	   <	   0.01).	   The	   distribution	   of	   FDR-­‐corrected	   p-­‐values	  indicates	   that	   certain	   transcripts	   are	   more	   strongly	   affected	   by	   dysregulation	   of	   editing	  enzymes	  	  (and	  perhaps	  other	  editing	  regulatory	  mechanisms)	  than	  others.	  In	  other	  words,	  dysregulation	   of	   ADAR	   enzyme	   expression	   does	   not	   uniformly	   affect	   editing	   in	   highly	  conserved	  Alu	  elements.	  Some	  of	  the	  most	  significantly	  differentially	  edited	  transcripts	  are	  shown	   in	   Table	   5.3.	   Most	   of	   the	   genes	   shown	   in	   Table	   5.3	   are	   differentially	   edited	   in	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multiple	   proximal	   positions	   throughout	   the	  Alu	   element,	   and	   for	   brevity	  we	  only	   list	   the	  most	  significant	  position	  from	  each	  Alu	  element.	  The	   most	   significantly	   differentially	   edited	   position	   (FDR=4.7e-­‐36)	   in	   an	   Alu	  element	  is	  Mdm4	  p53	  binding	  protein	  homolog	  (MDM4).	  	  This	  position	  (chr1:204526795)	  has	   an	   average	   editing	   percentage	   of	   23.3%	   in	   AST,	   30.1%	   in	   GBM,	   46.4%	   in	   non-­‐cerebellum	   normal	   brain,	   and	   72.9%	   in	   cerebellum.	   	   MDM4	   is	   known	   to	   bind	   to	   and	  inactivate	   the	   tumor	   suppressor	   P53,	   with	   amplification	   of	   MDM4	   identified	   as	   a	  mechanism	   by	   which	   malignant	   gliomas	   inactivate	   P53	   (Riemenschneider	   et	   al.	   1999).	  Figure	  5.3	  demonstrated	  how	  large-­‐scale	  shifts	  between	  expression	  of	  ADAR	  and	  ADARB1	  and	   editing	   percentages	   occurred	   across	   normal	   brain	   tissue	   and	   GBM.	   As	   a	   specific	  example	   of	   this,	   expression	   of	   ADARB1	   is	   predictive	   of	   editing	   percentages	   in	  MDM4	   in	  normal	   brain	   tissue,	   but	   in	   GBM	   expression	   of	   ADAR	   is	   most	   predictive	   (Figure	   5.6).	  Cathepsin	  B	  (CTSB)	  is	  the	  second	  most	  significantly	  differentially	  Alu-­‐edited	  gene.	  While	  the	  vast	  majority	  of	  Alu	  editing	  sites	  are	  suppressed	  in	  GBM,	  CTSB	  is	  edited	  more	  highly	  in	  GBM	  (53.3%)	   than	   normal	   brain	   tissue	   (35.2%),	   cerebellum	   (27.3%)	   or	   AST	   (26.0%).	   This	  pattern	  exists	   for	  several	  edit	  positions	  within	   the	  CTSB	  3’	  UTR.	  Recent	  studies	   implicate	  
CTSB	  in	  glioblastoma	  invasiveness	  (Shimizu	  et	  al.	  2013),	  as	  well	  as	  a	  modulator	  for	  the	  self-­‐renewal	  of	  glioma-­‐initiating	  cells	  (Gopinath	  et	  al.	  2013).	  	  	  	  
Discussion	  Using	   raw	   RNA-­‐seq	   data	   from	   50	   low-­‐grade	   astrocytoma	   primary	   tumors,	   142	  glioblastoma	   primary	   tumors,	   and	   159	   normal	   brain	   samples	   from	   10	   brain	   regions,	  we	  have	   examined	   variation	   in	   A-­‐to-­‐I	   editing	   in	   the	   brain	   to	   an	   unprecedented	   statistical	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resolution,	  enabling	  us	  to	  identify	  transcriptome-­‐wide	  changes	  in	  editing	  percentages.	  This	  work	  was	  enabled	  by	  the	  development	  of	  a	  new	  highly	  accurate	  read-­‐mapping	  algorithm	  as	  part	  of	  an	  RNA-­‐editing	  discovery	  pipeline.	  From	  this	  vantage	  point,	  we	  were	  able	  to	  shed	  light	  on	  the	  relationship	  between	  the	  expression	  of	  the	  three	  A-­‐to-­‐I	  editing	  enzymes,	  ADAR,	  
ADARB1,	   and	  ADARB2,	   and	   their	   influence	   on	   the	   editing	   profiles	   in	   both	   a	   healthy	   and	  diseased	  state	  of	  the	  brain.	  We	  find	  that	  the	  decrease	  in	  overall	  editing	  observed	  in	  AST	  and	  GBM	   cannot	   be	   explained	   by	   ADAR	   mRNA	   expression	   alone.	   ADAR	   mRNA	   expression	   is	  significantly	  increased	  in	  AST	  and	  GBM	  relative	  to	  normal	  brain	  tissues	  (Figure	  5.1),	  while	  overall	   editing	   in	   AST	   and	   GBM	   decreases	   (Figure	   5.2).	   However,	   consistent	   with	   the	  changes	  in	  overall	  editing	  levels,	  ADARB1	  mRNA	  is	  significantly	  decreased	  in	  AST	  and	  GBM	  relative	   to	   normal	   brain	   tissues—suggesting	   a	   more	   primary	   role	   in	   overall	   editing	   in	  normal	  brain.	  	  While	  our	  data	  is	  all	  based	  on	  the	  mRNA	  expression	  of	  the	  ADAR	  family	  members,	  the	   fact	   that	   the	   functional	   consequence	   (A-­‐to-­‐I	   editing)	   is	   highly	   correlated	  with	  mRNA	  expression	   suggests	  a	   consistent	   relationship	  between	   the	  mRNA	  expression	  and	  protein	  expression.	   This	   is	   supported	   in	   part	   by	   Bahn	   et	   al.,	   who	   knocked	   down	   ADAR	   mRNA,	  resulting	   in	   the	   abrogation	  of	  most	   observed	   edits	   in	  U87	   cells,	  where,	   as	  we	   also	   show,	  
ADAR	   is	  highly	  expressed	  while	  ADARB1	  and	  ADARB2	  are	  much	   lower	   relative	   to	  normal	  brain	  (Bahn	  et	  al.	  2012).	  What	  is	  unclear	  from	  our	  data	  is	  how	  mRNA	  expression	  relates	  to	  the	  protein	  expression	  of	  the	  ADARs	  with	  respect	  to	  each	  other.	  Changes	  in	  ADAR	  protein	  may	   change	   disproportionately	   to	   changes	   in	   the	   mRNA	   among	   ADAR	   family	   enzymes.	  Additionally,	   each	  ADAR	  member	  may	  have	  different	   regulatory	  mechanisms	   that	   impact	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protein	   half-­‐life	   and/or	   activity.	   For	   example,	   ADAR	   has	   been	   shown	   to	   be	   sumoylated,	  affecting	  its	  activity	  (Desterro,	  2005).	  ADAR	  and	  ADARB1	  are	  capable	  of	  forming	  homo-­‐	  and	  heterodimers	  (Chilibeck	  et	  al.	  2006).	  Dimer	  formation	  has	  been	  shown	  to	  be	  independent	  of	  RNA	  binding	  (Chilibeck	  et	  al.	  2006;	  Valente	  and	  Nishikura	  2007).	  What	  is	  not	  known	  is	  if	  ADAR-­‐ADARB1	  heterodimers	  are	   functional,	   and	   if	   so,	  what	   differences	   they	  may	   have	   in	   target	   specificity	   or	   activity.	  ADARB1	  is	  active	  in	  the	  nucleolus,	  though	  it	  is	  not	  known	  if	   its	  activity	  is	  exclusive	  to	  the	  nucleolus.	  ADAR	  has	  been	  found	  to	  be	  active	  in	  other	  subcellular	  compartments	  such	  as	  the	  nucleoplasm	   and	   cytoplasm.	   Subcellular	   localization	  may	   be	   tied	   to	   activity,	   such	   as	   the	  ability	   to	  bind	   to	  other	  proteins	   that	  assist	  or	  modify	   the	  activity	  of	  ADAR	  proteins.	   	  The	  ability	   for	   ADAR	   members	   to	   interact	   with	   target	   transcripts	   is	   also	   dependent	   on	   the	  location	  of	  the	  targets.	  For	  at	  least	  one	  editing	  target	  gene—BLCAP—it	  has	  been	  shown	  that	  both	  ADAR	  and	  ADARB1	  are	  capable	  of	  editing	  bases	  within	  the	  coding	  sequence,	   though	  ADAR	  exhibits	  lower	  editing	  efficiency	  (Galeano	  et	  al.	  2010).	  	  Supporting	  the	  idea	  that	  the	  ratio	   of	   ADAR	   and	   ADARB1	   expression	   is	   important	   (independent	   of	   the	   question	   of	  heterodimer	  formation	  or	  activity),	  overexpression	  of	  ADAR	  was	  shown	  to	  reduce	  editing	  at	  GluR-­‐B	  sites	  normally	  targeted	  by	  ADARB1	  (Cenci	  et	  al.	  2008).	  Applying	  our	  computational	  pipeline	   to	  RNA-­‐seq	  data	   from	  different	  brain	  regions	  also	   enabled	   a	  picture	   of	   editing	   in	   the	  brain	  not	   previously	   observed.	  ADARB1	  mRNA	   is	  significantly	  elevated	  in	  cerebellum	  and	  cerebellar	  hemisphere	  relative	  to	  the	  other	  brain	  regions	  (Figure	  5.1),	  as	  are	  A-­‐to-­‐I	  editing	  percentages	  (Figure	  5.2).	  We	  found	  that	  ADARB1	  mRNA	   expression	   is	  more	   highly	   correlated	  with	   the	   observed	   editing	   percentages	   than	  either	  of	   the	  other	   two	  editing	  enzymes	   in	  normal	  brain.	  Furthermore,	   in	   low-­‐	  and	  high-­‐
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grade	   astrocytoma,	   this	   correlation	   of	   editing	   percentage	   with	   ADARB1	   expression	  disappears,	   while	   editing	   correlation	   with	   ADAR	  expression	  appears	   (Figure	   5.3).	   In	   the	  previously	  mentioned	  study	  by	  Bahn	  et	  al.,	  ADAR	  knockdown	  in	  the	  U87	  glioblastoma	  cell	  line	  resulted	  in	  the	  almost	  complete	  elimination	  of	  editing	  compared	  to	  controls	  (Bahn	  et	  al.	  2012).	  U87	  also	  exhibits	  very	  low	  expression	  of	  ADARB1.	  This	  supports	  the	  idea	  that	  in	  the	  normal	  brain,	  expression	  of	  ADARB1	  strongly	  influences	  editing	  levels,	  as	  suggested	  by	  overexpression	  of	  ADARB1	  in	  cerebellum	  and	  the	  concordant	  increase	  in	  global	  editing,	  in	  addition	  to	  as	  the	  strong	  correlation	  between	  ADARB1	  expression	  and	  editing	  percentages	  in	   the	  normal	  brain.	   In	   low-­‐	  and	  high-­‐grade	  astrocytoma,	   reduced	  expression	  of	  ADARB1	  coupled	  with	   increased	  expression	  of	  ADAR	  may	   lead	   to	   the	   formation	  of	  ADAR/ADARB1	  heterodimers	  with	   little	   to	  no	  editing	  activity	  or	  ADAR	  homodimers	   that	  exhibit	   reduced	  editing	   efficacy.	   This	   is	   supported	   by	   the	   observed	   increase	   in	   correlation	   between	  expression	   of	   ADAR	   and	   editing	   percentages	   as	   well	   as	   the	   loss	   of	   correlation	   between	  
ADARB1	   expression	   and	   editing	   percentages	   in	   AST	   and	   GBM.	   While	   the	   functional	  consequences	  of	   increased	  editing	   in	   the	   cerebellum	  or	  mechanisms	  by	  which	  decreased	  editing	  in	  AST	  and	  GBM	  contribute	  to	  pathology	  are	  less	  clear,	  one	  curious	  observation	  is	  the	   exceptionally	   rare	   occurrence	   of	   GBM	   in	   the	   cerebellum	   (Adams	   et	   al.	   2013).	   It	   is	  tempting	  to	  speculate	  on	  a	  link	  between	  increased	  editing	  in	  the	  cerebellum	  and	  the	  rarity	  of	  cerebellar	  GBM.	  In	  addition	  to	  global	  analyses	  of	  editing,	  we	  used	  the	  non-­‐parametric	  Kruskal-­‐Wallis	  test	   to	   identify	   the	   most	   significant	   changes	   in	   editing	   percentages	   across	   phenotypes.	  While	   changes	   in	   global	   editing	   might	   be	   the	   expected	   response	   to	   changes	   in	   editing	  enzyme	  expression,	  we	   find	   certain	  positions	  are	  more	   significantly	   affected	   than	  others.	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We	  investigated	  the	  possibility	  that	  changes	  in	  editing	  levels	  were	  correlated	  with	  changes	  in	  edited	   transcript	  expression	  and	   found	  no	  correlation	   (data	  not	  shown).	  We	   identified	  240	  differentially	  edited	  bases	  in	  non-­‐repetitive	  regions	  of	  expressed	  transcripts,	  and	  7278	  differentially	  edited	  bases	  in	  Alu	  regions	  with	  an	  FDR-­‐adjusted	  p-­‐value	  <	  0.01.	  Among	  those	  differentially	  edited	  bases	  in	  non-­‐repetitive	  regions	  of	  the	  transcriptome	  were	  sites	  already	  characterized	   in	   previous	   studies,	   including	   several	   subunits	   of	   ionotropic	   glutamate	  receptors	  (GRIA2,	  GRIA3,	  GRIA4,	  GRIK2),	  insulin-­‐like	  growth	  factor	  receptor	  7	  (IGFBP7),	  and	  bladder	   cancer-­‐associated	   protein	   (BLCAP).	   In	   most	   cases,	   the	   editing	   percentages	  identified	   using	   transcriptome-­‐wide	   RNA-­‐seq	   data	   alone	   were	   consistent	   with	   earlier	  studies	   using	   direct	   sequencing	   of	   edited	   transcripts.	  We	   note	   that	   Antizyme	   inhibitor	   1	  (AZIN1),	  which	   has	   been	   observed	   to	   be	   hyperedited	   in	   hepatocellular	   carcinoma	   (Leilei	  Chen	   et	   al.	   2013),	   does	   not	   exhibit	   a	   significant	   change	   in	   editing	   in	   high-­‐	   or	   low-­‐grade	  astrocytoma	  when	  compared	  to	  normal	  brain.	  This	  is	  consistent	  with	  the	  observation	  that	  ADAR	  plays	  a	  critical	  role	   in	  non-­‐nervous	  tissue,	  such	  that	  ADAR-­‐/-­‐	  mouse	  embryos	  die	  of	  liver	  disintegration	  (Hartner	  et	  al.	  2004).	  That	  AZIN1	  is	  not	  differentially	  edited	  in	  the	  brain	  but	   important	   in	   the	   liver	   points	   to	   the	   possibility	   that	   editing	   of	   other	   genes	   may	   be	  important	  in	  other	  tissue	  types	  and	  pathologies.	  Our	  analysis	  also	  reveals	  many	  A-­‐to-­‐I	  editing	  positions	  that	  are	  differentially	  edited	  between	  normal	  brain	  and	  gliomas	  that	  have	  not	  been	  previously	  characterized.	  Among	  the	  most	   significantly	   differentially	   edited	   positions	   (FDR	   <	   1e-­‐19)	   is	   the	   3’	   UTR	   of	   the	  Calcium/calmodulin-­‐dependent	  protein	  kinase	  kinase	  1	   (CAMKK1)	  transcript.	  The	  change	  in	  editing	  levels	  of	  CAMKK1	  is	  as	  significant	  as	  that	  observed	  in	  glutamate	  receptors	  which	  have	   been	   extensively	   studied	   in	   the	   context	   of	   gliomas.	   Editing	   in	   glutamate	   receptors	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modulates	   cell	   permeability	   to	   Ca2+,	   which	   is	   known	   to	   activate	   the	   kinase	   activity	   of	  
CAMKK1.	  A	  decrease	  in	  editing	  of	  the	  coding	  regions	  of	  glutamate	  receptors	  GRIA2,	  GRIA3,	  
GRIA4	  and	  GRIK2	  causes	  an	  increase	  in	  influx	  of	  Ca2+	  in	  glioma,	  in	  turn	  activating	  the	  kinase	  activity	  of	  CAMKK1.	  While	  we	  have	  not	  examined	  here	  the	  phenotypic	  effect	  of	  this	  edit	  in	  
CAMKK1,	  the	  fact	  that	  it	  is	  edited	  as	  significantly	  as	  the	  glutamate	  receptors	  and	  depends	  on	  Ca2+	  signaling,	  strongly	  suggests	  a	  functional	  relationship	  in	  the	  brain	  Consistent	  with	  other	  studies	  using	  deep	  sequencing	  to	   identify	  edits,	  we	  also	  find	  the	  vast	  majority	  of	  edited	  positions	  occur	  in	  repetitive	  Alu	  regions	  (Bahn	  et	  al.	  2012;	  Peng	  et	  al.	  2012;	  Ramaswami	  et	  al.	  2013).	  However,	  ours	   is	   the	   first	  study	  to	  comprehensively	  look	  at	  changes	  in	  editing	  levels	  as	  a	  function	  of	  phenotype.	  Given	  the	  repetitive	  nature	  of	  
Alu	  elements,	  it	  might	  be	  expected	  that	  changes	  in	  transcription	  of	  editing	  enzymes	  would	  uniformly	  affect	  editing	  levels	  across	  the	  transcriptome.	  While	  this	  is	  true	  for	  ~75%	  of	  all	  edited	   bases	   between	   normal	   brain	   and	   gliomas,	   many	   edits	   display	   a	   highly	   divergent	  response.	  Of	  those	  Alu	  elements	  that	  are	  differentially	  edited,	  the	  distribution	  of	  p-­‐values	  is	  non-­‐uniform.	  Of	  course,	  p-­‐values	  depend	  on	  sample	  size	  as	  well	  as	  magnitude	  of	  change,	  so	  highly	   significant	   p-­‐values	  may	   indicate	   particularly	   reliable	  Alu	   editing	   positions	   in	   the	  normal	   brain	   that	   are	   consistently	   altered	   in	   gliomas,	   rather	   than	   a	   particularly	   large	  change	   in	   magnitude	   of	   editing	   percentage	   across	   phenotype.	   Nevertheless,	   highly	  significant	  p-­‐values	  do	  help	  identify	  the	  most	  biologically	  interesting	  transcripts	  for	  further	  study.	   Apparent	   differential	   editing	   could	   be	   a	   product	   (or	   even	   the	   result)	   of	   how	   the	  secondary	   structure	   of	   the	   RNA	   changes	   with	   editing	   and	   the	   resulting	   effect	   on	   RNA	  binding	  proteins.	  Some	  edit	  sites	  might	  be	  better	  protected	  by	  RNA	  binding	  proteins,	  while	  other	  RNA	  binding	  proteins	  could	  affect	  RNA	  half-­‐life,	  thus	  modulating	  the	  observed	  editing	  
	  	   	  	   	   	  96	  
percentage.	  With	  such	  a	  widespread	  occurrence	  of	  editing,	  it	  is	  conceivable	  that	  changes	  in	  editing	   percentage	   are	   affected	   similarly	   to	   how	   sponge	  RNAs	   or	   competing	   endogenous	  RNAs	   can	   titrate	   away	  microRNAs,	   thus	   affecting	   their	   action	   on	  other	   target	   transcripts	  (Tay	  et	  al.	  2011;	  Sumazin	  et	  al.	  2011).	  The	  most	  highly	  differentially	  edited	  transcripts	  in	  Alu	  elements	  include	  MDM4	  p53	  binding	  protein	  homolog	  (MDM4),	  cathepsin	  B	  (CTSB),	  and	  minichromosome	  maintenance	  complex	   component	   4	   (MCM4).	   	   All	   three	   of	   these	   genes	   have	   been	   implicated	   in	  glioblastoma,	  particularly	  with	  regards	  to	  tumor	  proliferation.	  MDM4	  is	  known	  to	  bind	  and	  inhibit	  the	  tumor	  suppressor	  P53	  at	  its	  transcriptional	  activation	  domain,	  and	  is	  a	  target	  for	  amplification	  in	  subset	  of	  malignant	  gliomas	  (Riemenschneider	  et	  al.	  1999).	  A	  recent	  study	  implicates	   cathepsin	   B	   as	   a	   modulator	   for	   the	   self-­‐renewal	   of	   glioma-­‐initiating	   cells	  (Gopinath	   et	   al.	   2013).	   MCM4	   has	   previously	   been	   identified	   as	   a	   marker	   for	   rapidly	  proliferating	   glioblastoma	   subpopulations	   (Al-­‐Mayhani	   et	   al.	   2011).	   Given	   that	  overexpression	  of	  ADAR	  and	  ADARB1	  has	  been	  shown	  to	  suppress	  cell	  proliferation	  in	  U87	  glioblastoma	   cell	   lines	   (Cenci	   et	   al.	   2008;	   Paz	   et	   al.	   2007),	   it	   is	   possible	   that	   multiple	  mechanisms	  of	  action	  lie	  among	  these	  genes.	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Figure	   5.1:	   Notched	   boxplot	   distributions	   of	   editing	   enzyme	   expression.	   The	   top	   and	  bottom	  of	  the	  boxes	  indicate	  first	  and	  third	  quartiles	  of	  the	  data,	  respectively.	  The	  center	  black	  line	  is	  the	  median,	  and	  the	  diamond	  is	  the	  mean.	  The	  whiskers	  indicate	  the	  range	  of	  the	  data	  excluding	  outliers,	  and	  black	  dots	  indicate	  outliers.	  Outliers	  are	  considered	  to	  be	  greater	  1.5X	  the	  interquartile	  range	  (IQR)	  from	  the	  median.	  The	  notches	  are	  a	  measure	  of	  statistical	   significance:	   if	   the	  notches	   from	  two	  different	  boxes	  do	  not	  overlap,	   they	  are	  significantly	  different.	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Figure	   5.2:	   (Top)	   Distribution	   of	   filtered	   SNVs	   by	  phenotype.	   	  Enrichment	   is	  observed	  at	  50%	  and	  100%,	  corresponding	  to	  heterozygous	  and	  homozygous	  genetic	  variants,	   respectively.	   GBM	   and	   AST	   deviate	   from	   the	  50%	   expected	   pattern,	   possibly	   due	   to	   tumor	   CNV.	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Figure	   5.3:	   Probability	   density	   plots	  of	   correlation	   between	   expression	   of	  
ADAR,	   ADARB1,	   and	   ADARB2,	   and	  editing	   percentages.	   In	   normal	   brain	  tissue,	   ADARB1	   is	   most	   strongly	  correlated	   with	   editing,	   although	  ADAR	   is	   also	   significantly	   correlated.	  	  In	  AST	  and	  GBM,	  ADARB1	  has	  become	  uncoupled	   from	   editing	   percentage,	  and	  ADAR	  takes	  on	  the	  primary	  role.	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Figure	   5.4:	   Scatterplots	   for	   log	   expression	   of	   ADAR	   and	   ADARB1	   vs.	   editing	  percentage	  at	  position	  chr4:158281294	  in	  GRIA2,	  including	  linear	  model	  fit.	  	  There	  is	   no	   predictive	   power	   between	   expression	   of	   ADAR	   and	   editing	   percentage	   in	  normal	   brain.	   In	   contrast,	   expression	   of	   ADARB1	   is	   predictive	   of	   editing	  percentage	   at	   this	   position	   in	   normal	   brain.	   	  Models	   fit	   to	  GBM	   samples	  are	   not	  predictive	  for	  either	  ADAR	  or	  ADARB1.	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Figure	   5.5:	   Editing	   levels	   of	   CAMKK1	   across	   phenotype	   and	   brain	   region.	   	   The	   top	   and	  bottom	  of	  the	  boxes	  indicate	  first	  and	  third	  quartiles	  of	  the	  data.	  	  The	  center	  black	  line	  is	  the	  median,	  and	  the	  diamond	  is	  the	  mean.	  The	  whiskers	  indicate	  the	  extreme	  values,	  and	  black	  dots	   indicate	   outliers.	   Outliers	   are	   considered	   to	   be	   greater	   or	   less	   than	   1.5X	   the	  interquartile	  range	  (IQR)	  from	  the	  median.	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Figure	   5.6:	   Scatterplots	   showing	   the	   regression	   fits	   of	   expression	   of	  ADAR	   and	  
ADARB1	  with	   the	   editing	  percentage	  of	  MDM4	   (chr1:204526795).	   	  Normal	  brain	  tissue	   exhibits	   a	   correlation	   between	   expression	   of	   ADARB1	   and	   editing	  percentage	  at	  this	  position.	  	  In	  contrast,	  GBM	  exhibits	  a	  correlation	  between	  ADAR	  and	  editing	  percentage	  at	  this	  position.	  	  
	  	   	  	   	   	  103	  
Table	   5.1:	   Previously	   identified	   editing	   positions	   in	   non-­‐repetitive	   regions	   of	  expressed	  transcripts,	  sorted	  by	  FDR.	  
Gene	   Chr	   Pos	   Feature	   FDR	   AST	   GBM	   Normal	   Cere.	  
GRIA2	   4	   158257875	   CDS	   2.8e-­‐23	   75.0	   76.5	   92.6	   98.7	  
GRIA2	   4	   158281294	   CDS	   8.2e-­‐19	   23.5	   22.7	   34.4	   71.6	  
GRIA3	   X	   122598962	   CDS	   2.9e-­‐18	   45.7	   52.3	   78.0	   N/A	  
GRIA4	   11	   105804694	   CDS	   1.7e-­‐16	   30.8	   34.7	   59.0	   63.1	  
GRIK2	   6	   102372589	   CDS	   3.1e-­‐10	   24.3	   22.8	   69.8	   83.1	  
IGFBP7	   4	   57976234	   CDS	   7.9e-­‐10	   35.4	   30.2	   38.5	   49.4	  
GRIK2	   6	   102337702	   CDS	   1.5e-­‐07	   32.5	   21.0	   59.5	   77.8	  
BLCAP	   20	   36147572	   CDS	   2.9e-­‐07	   15.2	   17.5	   19.0	   22.7	  
GRIK2	   6	   102337689	   CDS	   2.5e-­‐05	   22.0	   18.5	   41.7	   34.0	  
GABRA3	   X	   151358319	   CDS	   1.5e-­‐03	   43.1	   38.7	   71.3	   N/A	  
BLCAP	   20	   36147563	   CDS	   4.3e-­‐02	   N/A	   15.5	   17.2	   18.7	  
NOVA1	   14	   26917530	   CDS	   1.3e-­‐02	   N/A	   N/A	   26.5	   31.4	  
AZIN1	   8	   103841636	   CDS	   2.9e-­‐01	   19.9	   16.9	   18.4	   N/A	  	  
Table	  5.2:	  A	  subset	  of	  differentially	  edited	  positions	  across	  brain	  phenotype	  in	  non-­‐repetitive	  regions	  of	  expressed	  transcripts.	  
Gene	   Chr	   Pos	   Feature	   FDR	   AST	   GBM	   Normal	   Cere.	  
CAMKK1	   17	   3763779	   3’UTR	   1.0e-­‐19	   50.0	   29.8	   51.9	   26.4	  
PFKP	   10	   3168694	   5’	  UTR/Intron	   4.3e-­‐11	   N/A	   21.7	   37.7	   81.1	  
BOK	   2	   242512138	   3’UTR	   6.6e-­‐11	   31.3	   29.0	   39.1	   52.1	  
NOVA2	   19	   46438778	   3’UTR	   2.1e-­‐08	   16.2	   19.7	   28.0	   46.3	  
SON	   21	   34923319	   CDS	   3.5e-­‐08	   18.4	   20.4	   27.0	   36.8	  
COPA	   1	   160302244	   CDS	   6.1e-­‐04	   19.7	   26.5	   24.4	   20.2	  	  
Table	   5.3:	   Significantly	  differentially	   edited	  positions	  by	  phenotype	   in	  Alu	   regions.	  	  Most	  of	  these	  genes	  are	  differentially	  edited	  in	  multiple	  positions	  due	  to	  hyperediting	  of	  Alu	  elements,	  but	  we	  only	  list	  the	  most	  significant	  positions	  in	  this	  table.	  	  
Gene	   Chr	   Pos	   Feature	   FDR	   AST	   GBM	   Normal	   Cere.	  
MDM4	   1	   204526795	   3’	  UTR	   4.7e-­‐36	   23.3	   30.1	   46.4	   72.9	  
CTSB	   8	   11701323	   3’	  UTR	   5.8e-­‐34	   26.0	   53.3	   35.2	   27.3	  
MCM4	   8	   48890109	   3’	  UTR	   6.8e-­‐34	   41.7	   30.1	   68.3	   77.7	  
CWF19L1	   10	   101992810	   3’	  UTR	   7.4e-­‐30	   32.5	   35.1	   65.7	   94.6	  
PDDC1	   11	   769057	   3’	  UTR	   5.4e-­‐29	   25.5	   41.6	   53.0	   72.9	  
ORC2	   2	   201774244	   3’	  UTR	   2.2e-­‐28	   41.2	   49.1	   74.3	   89.0	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CHAPTER	  6:	  CONCLUSIONS	  AND	  FUTURE	  WORK	  
RNA	   sequencing	   has	   changed	   our	   view	   of	   transcriptomics	   in	   several	  ways.	   Direct	  sequencing	  of	  expressed	  transcripts	  allows	  a	  global	  view	  of	  RNA	  species	  that	  are	  present	  in	  the	  cell,	  rather	  than	  the	  more	  restrictive	  probe-­‐based	  queries	  of	  microarrays.	  There	   is	  no	  upper	  bound	  on	  the	  dynamic	  range	  of	  measurements	  with	  RNA-­‐seq,	  whereas	  fluorescence	  measurements	  of	  microarrays	  have	  such	  limitations.	  In	  addition,	  RNA-­‐seq	  has	  revealed	  that	  RNA	  editing	  is	  far	  more	  commonplace	  than	  previously	  thought.	  However,	  these	  advantages	  are	  accompanied	  by	  novel	  difficulties	  in	  analysis.	  RNA-­‐seq	  relies	  on	  accurate	  alignment	  of	  short	   reads	   to	   a	   sequenced	   genome	   and/or	   transcriptome,	  which	   can	   be	   confounded	   by	  repetitive	   regions,	   pseudogenes,	   and	   paralogs.	   The	   identification	   of	   RNA	   editing	   sites	   is	  particularly	   susceptible	   to	   this	   effect,	   as	   editing	   occurs	   predominantly	   in	   repetitive	   Alu	  regions	  that	  comprise	  more	  than	  10%	  of	  the	  human	  genome.	  Furthermore,	  the	  discovery	  of	  biological	  relationships	  from	  heterogeneous	  populations	  of	  cells,	  tumors,	  or	  tissues	  derived	  from	   different	   individuals	   requires	   sufficient	   statistical	   power	   to	   render	   the	   conclusions	  valid.	   Such	   statistical	   power	   is	   enabled	   through	   large	   numbers	   of	   biological	   replicates,	  something	   that	   was	   lacking	   in	   early	   RNA-­‐seq	   studies	   due	   to	   the	   initial	   high	   expense.	  However,	  modern	  databases	  such	  as	  the	  Sequence	  Read	  Archive	  (Leinonen	  et	  al.	  2010)	  and	  The	   Cancer	   Genome	   Atlas	   contain	   terabases	   of	   sequence	   data	   that	   can	   be	   leveraged	   to	  identify	  new	  biological	  relationships,	  and	  the	  rate	  of	  generation	  of	  short	  read	  sequencing	  data	   is	   accelerating.	   The	   bottleneck	   is	   now	   the	   computational	   pipelines	   that	   have	   been	  developed	   to	   analyze	   this	   data.	   To	   address	   this	   issue	   I	   have	   developed	   SNAP-­‐RNA,	   a	  software	   package	   that	   accelerates	   the	   analysis	   of	   RNA-­‐seq	   datasets	   by	   an	   order	   of	  magnitude	   over	   the	   most	   commonly	   used	   tools	   today,	   while	   maintaining	   the	   highest	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standard	  in	  accuracy.	  Furthermore,	  SNAP-­‐RNA	  automatically	  performs	  additional	  analyses,	  generating	   aligned	   read	   counts,	   reporting	   on	   viral	   infections	   or	   bacterial/fungal	  contamination,	   and	   identifying	   intra-­‐	   and	   inter-­‐chromosomal	   gene	   fusions.	   SNAP-­‐RNA	  enables	   large-­‐scale	   analysis	   of	   hundreds	   or	   thousands	   of	   RNA-­‐seq	   samples	   in	   a	   feasible	  amount	  of	  time	  and	  at	  low	  cost.	  	  	   A	  major	  limitation	  in	  the	  analysis	  of	  short	  read	  sequencing	  data	  is	  the	  quantification	  of	   transcript	   isoform	  expression,	  as	  opposed	   to	  overall	  gene	  expression.	  Tools	  have	  been	  developed	  that	  attempt	  to	  quantify	  individual	  transcript	  expression	  for	  biological	  samples,	  such	  as	  Cufflinks	  (Trapnell	  et	  al.	  2010),	  as	  well	  as	  exon-­‐level	  expression,	  such	  as	  DEXSeq	  (Anders	   et	   al.	   2012).	   Unfortunately,	   reads	   usually	   cannot	   be	   associated	   with	   specific	  isoforms,	  as	  it	  is	  common	  for	  exons	  to	  be	  shared	  across	  multiple	  annotated	  transcripts.	  This	  necessitates	   fitting	   likelihood	   models	   to	   the	   observed	   data	   and	   attempting	   to	   estimate	  isoform	  expression	  based	  on	  the	  model,	  which	  is	  error-­‐prone	  and	  hence	  unreliable.	  Reads	  that	   cross	   annotated	   splice	   junctions	   are	   another	   source	   of	   evidence	   for	   the	   presence	   of	  particular	   isoforms,	  but	   like	  exons,	  splice	   junctions	  are	  commonly	  shared	  across	  multiple	  transcripts.	  Ultimately,	  true	  accuracy	  in	  isoform	  quantification	  will	  come	  with	  longer	  read	  lengths	   that	   can	  be	  uniquely	   associated	  with	   specific	   isoforms.	  As	   IlluminaTM	   sequencing	  technology	  is	  expected	  to	  yield	  longer	  read	  lengths	  in	  the	  near	  future	  (200-­‐300	  bp),	  future	  work	   with	   SNAP-­‐RNA	   will	   focus	   on	   accurate	   isoform	   quantification	   using	   annotated	  transcripts	  and	  longer	  reads.	  As	   mentioned	   above,	   exons	   are	   commonly	   associated	   with	   multiple	   annotated	  transcripts,	   preventing	   accurate	   quantification	   of	   isoform	  expression	   from	  aligned	   reads.	  One	  notable	  exception	  is	  the	  flip/flop	  splice	  variants	  of	  alpha-­‐amino-­‐3-­‐hydroxy-­‐5-­‐methyl-­‐
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4-­‐isoxazole-­‐propionate	  (AMPA)	  receptors	  in	  the	  mammalian	  central	  nervous	  system,	  which	  govern	  the	  electrophysiology	  of	  the	  ion	  channels	  (Sommer	  et	  al.	  1990).	  Interestingly,	  these	  AMPA	  receptors	  contain	  several	  of	  the	  most	  highly	  studied	  RNA	  editing	  sites,	  the	  physical	  effect	   of	   which	   is	   to	   modulate	   calcium	   signaling	   through	   the	   channel.	   Both	   alternative	  splicing	  and	  RNA	  editing	  therefore	  play	  a	  role	  in	  generating	  diversity	  in	  the	  brain	  through	  ion	  channel	  permeability.	  The	  second	  part	  of	  my	  research	  was	  focused	  on	  RNA	  editing	   in	  human	   brain,	   and	   how	   it	   is	   altered	   in	   different	   brain	   regions	   and	   glioma.	  Using	   a	   highly	  accurate	  RNA	  editing	  discovery	  pipeline	  that	  I	  developed	  using	  SNAP-­‐RNA,	  I	  analyzed	  over	  400	  RNA-­‐seq	  samples	  from	  grade	  II	  and	  III	  astrocytoma,	  grade	  IV	  glioblastoma	  multiforme,	  and	  normal	   samples	  derived	   from	   ten	  brain	   regions.	  This	  was	   the	   first	   study	   to	   examine	  transcriptome-­‐wide	  differential	  RNA	  editing,	  and	  the	  largest	  study	  examining	  RNA	  editing	  to	   date.	   The	   results	   of	   this	   study	   revealed	   that	   expression	   of	   the	   editing	   enzymes	  ADAR,	  
ADARB1,	  and	  ADARB2	   exhibit	   altered	   expression	   in	   different	   regions	   of	   the	   human	  brain	  and	  glioma.	  In	  particular,	  ADAR	  is	  overexpressed	  in	  glioma	  relative	  to	  normal	  brain,	  while	  
ADARB1	   is	   overexpressed	   in	   cerebellum.	   ADARB2	   is	   characteristically	   repressed	   in	  glioblastoma	  but	  not	  in	  other	  forms	  of	  astrocytoma.	  Furthermore,	  the	  breadth	  of	  this	  study	  allowed	  me	   to	   test	   the	   correlations	   between	   expression	   of	   the	   editing	   enzymes	   and	   the	  editing	   levels	   in	   each	   phenotype,	   revealing	   that	  ADARB1	   tends	   to	   correlate	   with	   editing	  percentage	   in	   normal	   brain	   while	   ADAR	   tends	   to	   correlate	   with	   editing	   percentage	   in	  glioma,	  consistent	  with	  the	  gene	  expression	  patterns	  observed	  in	  these	  phenotypes.	  Finally,	  I	   identified	   thousands	  of	  differentially	  edited	  bases	   in	   the	  human	   transcriptome	  between	  glioma	   and	   normal	   brain.	   The	  most	   significantly	   differentially	   edited	   sites	   include	   those	  already	  characterized	  in	  the	  brain,	  such	  as	  the	  aforementioned	  AMPA	  receptors,	  as	  well	  as	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many	   novel	   sites	   that	   have	   not	   previously	   been	   studied	   for	   their	   phenotypic	   effects	   in	  glioma.	   Several	   of	   these	   editing	   sites	   have	   now	   been	   externally	   validated	   using	   Sanger	  sequencing	   of	   primary	   tumor	   and	   normal	   brain	   tissue	   samples,	   demonstrating	   that	   the	  changes	  in	  editing	  percentage	  are	  consistent	  with	  what	  we	  observed	  using	  next-­‐generation	  sequencing	  data.	  However,	   there	   still	   remains	  much	  work	   to	  be	  done	   to	   characterize	   the	  phenotypic	  effects	  of	  these	  edits.	  Many	  of	  the	  most	  highly	  differentially	  edited	  bases	  in	  both	  non-­‐repetitive	   and	   repetitive	   Alu	   regions	   are	   localized	   in	   the	   UTR	   of	   their	   respective	  transcripts,	  suggesting	  a	  possible	  regulatory	  role	  for	  the	  edit	  rather	  than	  a	  coding	  change.	  Selected	  reaction	  monitoring	  (SRM)	  experiments	  are	  underway	  to	  quantitatively	  measure	  protein	  levels	  of	  ADAR,	  ADARB1,	  and	  ADARB2	  in	  the	  obtained	  tissue	  samples,	   in	  order	  to	  correlate	   protein	   levels	   with	   measured	   editing	   levels	   observed	   in	   both	   next	   generation	  sequencing	  and	  Sanger	   sequencing.	  Furthermore,	   experiments	  are	  being	  designed	   to	   test	  the	   functional	   effects	   of	   CAMKK1	   editing	   using	   calcium	   signaling	   assays.	   A	   specific	  differentially	   edited	   position	   in	   AZIN1	   was	   recently	   associated	   with	   accelerated	   tumor	  growth	   in	   hepatocellular	   carcinoma	   (Leilei	   Chen	   et	   al.	   2013).	   It	   is	   possible	   that	   our	  identified	   differentially	   edited	   positions	   may	   in	   turn	   be	   associated	   with	   glioblastoma	  multiforme	   progression.	   Future	   research	   will	   attempt	   to	   characterize	   these	   editing	  positions	  for	  phenotypic	  effects.	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